5545f05eee
Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>
343 KiB
343 KiB
| 1 | Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies. | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2 | Subject | Subject Data Revision | Screen No. | Age | Age Unit | Gender | Visit | Visit Data Revision | Collected Time | Accession | Test Group | Test | Administrative Question | Value | Result Data Revision | Flags | Cancellation Reason | Comments | Range | Units |
| 3 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | May 13, 2026 8:15 AM | 6228234298 | C-REACTIVE PROTEIN | C Reactive Protein HS | 2.2 | 0 - 5 | mg/L | ||||||||
| 4 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | May 13, 2026 8:15 AM | 6228234298 | CHEMISTRY PANEL | Total Bilirubin | 5 | 3 - 21 | umol/L | ||||||||
| 5 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | May 13, 2026 8:15 AM | 6228234298 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 2.3 | 0 - 6.2 | umol/L | ||||||||
| 6 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | May 13, 2026 8:15 AM | 6228234298 | CHEMISTRY PANEL | Alkaline Phosphatase | 59 | 35 - 104 | U/L | ||||||||
| 7 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | May 13, 2026 8:15 AM | 6228234298 | CHEMISTRY PANEL | ALT (SGPT) | 20 | 4 - 43 | U/L | ||||||||
| 8 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | May 13, 2026 8:15 AM | 6228234298 | CHEMISTRY PANEL | AST (SGOT) | 24 | 8 - 40 | U/L | ||||||||
| 9 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | May 13, 2026 8:15 AM | 6228234298 | CHEMISTRY PANEL | GGT | 27 | 4 - 49 | U/L | ||||||||
| 10 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | May 13, 2026 8:15 AM | 6228234298 | CHEMISTRY PANEL | LDH | 176 | 53 - 234 | U/L | ||||||||
| 11 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | May 13, 2026 8:15 AM | 6228234298 | CHEMISTRY PANEL | Urea Nitrogen | 4.3 | 1.4 - 8.6 | mmol/L | ||||||||
| 12 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | May 13, 2026 8:15 AM | 6228234298 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 74 | 31 - 101 | umol/L | ||||||||
| 13 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | May 13, 2026 8:15 AM | 6228234298 | CHEMISTRY PANEL | Glucose Fasting | 4.7 | 3.9 - 5.6 | mmol/L | ||||||||
| 14 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | May 13, 2026 8:15 AM | 6228234298 | CHEMISTRY PANEL | Serum Uric Acid | 289 | 149 - 446 | umol/L | ||||||||
| 15 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | May 13, 2026 8:15 AM | 6228234298 | CHEMISTRY PANEL | Calcium (EDTA) | 2.38 | 2.07 - 2.64 | mmol/L | ||||||||
| 16 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | May 13, 2026 8:15 AM | 6228234298 | CHEMISTRY PANEL | Phosphorus | 1.12 | 0.71 - 1.65 | mmol/L | ||||||||
| 17 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | May 13, 2026 8:15 AM | 6228234298 | CHEMISTRY PANEL | Total Protein | 71 | 61 - 84 | g/L | ||||||||
| 18 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | May 13, 2026 8:15 AM | 6228234298 | CHEMISTRY PANEL | Albumin-BCG | 46 | 33 - 49 | g/L | ||||||||
| 19 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | May 13, 2026 8:15 AM | 6228234298 | CHEMISTRY PANEL | Creatine Kinase | 263 | H | 26 - 192 | U/L | |||||||
| 20 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | May 13, 2026 8:15 AM | 6228234298 | CHEMISTRY PANEL | Serum Sodium | 139 | 132 - 147 | mmol/L | ||||||||
| 21 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | May 13, 2026 8:15 AM | 6228234298 | CHEMISTRY PANEL | Serum Potassium | 4.5 | 3.5 - 5.2 | mmol/L | ||||||||
| 22 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | May 13, 2026 8:15 AM | 6228234298 | CHEMISTRY PANEL | Serum Bicarbonate | 23.3 | 19.3 - 29.3 | mmol/L | ||||||||
| 23 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | May 13, 2026 8:15 AM | 6228234298 | CHEMISTRY PANEL | Serum Chloride | 102 | 94 - 112 | mmol/L | ||||||||
| 24 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | May 13, 2026 8:15 AM | 6228234298 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 139 | Result verified by repeat analysis | 116 - 164 | g/L | |||||||
| 25 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | May 13, 2026 8:15 AM | 6228234298 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.40 | Result verified by repeat analysis | 0.34 - 0.48 | ||||||||
| 26 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | May 13, 2026 8:15 AM | 6228234298 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.4 | Result verified by repeat analysis | 4.1 - 5.6 | TI/L | |||||||
| 27 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | May 13, 2026 8:15 AM | 6228234298 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | Normocytic | NORMOCYTIC;$NORMOCHROMIC | |||||||||
| 28 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | May 13, 2026 8:15 AM | 6228234298 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 92 | Result verified by repeat analysis | 79 - 98 | fL | |||||||
| 29 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | May 13, 2026 8:15 AM | 6228234298 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 7.14 | Result verified by repeat analysis | 3.8 - 10.7 | GI/L | |||||||
| 30 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | May 13, 2026 8:15 AM | 6228234298 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 4.07 | 1.96 - 7.23 | GI/L | ||||||||
| 31 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | May 13, 2026 8:15 AM | 6228234298 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 2.57 | 0.91 - 4.28 | GI/L | ||||||||
| 32 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | May 13, 2026 8:15 AM | 6228234298 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.29 | 0.12 - 0.92 | GI/L | ||||||||
| 33 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | May 13, 2026 8:15 AM | 6228234298 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.14 | 0 - 0.57 | GI/L | ||||||||
| 34 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | May 13, 2026 8:15 AM | 6228234298 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.07 | 0 - 0.2 | GI/L | ||||||||
| 35 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | May 13, 2026 8:15 AM | 6228234298 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 57.0 | 40.5 - 75 | % | ||||||||
| 36 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | May 13, 2026 8:15 AM | 6228234298 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 36.0 | 15.4 - 48.5 | % | ||||||||
| 37 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | May 13, 2026 8:15 AM | 6228234298 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 4.0 | 2.6 - 10.1 | % | ||||||||
| 38 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | May 13, 2026 8:15 AM | 6228234298 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 2.0 | 0 - 6.8 | % | ||||||||
| 39 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | May 13, 2026 8:15 AM | 6228234298 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 1.0 | 0 - 2 | % | ||||||||
| 40 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | May 13, 2026 8:15 AM | 6228234298 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 309 | Result verified by repeat analysis | 140 - 400 | GI/L | |||||||
| 41 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | May 13, 2026 8:15 AM | 6228234298 | HEMOGLOBIN A1C | Hemoglobin A1c,NGSP-RM | 5.1 | <6.5 % | |||||||||
| 42 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | May 13, 2026 8:15 AM | 6228234298 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | 4.37 | 1.9 - 23 | uIU/mL | ||||||||
| 43 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | May 13, 2026 8:15 AM | 6228234298 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||
| 44 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | May 13, 2026 8:15 AM | 6228234298 | LIPID PANEL | Direct HDL-C 4th Generation | 1.79 | H | 1.03 - 1.53 | mmol/L | |||||||
| 45 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | May 13, 2026 8:15 AM | 6228234298 | LIPID PANEL | Triglycerides (GPO) | 1.51 | 0.59 - 2.96 | mmol/L | ||||||||
| 46 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | May 13, 2026 8:15 AM | 6228234298 | LIPID PANEL | Cholesterol (High Performance) | 5.75 | 4.42 - 7.53 | mmol/L | ||||||||
| 47 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | May 13, 2026 8:15 AM | 6228234298 | LIPID PANEL | LDL Chol Friedewald 4th | 3.27 | 0 - 3.34 | mmol/L | ||||||||
| 48 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | May 13, 2026 8:15 AM | 6228234298 | RETICULOCYTES | Reticulocyte Count % | 1.2 | 0.6 - 2.5 | % | ||||||||
| 49 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | May 13, 2026 8:15 AM | 6228234298 | TSH | TSH 3rd IS-QT | 4.824 | 0.45 - 5.33 | mIU/L | ||||||||
| 50 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | May 13, 2026 8:15 AM | 6228234298 | URINE MACRO PANEL | Ur Specific Gravity | 1.029 | 1 - 1.04 | |||||||||
| 51 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | May 13, 2026 8:15 AM | 6228234298 | URINE MACRO PANEL | Ur pH | 5.5 | 5 - 8 | |||||||||
| 52 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | May 13, 2026 8:15 AM | 6228234298 | URINE MACRO PANEL | Ur Protein | Negative | Ref Rng:Negative | |||||||||
| 53 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | May 13, 2026 8:15 AM | 6228234298 | URINE MACRO PANEL | Ur Glucose | Normal | Ref Rng:Normal | |||||||||
| 54 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | May 13, 2026 8:15 AM | 6228234298 | URINE MACRO PANEL | Ur Ketones | Negative | Ref Rng:Negative | |||||||||
| 55 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | May 13, 2026 8:15 AM | 6228234298 | URINE MACRO PANEL | Ur Bilirubin | Negative | Ref Rng:Negative | |||||||||
| 56 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | May 13, 2026 8:15 AM | 6228234298 | URINE MACRO PANEL | Ur Urobilinogen | Normal | Ref Rng:Normal | |||||||||
| 57 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | May 13, 2026 8:15 AM | 6228234298 | URINE MACRO PANEL | Ur Blood | Negative | Ref Rng:$Negative-Trace | |||||||||
| 58 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | May 13, 2026 8:15 AM | 6228234298 | URINE MACRO PANEL | Ur Nitrite | Negative | Ref Rng:Negative | |||||||||
| 59 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | May 13, 2026 8:15 AM | 6228234298 | URINE MACRO PANEL | Ur Leukocyte Esterase | Negative | Ref Rng:Negative | |||||||||
| 60 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | May 4, 2026 8:44 AM | 6228234297 | C-REACTIVE PROTEIN | C Reactive Protein HS | 7.3 | H | 0 - 5 | mg/L | |||||||
| 61 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | May 4, 2026 8:44 AM | 6228234297 | CHEMISTRY PANEL | Total Bilirubin | 11 | 3 - 21 | umol/L | ||||||||
| 62 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | May 4, 2026 8:44 AM | 6228234297 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 4.9 | 0 - 6.2 | umol/L | ||||||||
| 63 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | May 4, 2026 8:44 AM | 6228234297 | CHEMISTRY PANEL | Alkaline Phosphatase | 80 | 40 - 129 | U/L | ||||||||
| 64 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | May 4, 2026 8:44 AM | 6228234297 | CHEMISTRY PANEL | ALT (SGPT) | 163 | H RX | 5 - 48 | U/L | |||||||
| 65 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | May 4, 2026 8:44 AM | 6228234297 | CHEMISTRY PANEL | AST (SGOT) | 127 | H RX | 8 - 40 | U/L | |||||||
| 66 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | May 4, 2026 8:44 AM | 6228234297 | CHEMISTRY PANEL | GGT | 350 | HT | Result verified by repeat analysis | 10 - 50 | U/L | ||||||
| 67 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | May 4, 2026 8:44 AM | 6228234297 | CHEMISTRY PANEL | LDH | 224 | 53 - 234 | U/L | ||||||||
| 68 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | May 4, 2026 8:44 AM | 6228234297 | CHEMISTRY PANEL | Urea Nitrogen | 4.1 | 1.4 - 8.6 | mmol/L | ||||||||
| 69 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | May 4, 2026 8:44 AM | 6228234297 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 106 | 40 - 119 | umol/L | ||||||||
| 70 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | May 4, 2026 8:44 AM | 6228234297 | CHEMISTRY PANEL | Glucose Fasting | 6.1 | H | 3.9 - 5.6 | mmol/L | |||||||
| 71 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | May 4, 2026 8:44 AM | 6228234297 | CHEMISTRY PANEL | Serum Uric Acid | 512 | H | 149 - 494 | umol/L | |||||||
| 72 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | May 4, 2026 8:44 AM | 6228234297 | CHEMISTRY PANEL | Calcium (EDTA) | 2.39 | 2.07 - 2.64 | mmol/L | ||||||||
| 73 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | May 4, 2026 8:44 AM | 6228234297 | CHEMISTRY PANEL | Phosphorus | 0.81 | 0.71 - 1.65 | mmol/L | ||||||||
| 74 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | May 4, 2026 8:44 AM | 6228234297 | CHEMISTRY PANEL | Total Protein | 77 | 60 - 80 | g/L | ||||||||
| 75 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | May 4, 2026 8:44 AM | 6228234297 | CHEMISTRY PANEL | Albumin-BCG | 48 | 33 - 49 | g/L | ||||||||
| 76 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | May 4, 2026 8:44 AM | 6228234297 | CHEMISTRY PANEL | Creatine Kinase | 348 | H | 39 - 308 | U/L | |||||||
| 77 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | May 4, 2026 8:44 AM | 6228234297 | CHEMISTRY PANEL | Serum Sodium | 137 | 135 - 145 | mmol/L | ||||||||
| 78 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | May 4, 2026 8:44 AM | 6228234297 | CHEMISTRY PANEL | Serum Potassium | 4.3 | 3.5 - 5.2 | mmol/L | ||||||||
| 79 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | May 4, 2026 8:44 AM | 6228234297 | CHEMISTRY PANEL | Serum Bicarbonate | 21.3 | 19.3 - 29.3 | mmol/L | ||||||||
| 80 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | May 4, 2026 8:44 AM | 6228234297 | CHEMISTRY PANEL | Serum Chloride | 100 | 94 - 112 | mmol/L | ||||||||
| 81 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | May 4, 2026 8:44 AM | 6228234297 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 134 | 125 - 170 | g/L | ||||||||
| 82 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | May 4, 2026 8:44 AM | 6228234297 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.41 | 0.37 - 0.51 | |||||||||
| 83 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | May 4, 2026 8:44 AM | 6228234297 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.1 | 4 - 5.8 | TI/L | ||||||||
| 84 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | May 4, 2026 8:44 AM | 6228234297 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||
| 85 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | May 4, 2026 8:44 AM | 6228234297 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 100 | 80 - 100 | fL | ||||||||
| 86 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | May 4, 2026 8:44 AM | 6228234297 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 3.89 | 3.8 - 10.7 | GI/L | ||||||||
| 87 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | May 4, 2026 8:44 AM | 6228234297 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 2.35 | 1.96 - 7.23 | GI/L | ||||||||
| 88 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | May 4, 2026 8:44 AM | 6228234297 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.13 | 0.8 - 3 | GI/L | ||||||||
| 89 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | May 4, 2026 8:44 AM | 6228234297 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.34 | 0.12 - 0.92 | GI/L | ||||||||
| 90 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | May 4, 2026 8:44 AM | 6228234297 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.03 | 0 - 0.57 | GI/L | ||||||||
| 91 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | May 4, 2026 8:44 AM | 6228234297 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.04 | 0 - 0.2 | GI/L | ||||||||
| 92 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | May 4, 2026 8:44 AM | 6228234297 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 60.5 | 40.5 - 75 | % | ||||||||
| 93 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | May 4, 2026 8:44 AM | 6228234297 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 29.0 | 15.4 - 48.5 | % | ||||||||
| 94 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | May 4, 2026 8:44 AM | 6228234297 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 8.7 | 2.6 - 10.1 | % | ||||||||
| 95 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | May 4, 2026 8:44 AM | 6228234297 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 0.9 | 0 - 6.8 | % | ||||||||
| 96 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | May 4, 2026 8:44 AM | 6228234297 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 0.9 | 0 - 2 | % | ||||||||
| 97 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | May 4, 2026 8:44 AM | 6228234297 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 137 | R | L | 140 - 400 | GI/L | ||||||
| 98 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | May 4, 2026 8:44 AM | 6228234297 | HEMOGLOBIN A1C | Hemoglobin A1c,NGSP-RM | 6.3 | <6.5 % | |||||||||
| 99 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | May 4, 2026 8:44 AM | 6228234297 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | 30.61 | H | 1.9 - 23 | uIU/mL | |||||||
| 100 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | May 4, 2026 8:44 AM | 6228234297 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||
| 101 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | May 4, 2026 8:44 AM | 6228234297 | LIPID PANEL | Direct HDL-C 4th Generation | 1.03 | 1.03 - 1.53 | mmol/L | ||||||||
| 102 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | May 4, 2026 8:44 AM | 6228234297 | LIPID PANEL | Triglycerides (GPO) | 2.89 | 0.65 - 3.61 | mmol/L | ||||||||
| 103 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | May 4, 2026 8:44 AM | 6228234297 | LIPID PANEL | Cholesterol (High Performance) | 4.82 | 4.4 - 7.53 | mmol/L | ||||||||
| 104 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | May 4, 2026 8:44 AM | 6228234297 | LIPID PANEL | LDL Chol Friedewald 4th | 2.47 | 0 - 3.34 | mmol/L | ||||||||
| 105 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | May 4, 2026 8:44 AM | 6228234297 | RETICULOCYTES | Reticulocyte Count % | 1.5 | 0.6 - 2.5 | % | ||||||||
| 106 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | May 4, 2026 8:44 AM | 6228234297 | TSH | TSH 3rd IS-QT | 1.982 | 0.45 - 5.33 | mIU/L | ||||||||
| 107 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | May 4, 2026 8:44 AM | 6228234297 | URINE MACRO PANEL | Ur Specific Gravity | 1.010 | 1.01 - 1.03 | |||||||||
| 108 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | May 4, 2026 8:44 AM | 6228234297 | URINE MACRO PANEL | Ur pH | 5.5 | 5 - 8 | |||||||||
| 109 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | May 4, 2026 8:44 AM | 6228234297 | URINE MACRO PANEL | Ur Protein | Negative | Ref Rng:Negative | |||||||||
| 110 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | May 4, 2026 8:44 AM | 6228234297 | URINE MACRO PANEL | Ur Glucose | Normal | Ref Rng:Normal | |||||||||
| 111 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | May 4, 2026 8:44 AM | 6228234297 | URINE MACRO PANEL | Ur Ketones | Negative | Ref Rng:Negative | |||||||||
| 112 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | May 4, 2026 8:44 AM | 6228234297 | URINE MACRO PANEL | Ur Bilirubin | Negative | Ref Rng:Negative | |||||||||
| 113 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | May 4, 2026 8:44 AM | 6228234297 | URINE MACRO PANEL | Ur Urobilinogen | Normal | Ref Rng:Normal | |||||||||
| 114 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | May 4, 2026 8:44 AM | 6228234297 | URINE MACRO PANEL | Ur Blood | Negative | Ref Rng:Negative | |||||||||
| 115 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | May 4, 2026 8:44 AM | 6228234297 | URINE MACRO PANEL | Ur Nitrite | Negative | Ref Rng:Negative | |||||||||
| 116 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | May 4, 2026 8:44 AM | 6228234297 | URINE MACRO PANEL | Ur Leukocyte Esterase | Negative | Ref Rng:Negative | |||||||||
| 117 | CZ100110010 | 25 | years | Male | End of Phase/Treatment | Apr 21, 2026 10:37 AM | 6228234300 | C-REACTIVE PROTEIN | C Reactive Protein HS | 0.9 | 0 - 5 | mg/L | ||||||||
| 118 | CZ100110010 | 25 | years | Male | End of Phase/Treatment | Apr 21, 2026 10:37 AM | 6228234300 | CHEMISTRY PANEL | Total Bilirubin | 8 | 3 - 21 | umol/L | ||||||||
| 119 | CZ100110010 | 25 | years | Male | End of Phase/Treatment | Apr 21, 2026 10:37 AM | 6228234300 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 3.0 | 0 - 6.2 | umol/L | ||||||||
| 120 | CZ100110010 | 25 | years | Male | End of Phase/Treatment | Apr 21, 2026 10:37 AM | 6228234300 | CHEMISTRY PANEL | Alkaline Phosphatase | 92 | 40 - 129 | U/L | ||||||||
| 121 | CZ100110010 | 25 | years | Male | End of Phase/Treatment | Apr 21, 2026 10:37 AM | 6228234300 | CHEMISTRY PANEL | ALT (SGPT) | 19 | 5 - 48 | U/L | ||||||||
| 122 | CZ100110010 | 25 | years | Male | End of Phase/Treatment | Apr 21, 2026 10:37 AM | 6228234300 | CHEMISTRY PANEL | AST (SGOT) | 14 | 8 - 40 | U/L | ||||||||
| 123 | CZ100110010 | 25 | years | Male | End of Phase/Treatment | Apr 21, 2026 10:37 AM | 6228234300 | CHEMISTRY PANEL | GGT | 13 | 10 - 61 | U/L | ||||||||
| 124 | CZ100110010 | 25 | years | Male | End of Phase/Treatment | Apr 21, 2026 10:37 AM | 6228234300 | CHEMISTRY PANEL | LDH | 144 | 53 - 234 | U/L | ||||||||
| 125 | CZ100110010 | 25 | years | Male | End of Phase/Treatment | Apr 21, 2026 10:37 AM | 6228234300 | CHEMISTRY PANEL | Urea Nitrogen | 4.6 | 1.4 - 8.6 | mmol/L | ||||||||
| 126 | CZ100110010 | 25 | years | Male | End of Phase/Treatment | Apr 21, 2026 10:37 AM | 6228234300 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 92 | 40 - 110 | umol/L | ||||||||
| 127 | CZ100110010 | 25 | years | Male | End of Phase/Treatment | Apr 21, 2026 10:37 AM | 6228234300 | CHEMISTRY PANEL | Glucose Fasting | 5.1 | 3.9 - 5.6 | mmol/L | ||||||||
| 128 | CZ100110010 | 25 | years | Male | End of Phase/Treatment | Apr 21, 2026 10:37 AM | 6228234300 | CHEMISTRY PANEL | Serum Uric Acid | 249 | 125 - 488 | umol/L | ||||||||
| 129 | CZ100110010 | 25 | years | Male | End of Phase/Treatment | Apr 21, 2026 10:37 AM | 6228234300 | CHEMISTRY PANEL | Calcium (EDTA) | 2.51 | 2.07 - 2.64 | mmol/L | ||||||||
| 130 | CZ100110010 | 25 | years | Male | End of Phase/Treatment | Apr 21, 2026 10:37 AM | 6228234300 | CHEMISTRY PANEL | Phosphorus | 0.97 | 0.71 - 1.65 | mmol/L | ||||||||
| 131 | CZ100110010 | 25 | years | Male | End of Phase/Treatment | Apr 21, 2026 10:37 AM | 6228234300 | CHEMISTRY PANEL | Total Protein | 72 | 61 - 84 | g/L | ||||||||
| 132 | CZ100110010 | 25 | years | Male | End of Phase/Treatment | Apr 21, 2026 10:37 AM | 6228234300 | CHEMISTRY PANEL | Albumin-BCG | 50 | R | H | 33 - 49 | g/L | ||||||
| 133 | CZ100110010 | 25 | years | Male | End of Phase/Treatment | Apr 21, 2026 10:37 AM | 6228234300 | CHEMISTRY PANEL | Creatine Kinase | 224 | 39 - 308 | U/L | ||||||||
| 134 | CZ100110010 | 25 | years | Male | End of Phase/Treatment | Apr 21, 2026 10:37 AM | 6228234300 | CHEMISTRY PANEL | Serum Sodium | 138 | 132 - 147 | mmol/L | ||||||||
| 135 | CZ100110010 | 25 | years | Male | End of Phase/Treatment | Apr 21, 2026 10:37 AM | 6228234300 | CHEMISTRY PANEL | Serum Potassium | 4.1 | 3.5 - 5.2 | mmol/L | ||||||||
| 136 | CZ100110010 | 25 | years | Male | End of Phase/Treatment | Apr 21, 2026 10:37 AM | 6228234300 | CHEMISTRY PANEL | Serum Bicarbonate | 27.9 | 19.3 - 29.3 | mmol/L | ||||||||
| 137 | CZ100110010 | 25 | years | Male | End of Phase/Treatment | Apr 21, 2026 10:37 AM | 6228234300 | CHEMISTRY PANEL | Serum Chloride | 98 | 94 - 112 | mmol/L | ||||||||
| 138 | CZ100110010 | 25 | years | Male | End of Phase/Treatment | Apr 21, 2026 10:37 AM | 6228234300 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 145 | 127 - 181 | g/L | ||||||||
| 139 | CZ100110010 | 25 | years | Male | End of Phase/Treatment | Apr 21, 2026 10:37 AM | 6228234300 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.44 | 0.39 - 0.54 | |||||||||
| 140 | CZ100110010 | 25 | years | Male | End of Phase/Treatment | Apr 21, 2026 10:37 AM | 6228234300 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.9 | 4.5 - 6.4 | TI/L | ||||||||
| 141 | CZ100110010 | 25 | years | Male | End of Phase/Treatment | Apr 21, 2026 10:37 AM | 6228234300 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||
| 142 | CZ100110010 | 25 | years | Male | End of Phase/Treatment | Apr 21, 2026 10:37 AM | 6228234300 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 90 | 79 - 96 | fL | ||||||||
| 143 | CZ100110010 | 25 | years | Male | End of Phase/Treatment | Apr 21, 2026 10:37 AM | 6228234300 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 4.75 | 3.8 - 10.7 | GI/L | ||||||||
| 144 | CZ100110010 | 25 | years | Male | End of Phase/Treatment | Apr 21, 2026 10:37 AM | 6228234300 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 3.09 | 1.96 - 7.23 | GI/L | ||||||||
| 145 | CZ100110010 | 25 | years | Male | End of Phase/Treatment | Apr 21, 2026 10:37 AM | 6228234300 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.22 | 0.91 - 4.28 | GI/L | ||||||||
| 146 | CZ100110010 | 25 | years | Male | End of Phase/Treatment | Apr 21, 2026 10:37 AM | 6228234300 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.35 | 0.12 - 0.92 | GI/L | ||||||||
| 147 | CZ100110010 | 25 | years | Male | End of Phase/Treatment | Apr 21, 2026 10:37 AM | 6228234300 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.06 | 0 - 0.57 | GI/L | ||||||||
| 148 | CZ100110010 | 25 | years | Male | End of Phase/Treatment | Apr 21, 2026 10:37 AM | 6228234300 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.03 | 0 - 0.2 | GI/L | ||||||||
| 149 | CZ100110010 | 25 | years | Male | End of Phase/Treatment | Apr 21, 2026 10:37 AM | 6228234300 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 65.0 | 40.5 - 75 | % | ||||||||
| 150 | CZ100110010 | 25 | years | Male | End of Phase/Treatment | Apr 21, 2026 10:37 AM | 6228234300 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 25.8 | 15.4 - 48.5 | % | ||||||||
| 151 | CZ100110010 | 25 | years | Male | End of Phase/Treatment | Apr 21, 2026 10:37 AM | 6228234300 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 7.3 | 2.6 - 10.1 | % | ||||||||
| 152 | CZ100110010 | 25 | years | Male | End of Phase/Treatment | Apr 21, 2026 10:37 AM | 6228234300 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 1.4 | 0 - 6.8 | % | ||||||||
| 153 | CZ100110010 | 25 | years | Male | End of Phase/Treatment | Apr 21, 2026 10:37 AM | 6228234300 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 0.6 | 0 - 2 | % | ||||||||
| 154 | CZ100110010 | 25 | years | Male | End of Phase/Treatment | Apr 21, 2026 10:37 AM | 6228234300 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 216 | 140 - 400 | GI/L | ||||||||
| 155 | CZ100110010 | 25 | years | Male | End of Phase/Treatment | Apr 21, 2026 10:37 AM | 6228234300 | HEMOGLOBIN A1C | Hemoglobin A1c,NGSP-RM | 5.3 | <6.5 % | |||||||||
| 156 | CZ100110010 | 25 | years | Male | End of Phase/Treatment | Apr 21, 2026 10:37 AM | 6228234300 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | 4.44 | 1.9 - 23 | uIU/mL | ||||||||
| 157 | CZ100110010 | 25 | years | Male | End of Phase/Treatment | Apr 21, 2026 10:37 AM | 6228234300 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||
| 158 | CZ100110010 | 25 | years | Male | End of Phase/Treatment | Apr 21, 2026 10:37 AM | 6228234300 | LIPID PANEL | Direct HDL-C 4th Generation | 1.34 | 1.03 - 1.53 | mmol/L | ||||||||
| 159 | CZ100110010 | 25 | years | Male | End of Phase/Treatment | Apr 21, 2026 10:37 AM | 6228234300 | LIPID PANEL | Triglycerides (GPO) | 0.59 | 0.5 - 2.81 | mmol/L | ||||||||
| 160 | CZ100110010 | 25 | years | Male | End of Phase/Treatment | Apr 21, 2026 10:37 AM | 6228234300 | LIPID PANEL | Cholesterol (High Performance) | 3.92 | 3.31 - 6.1 | mmol/L | ||||||||
| 161 | CZ100110010 | 25 | years | Male | End of Phase/Treatment | Apr 21, 2026 10:37 AM | 6228234300 | LIPID PANEL | LDL Chol Friedewald 4th | 2.31 | 0 - 3.34 | mmol/L | ||||||||
| 162 | CZ100110010 | 25 | years | Male | End of Phase/Treatment | Apr 21, 2026 10:37 AM | 6228234300 | RETICULOCYTES | Reticulocyte Count % | 1.2 | 0.6 - 2.5 | % | ||||||||
| 163 | CZ100110010 | 25 | years | Male | End of Phase/Treatment | Apr 21, 2026 10:37 AM | 6228234300 | TSH | TSH 3rd IS-QT | 1.256 | 0.45 - 5.33 | mIU/L | ||||||||
| 164 | CZ100110010 | 25 | years | Male | End of Phase/Treatment | Apr 21, 2026 10:37 AM | 6228234300 | URINE MACRO PANEL | Ur Specific Gravity | 1.012 | 1 - 1.04 | |||||||||
| 165 | CZ100110010 | 25 | years | Male | End of Phase/Treatment | Apr 21, 2026 10:37 AM | 6228234300 | URINE MACRO PANEL | Ur pH | 6.0 | 5 - 8 | |||||||||
| 166 | CZ100110010 | 25 | years | Male | End of Phase/Treatment | Apr 21, 2026 10:37 AM | 6228234300 | URINE MACRO PANEL | Ur Protein | Negative | Ref Rng:Negative | |||||||||
| 167 | CZ100110010 | 25 | years | Male | End of Phase/Treatment | Apr 21, 2026 10:37 AM | 6228234300 | URINE MACRO PANEL | Ur Glucose | Normal | Ref Rng:Normal | |||||||||
| 168 | CZ100110010 | 25 | years | Male | End of Phase/Treatment | Apr 21, 2026 10:37 AM | 6228234300 | URINE MACRO PANEL | Ur Ketones | Negative | Ref Rng:Negative | |||||||||
| 169 | CZ100110010 | 25 | years | Male | End of Phase/Treatment | Apr 21, 2026 10:37 AM | 6228234300 | URINE MACRO PANEL | Ur Bilirubin | Negative | Ref Rng:Negative | |||||||||
| 170 | CZ100110010 | 25 | years | Male | End of Phase/Treatment | Apr 21, 2026 10:37 AM | 6228234300 | URINE MACRO PANEL | Ur Urobilinogen | Normal | Ref Rng:Normal | |||||||||
| 171 | CZ100110010 | 25 | years | Male | End of Phase/Treatment | Apr 21, 2026 10:37 AM | 6228234300 | URINE MACRO PANEL | Ur Blood | Negative | Ref Rng:Negative | |||||||||
| 172 | CZ100110010 | 25 | years | Male | End of Phase/Treatment | Apr 21, 2026 10:37 AM | 6228234300 | URINE MACRO PANEL | Ur Nitrite | Negative | Ref Rng:Negative | |||||||||
| 173 | CZ100110010 | 25 | years | Male | End of Phase/Treatment | Apr 21, 2026 10:37 AM | 6228234300 | URINE MACRO PANEL | Ur Leukocyte Esterase | Negative | Ref Rng:Negative | |||||||||
| 174 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | C-REACTIVE PROTEIN | C Reactive Protein HS | 1.3 | 0 - 5 | mg/L | ||||||||
| 175 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | CHEMISTRY PANEL | Total Bilirubin | 5 | 3 - 21 | umol/L | ||||||||
| 176 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 1.8 | 0 - 6.2 | umol/L | ||||||||
| 177 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | CHEMISTRY PANEL | Alkaline Phosphatase | 104 | 40 - 129 | U/L | ||||||||
| 178 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | CHEMISTRY PANEL | ALT (SGPT) | 17 | 5 - 48 | U/L | ||||||||
| 179 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | CHEMISTRY PANEL | AST (SGOT) | 18 | 8 - 40 | U/L | ||||||||
| 180 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | CHEMISTRY PANEL | GGT | 13 | 10 - 61 | U/L | ||||||||
| 181 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | CHEMISTRY PANEL | LDH | Test cancelled: Hemolysis-test not performed | ||||||||||
| 182 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | CHEMISTRY PANEL | Urea Nitrogen | 6.2 | 1.4 - 8.6 | mmol/L | ||||||||
| 183 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 95 | 40 - 110 | umol/L | ||||||||
| 184 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | CHEMISTRY PANEL | Glucose Fasting | 4.9 | 3.9 - 5.6 | mmol/L | ||||||||
| 185 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | CHEMISTRY PANEL | Serum Uric Acid | 216 | 125 - 488 | umol/L | ||||||||
| 186 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | CHEMISTRY PANEL | Calcium (EDTA) | 2.45 | 2.07 - 2.64 | mmol/L | ||||||||
| 187 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | CHEMISTRY PANEL | Phosphorus | 1.25 | 0.71 - 1.65 | mmol/L | ||||||||
| 188 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | CHEMISTRY PANEL | Total Protein | 75 | 61 - 84 | g/L | ||||||||
| 189 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | CHEMISTRY PANEL | Albumin-BCG | 52 | H | 33 - 49 | g/L | |||||||
| 190 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | CHEMISTRY PANEL | Creatine Kinase | 196 | 39 - 308 | U/L | ||||||||
| 191 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | CHEMISTRY PANEL | Serum Sodium | 142 | 132 - 147 | mmol/L | ||||||||
| 192 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | CHEMISTRY PANEL | Serum Potassium | 4.4 | 3.5 - 5.2 | mmol/L | ||||||||
| 193 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | CHEMISTRY PANEL | Serum Bicarbonate | 22.8 | 19.3 - 29.3 | mmol/L | ||||||||
| 194 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | CHEMISTRY PANEL | Serum Chloride | 101 | 94 - 112 | mmol/L | ||||||||
| 195 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | CREATININE CLEARANCE CC&G | CreatininClearancCockcrftGault | 1.59 | 1.42 - 2.08 | mL/sec | ||||||||
| 196 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | CREATININE CLEARANCE CC&G | Creatinine(Rate Blanked)-2dp | 95 | 40 - 110 | umol/L | ||||||||
| 197 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | CREATININE CLEARANCE CC&G | Weight (kg,1dec place) | Y | 64.0 | kg | ||||||||
| 198 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | FSH | Follicle Stimulating Hormone | 6.14 | RX | 1.3 - 19.3 | IU/L | |||||||
| 199 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 146 | 127 - 181 | g/L | ||||||||
| 200 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.44 | 0.39 - 0.54 | |||||||||
| 201 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 5.0 | 4.5 - 6.4 | TI/L | ||||||||
| 202 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||
| 203 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 88 | 79 - 96 | fL | ||||||||
| 204 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 6.24 | 3.8 - 10.7 | GI/L | ||||||||
| 205 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 3.97 | 1.96 - 7.23 | GI/L | ||||||||
| 206 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.72 | 0.91 - 4.28 | GI/L | ||||||||
| 207 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.40 | 0.12 - 0.92 | GI/L | ||||||||
| 208 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.12 | 0 - 0.57 | GI/L | ||||||||
| 209 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.03 | 0 - 0.2 | GI/L | ||||||||
| 210 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 63.6 | 40.5 - 75 | % | ||||||||
| 211 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 27.6 | 15.4 - 48.5 | % | ||||||||
| 212 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 6.5 | 2.6 - 10.1 | % | ||||||||
| 213 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 1.9 | 0 - 6.8 | % | ||||||||
| 214 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 0.5 | 0 - 2 | % | ||||||||
| 215 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 223 | 140 - 400 | GI/L | ||||||||
| 216 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | HEMOGLOBIN A1C | Hemoglobin A1c,NGSP-RM | 5.3 | <6.5 % | |||||||||
| 217 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | 4.85 | 1.9 - 23 | uIU/mL | ||||||||
| 218 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||
| 219 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | LIPID PANEL | Direct HDL-C 4th Generation | 1.40 | 1.03 - 1.53 | mmol/L | ||||||||
| 220 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | LIPID PANEL | Triglycerides (GPO) | 0.81 | 0.5 - 2.81 | mmol/L | ||||||||
| 221 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | LIPID PANEL | Cholesterol (High Performance) | 4.33 | 3.31 - 6.1 | mmol/L | ||||||||
| 222 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | LIPID PANEL | LDL Chol Friedewald 4th | 2.56 | 0 - 3.34 | mmol/L | ||||||||
| 223 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | RETICULOCYTES | Reticulocyte Count % | 0.9 | 0.6 - 2.5 | % | ||||||||
| 224 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | TSH | TSH 3rd IS-QT | 1.789 | 0.45 - 5.33 | mIU/L | ||||||||
| 225 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | URINE MACRO PANEL | Ur Specific Gravity | 1.028 | 1 - 1.04 | |||||||||
| 226 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | URINE MACRO PANEL | Ur pH | 5.5 | 5 - 8 | |||||||||
| 227 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | URINE MACRO PANEL | Ur Protein | Negative | Ref Rng:Negative | |||||||||
| 228 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | URINE MACRO PANEL | Ur Glucose | Normal | Ref Rng:Normal | |||||||||
| 229 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | URINE MACRO PANEL | Ur Ketones | Negative | Ref Rng:Negative | |||||||||
| 230 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | URINE MACRO PANEL | Ur Bilirubin | Negative | Ref Rng:Negative | |||||||||
| 231 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | URINE MACRO PANEL | Ur Urobilinogen | Normal | Ref Rng:Normal | |||||||||
| 232 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | URINE MACRO PANEL | Ur Blood | Negative | Ref Rng:Negative | |||||||||
| 233 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | URINE MACRO PANEL | Ur Nitrite | Negative | Ref Rng:Negative | |||||||||
| 234 | CZ100110010 | 25 | years | Male | Retest | Apr 10, 2026 8:16 AM | 6227542182 | URINE MACRO PANEL | Ur Leukocyte Esterase | Negative | Ref Rng:Negative | |||||||||
| 235 | CZ100110008 | 59 | years | Male | Part 2 OL Induction Day 29 | Apr 7, 2026 9:21 AM | 6228114460 | C-REACTIVE PROTEIN | C Reactive Protein HS | 4.1 | 0 - 5 | mg/L | ||||||||
| 236 | CZ100110008 | 59 | years | Male | Part 2 OL Induction Day 29 | Apr 7, 2026 9:21 AM | 6228114460 | CHEMISTRY PANEL | Total Bilirubin | 10 | 3 - 21 | umol/L | ||||||||
| 237 | CZ100110008 | 59 | years | Male | Part 2 OL Induction Day 29 | Apr 7, 2026 9:21 AM | 6228114460 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 3.6 | 0 - 6.2 | umol/L | ||||||||
| 238 | CZ100110008 | 59 | years | Male | Part 2 OL Induction Day 29 | Apr 7, 2026 9:21 AM | 6228114460 | CHEMISTRY PANEL | Alkaline Phosphatase | 58 | 40 - 129 | U/L | ||||||||
| 239 | CZ100110008 | 59 | years | Male | Part 2 OL Induction Day 29 | Apr 7, 2026 9:21 AM | 6228114460 | CHEMISTRY PANEL | ALT (SGPT) | 86 | H RX | 5 - 48 | U/L | |||||||
| 240 | CZ100110008 | 59 | years | Male | Part 2 OL Induction Day 29 | Apr 7, 2026 9:21 AM | 6228114460 | CHEMISTRY PANEL | AST (SGOT) | 74 | H RX | 8 - 40 | U/L | |||||||
| 241 | CZ100110008 | 59 | years | Male | Part 2 OL Induction Day 29 | Apr 7, 2026 9:21 AM | 6228114460 | CHEMISTRY PANEL | GGT | 83 | H | 10 - 50 | U/L | |||||||
| 242 | CZ100110008 | 59 | years | Male | Part 2 OL Induction Day 29 | Apr 7, 2026 9:21 AM | 6228114460 | CHEMISTRY PANEL | LDH | 187 | 53 - 234 | U/L | ||||||||
| 243 | CZ100110008 | 59 | years | Male | Part 2 OL Induction Day 29 | Apr 7, 2026 9:21 AM | 6228114460 | CHEMISTRY PANEL | Urea Nitrogen | 5.4 | 1.4 - 8.6 | mmol/L | ||||||||
| 244 | CZ100110008 | 59 | years | Male | Part 2 OL Induction Day 29 | Apr 7, 2026 9:21 AM | 6228114460 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 107 | 40 - 119 | umol/L | ||||||||
| 245 | CZ100110008 | 59 | years | Male | Part 2 OL Induction Day 29 | Apr 7, 2026 9:21 AM | 6228114460 | CHEMISTRY PANEL | Glucose Fasting | 8.0 | H | 3.9 - 5.6 | mmol/L | |||||||
| 246 | CZ100110008 | 59 | years | Male | Part 2 OL Induction Day 29 | Apr 7, 2026 9:21 AM | 6228114460 | CHEMISTRY PANEL | Serum Uric Acid | 500 | H | 149 - 494 | umol/L | |||||||
| 247 | CZ100110008 | 59 | years | Male | Part 2 OL Induction Day 29 | Apr 7, 2026 9:21 AM | 6228114460 | CHEMISTRY PANEL | Calcium (EDTA) | 2.36 | 2.07 - 2.64 | mmol/L | ||||||||
| 248 | CZ100110008 | 59 | years | Male | Part 2 OL Induction Day 29 | Apr 7, 2026 9:21 AM | 6228114460 | CHEMISTRY PANEL | Phosphorus | 0.92 | 0.71 - 1.65 | mmol/L | ||||||||
| 249 | CZ100110008 | 59 | years | Male | Part 2 OL Induction Day 29 | Apr 7, 2026 9:21 AM | 6228114460 | CHEMISTRY PANEL | Total Protein | 77 | 60 - 80 | g/L | ||||||||
| 250 | CZ100110008 | 59 | years | Male | Part 2 OL Induction Day 29 | Apr 7, 2026 9:21 AM | 6228114460 | CHEMISTRY PANEL | Albumin-BCG | 48 | 33 - 49 | g/L | ||||||||
| 251 | CZ100110008 | 59 | years | Male | Part 2 OL Induction Day 29 | Apr 7, 2026 9:21 AM | 6228114460 | CHEMISTRY PANEL | Creatine Kinase | 238 | 39 - 308 | U/L | ||||||||
| 252 | CZ100110008 | 59 | years | Male | Part 2 OL Induction Day 29 | Apr 7, 2026 9:21 AM | 6228114460 | CHEMISTRY PANEL | Serum Sodium | 137 | 135 - 145 | mmol/L | ||||||||
| 253 | CZ100110008 | 59 | years | Male | Part 2 OL Induction Day 29 | Apr 7, 2026 9:21 AM | 6228114460 | CHEMISTRY PANEL | Serum Potassium | 3.8 | 3.5 - 5.2 | mmol/L | ||||||||
| 254 | CZ100110008 | 59 | years | Male | Part 2 OL Induction Day 29 | Apr 7, 2026 9:21 AM | 6228114460 | CHEMISTRY PANEL | Serum Bicarbonate | 21.3 | 19.3 - 29.3 | mmol/L | ||||||||
| 255 | CZ100110008 | 59 | years | Male | Part 2 OL Induction Day 29 | Apr 7, 2026 9:21 AM | 6228114460 | CHEMISTRY PANEL | Serum Chloride | 99 | 94 - 112 | mmol/L | ||||||||
| 256 | CZ100110008 | 59 | years | Male | Part 2 OL Induction Day 29 | Apr 7, 2026 9:21 AM | 6228114460 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 137 | 125 - 170 | g/L | ||||||||
| 257 | CZ100110008 | 59 | years | Male | Part 2 OL Induction Day 29 | Apr 7, 2026 9:21 AM | 6228114460 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.40 | 0.37 - 0.51 | |||||||||
| 258 | CZ100110008 | 59 | years | Male | Part 2 OL Induction Day 29 | Apr 7, 2026 9:21 AM | 6228114460 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.2 | 4 - 5.8 | TI/L | ||||||||
| 259 | CZ100110008 | 59 | years | Male | Part 2 OL Induction Day 29 | Apr 7, 2026 9:21 AM | 6228114460 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | Normocytic | NORMOCYTIC;$NORMOCHROMIC | |||||||||
| 260 | CZ100110008 | 59 | years | Male | Part 2 OL Induction Day 29 | Apr 7, 2026 9:21 AM | 6228114460 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 97 | 80 - 100 | fL | ||||||||
| 261 | CZ100110008 | 59 | years | Male | Part 2 OL Induction Day 29 | Apr 7, 2026 9:21 AM | 6228114460 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 5.57 | 3.8 - 10.7 | GI/L | ||||||||
| 262 | CZ100110008 | 59 | years | Male | Part 2 OL Induction Day 29 | Apr 7, 2026 9:21 AM | 6228114460 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 3.18 | 1.96 - 7.23 | GI/L | ||||||||
| 263 | CZ100110008 | 59 | years | Male | Part 2 OL Induction Day 29 | Apr 7, 2026 9:21 AM | 6228114460 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.84 | 0.8 - 3 | GI/L | ||||||||
| 264 | CZ100110008 | 59 | years | Male | Part 2 OL Induction Day 29 | Apr 7, 2026 9:21 AM | 6228114460 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.44 | 0.12 - 0.92 | GI/L | ||||||||
| 265 | CZ100110008 | 59 | years | Male | Part 2 OL Induction Day 29 | Apr 7, 2026 9:21 AM | 6228114460 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.06 | 0 - 0.57 | GI/L | ||||||||
| 266 | CZ100110008 | 59 | years | Male | Part 2 OL Induction Day 29 | Apr 7, 2026 9:21 AM | 6228114460 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.05 | 0 - 0.2 | GI/L | ||||||||
| 267 | CZ100110008 | 59 | years | Male | Part 2 OL Induction Day 29 | Apr 7, 2026 9:21 AM | 6228114460 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 57.1 | 40.5 - 75 | % | ||||||||
| 268 | CZ100110008 | 59 | years | Male | Part 2 OL Induction Day 29 | Apr 7, 2026 9:21 AM | 6228114460 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 33.0 | 15.4 - 48.5 | % | ||||||||
| 269 | CZ100110008 | 59 | years | Male | Part 2 OL Induction Day 29 | Apr 7, 2026 9:21 AM | 6228114460 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 7.9 | 2.6 - 10.1 | % | ||||||||
| 270 | CZ100110008 | 59 | years | Male | Part 2 OL Induction Day 29 | Apr 7, 2026 9:21 AM | 6228114460 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 1.0 | 0 - 6.8 | % | ||||||||
| 271 | CZ100110008 | 59 | years | Male | Part 2 OL Induction Day 29 | Apr 7, 2026 9:21 AM | 6228114460 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 0.9 | 0 - 2 | % | ||||||||
| 272 | CZ100110008 | 59 | years | Male | Part 2 OL Induction Day 29 | Apr 7, 2026 9:21 AM | 6228114460 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 169 | 140 - 400 | GI/L | ||||||||
| 273 | CZ100110008 | 59 | years | Male | Part 2 OL Induction Day 29 | Apr 7, 2026 9:21 AM | 6228114460 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | 33.13 | H | 1.9 - 23 | uIU/mL | |||||||
| 274 | CZ100110008 | 59 | years | Male | Part 2 OL Induction Day 29 | Apr 7, 2026 9:21 AM | 6228114460 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||
| 275 | CZ100110008 | 59 | years | Male | Part 2 OL Induction Day 29 | Apr 7, 2026 9:21 AM | 6228114460 | LIPID PANEL | Direct HDL-C 4th Generation | 0.70 | L | 1.03 - 1.53 | mmol/L | |||||||
| 276 | CZ100110008 | 59 | years | Male | Part 2 OL Induction Day 29 | Apr 7, 2026 9:21 AM | 6228114460 | LIPID PANEL | Triglycerides (GPO) | 2.48 | 0.65 - 3.61 | mmol/L | ||||||||
| 277 | CZ100110008 | 59 | years | Male | Part 2 OL Induction Day 29 | Apr 7, 2026 9:21 AM | 6228114460 | LIPID PANEL | Cholesterol (High Performance) | 4.55 | 4.4 - 7.53 | mmol/L | ||||||||
| 278 | CZ100110008 | 59 | years | Male | Part 2 OL Induction Day 29 | Apr 7, 2026 9:21 AM | 6228114460 | LIPID PANEL | LDL Chol Friedewald 4th | 2.71 | 0 - 3.34 | mmol/L | ||||||||
| 279 | CZ100110008 | 59 | years | Male | Part 2 OL Induction Day 29 | Apr 7, 2026 9:21 AM | 6228114460 | RETICULOCYTES | Reticulocyte Count % | 2.1 | 0.6 - 2.5 | % | ||||||||
| 280 | CZ100110008 | 59 | years | Male | Part 2 OL Induction Day 29 | Apr 7, 2026 9:21 AM | 6228114460 | URINE MACRO PANEL | Ur Specific Gravity | 1.018 | 1.01 - 1.03 | |||||||||
| 281 | CZ100110008 | 59 | years | Male | Part 2 OL Induction Day 29 | Apr 7, 2026 9:21 AM | 6228114460 | URINE MACRO PANEL | Ur pH | 5.5 | 5 - 8 | |||||||||
| 282 | CZ100110008 | 59 | years | Male | Part 2 OL Induction Day 29 | Apr 7, 2026 9:21 AM | 6228114460 | URINE MACRO PANEL | Ur Protein | Negative | Ref Rng:Negative | |||||||||
| 283 | CZ100110008 | 59 | years | Male | Part 2 OL Induction Day 29 | Apr 7, 2026 9:21 AM | 6228114460 | URINE MACRO PANEL | Ur Glucose | Normal | Ref Rng:Normal | |||||||||
| 284 | CZ100110008 | 59 | years | Male | Part 2 OL Induction Day 29 | Apr 7, 2026 9:21 AM | 6228114460 | URINE MACRO PANEL | Ur Ketones | Negative | Ref Rng:Negative | |||||||||
| 285 | CZ100110008 | 59 | years | Male | Part 2 OL Induction Day 29 | Apr 7, 2026 9:21 AM | 6228114460 | URINE MACRO PANEL | Ur Bilirubin | Negative | Ref Rng:Negative | |||||||||
| 286 | CZ100110008 | 59 | years | Male | Part 2 OL Induction Day 29 | Apr 7, 2026 9:21 AM | 6228114460 | URINE MACRO PANEL | Ur Urobilinogen | Normal | Ref Rng:Normal | |||||||||
| 287 | CZ100110008 | 59 | years | Male | Part 2 OL Induction Day 29 | Apr 7, 2026 9:21 AM | 6228114460 | URINE MACRO PANEL | Ur Blood | Negative | Ref Rng:Negative | |||||||||
| 288 | CZ100110008 | 59 | years | Male | Part 2 OL Induction Day 29 | Apr 7, 2026 9:21 AM | 6228114460 | URINE MACRO PANEL | Ur Nitrite | Negative | Ref Rng:Negative | |||||||||
| 289 | CZ100110008 | 59 | years | Male | Part 2 OL Induction Day 29 | Apr 7, 2026 9:21 AM | 6228114460 | URINE MACRO PANEL | Ur Leukocyte Esterase | Negative | Ref Rng:Negative | |||||||||
| 290 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | C-REACTIVE PROTEIN | C Reactive Protein HS | 3.7 | 0 - 5 | mg/L | ||||||||
| 291 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | CELLULAR ELEMENTS | Ur WBC/HPF | 1 | 0 - 12 | /HPF | ||||||||
| 292 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | CHEMISTRY PANEL | Total Bilirubin | 15 | 3 - 21 | umol/L | ||||||||
| 293 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 4.6 | 0 - 6.2 | umol/L | ||||||||
| 294 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | CHEMISTRY PANEL | Alkaline Phosphatase | 101 | 35 - 104 | U/L | ||||||||
| 295 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | CHEMISTRY PANEL | ALT (SGPT) | 19 | 4 - 43 | U/L | ||||||||
| 296 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | CHEMISTRY PANEL | AST (SGOT) | 21 | 8 - 40 | U/L | ||||||||
| 297 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | CHEMISTRY PANEL | GGT | 13 | 4 - 49 | U/L | ||||||||
| 298 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | CHEMISTRY PANEL | LDH | 175 | 53 - 234 | U/L | ||||||||
| 299 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | CHEMISTRY PANEL | Urea Nitrogen | 3.9 | 1.4 - 8.6 | mmol/L | ||||||||
| 300 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 54 | 31 - 101 | umol/L | ||||||||
| 301 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | CHEMISTRY PANEL | Glucose Fasting | 4.6 | 3.9 - 5.6 | mmol/L | ||||||||
| 302 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | CHEMISTRY PANEL | Serum Uric Acid | 232 | 125 - 428 | umol/L | ||||||||
| 303 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | CHEMISTRY PANEL | Calcium (EDTA) | 2.37 | 2.07 - 2.64 | mmol/L | ||||||||
| 304 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | CHEMISTRY PANEL | Phosphorus | 1.06 | 0.71 - 1.65 | mmol/L | ||||||||
| 305 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | CHEMISTRY PANEL | Total Protein | 80 | 61 - 84 | g/L | ||||||||
| 306 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | CHEMISTRY PANEL | Albumin-BCG | 48 | 33 - 49 | g/L | ||||||||
| 307 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | CHEMISTRY PANEL | Creatine Kinase | 52 | 26 - 192 | U/L | ||||||||
| 308 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | CHEMISTRY PANEL | Serum Sodium | 138 | 132 - 147 | mmol/L | ||||||||
| 309 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | CHEMISTRY PANEL | Serum Potassium | 4.4 | 3.5 - 5.2 | mmol/L | ||||||||
| 310 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | CHEMISTRY PANEL | Serum Bicarbonate | 22.0 | 19.3 - 29.3 | mmol/L | ||||||||
| 311 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | CHEMISTRY PANEL | Serum Chloride | 103 | 94 - 112 | mmol/L | ||||||||
| 312 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | CRYSTALS | Ur Uric Acid Crystals | Present | Ref Rng:Not present | |||||||||
| 313 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | FREE T4 | Free Thyroxine-QT | 18 | H | 8 - 14 | pmol/L | |||||||
| 314 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 128 | 116 - 164 | g/L | ||||||||
| 315 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.39 | 0.34 - 0.48 | |||||||||
| 316 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.4 | 4.1 - 5.6 | TI/L | ||||||||
| 317 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||
| 318 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 89 | 79 - 98 | fL | ||||||||
| 319 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 5.85 | 3.8 - 10.7 | GI/L | ||||||||
| 320 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 3.16 | 1.96 - 7.23 | GI/L | ||||||||
| 321 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 2.28 | 0.91 - 4.28 | GI/L | ||||||||
| 322 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.31 | 0.12 - 0.92 | GI/L | ||||||||
| 323 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.05 | 0 - 0.57 | GI/L | ||||||||
| 324 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.06 | 0 - 0.2 | GI/L | ||||||||
| 325 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 54.0 | 40.5 - 75 | % | ||||||||
| 326 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 38.9 | 15.4 - 48.5 | % | ||||||||
| 327 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 5.3 | 2.6 - 10.1 | % | ||||||||
| 328 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 0.9 | 0 - 6.8 | % | ||||||||
| 329 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 1.0 | 0 - 2 | % | ||||||||
| 330 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 312 | 140 - 400 | GI/L | ||||||||
| 331 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | HEMOGLOBIN A1C | Hemoglobin A1c,NGSP-RM | 4.7 | <6.5 % | |||||||||
| 332 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | 3.75 | 1.9 - 23 | uIU/mL | ||||||||
| 333 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||
| 334 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | LIPID PANEL | Direct HDL-C 4th Generation | 1.07 | 1.03 - 1.53 | mmol/L | ||||||||
| 335 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | LIPID PANEL | Triglycerides (GPO) | 0.77 | 0.44 - 1.99 | mmol/L | ||||||||
| 336 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | LIPID PANEL | Cholesterol (High Performance) | 3.77 | 3.65 - 6.21 | mmol/L | ||||||||
| 337 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | LIPID PANEL | LDL Chol Friedewald 4th | 2.35 | 0 - 3.34 | mmol/L | ||||||||
| 338 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | MICROORGANISMS | Ur Bacteria | Present | Ref Rng:Not present | |||||||||
| 339 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | RETICULOCYTES | Reticulocyte Count % | 1.5 | 0.6 - 2.5 | % | ||||||||
| 340 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | TSH | TSH 3rd IS-QT | 0.119 | L SF | 0.45 - 5.33 | mIU/L | |||||||
| 341 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | URINE MACRO PANEL | Ur Specific Gravity | 1.025 | 1 - 1.04 | |||||||||
| 342 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | URINE MACRO PANEL | Ur pH | 5.0 | 5 - 8 | |||||||||
| 343 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | URINE MACRO PANEL | Ur Protein | Negative | Ref Rng:Negative | |||||||||
| 344 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | URINE MACRO PANEL | Ur Glucose | Normal | Ref Rng:Normal | |||||||||
| 345 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | URINE MACRO PANEL | Ur Ketones | Negative | Ref Rng:Negative | |||||||||
| 346 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | URINE MACRO PANEL | Ur Bilirubin | Negative | Ref Rng:Negative | |||||||||
| 347 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | URINE MACRO PANEL | Ur Urobilinogen | Normal | Ref Rng:Normal | |||||||||
| 348 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | URINE MACRO PANEL | Ur Blood | Negative | Ref Rng:$Negative-Trace | |||||||||
| 349 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | URINE MACRO PANEL | Ur Nitrite | Negative | Ref Rng:Negative | |||||||||
| 350 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | URINE MACRO PANEL | Ur Leukocyte Esterase | Trace | H | Ref Rng:Negative | ||||||||
| 351 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | Mar 31, 2026 10:10 AM | 6228232037 | URINE MICRO PANEL | Ur Microscopic | Positive | NEGATIVE$ | NEGATIVE | ||||||||
| 352 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Mar 30, 2026 9:31 AM | 6227542172 | C-REACTIVE PROTEIN | C Reactive Protein HS | 0.7 | 0 - 5 | mg/L | ||||||||
| 353 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Mar 30, 2026 9:31 AM | 6227542172 | CHEMISTRY PANEL | Total Bilirubin | 5 | 3 - 21 | umol/L | ||||||||
| 354 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Mar 30, 2026 9:31 AM | 6227542172 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 2.4 | 0 - 6.2 | umol/L | ||||||||
| 355 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Mar 30, 2026 9:31 AM | 6227542172 | CHEMISTRY PANEL | Alkaline Phosphatase | 53 | 35 - 104 | U/L | ||||||||
| 356 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Mar 30, 2026 9:31 AM | 6227542172 | CHEMISTRY PANEL | ALT (SGPT) | 9 | 4 - 43 | U/L | ||||||||
| 357 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Mar 30, 2026 9:31 AM | 6227542172 | CHEMISTRY PANEL | AST (SGOT) | 11 | 8 - 40 | U/L | ||||||||
| 358 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Mar 30, 2026 9:31 AM | 6227542172 | CHEMISTRY PANEL | GGT | 12 | 4 - 49 | U/L | ||||||||
| 359 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Mar 30, 2026 9:31 AM | 6227542172 | CHEMISTRY PANEL | LDH | 134 | 53 - 234 | U/L | ||||||||
| 360 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Mar 30, 2026 9:31 AM | 6227542172 | CHEMISTRY PANEL | Urea Nitrogen | 5.0 | 1.4 - 8.6 | mmol/L | ||||||||
| 361 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Mar 30, 2026 9:31 AM | 6227542172 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 76 | 31 - 101 | umol/L | ||||||||
| 362 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Mar 30, 2026 9:31 AM | 6227542172 | CHEMISTRY PANEL | Glucose Fasting | 5.7 | H | 3.9 - 5.6 | mmol/L | |||||||
| 363 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Mar 30, 2026 9:31 AM | 6227542172 | CHEMISTRY PANEL | Serum Uric Acid | 216 | 125 - 428 | umol/L | ||||||||
| 364 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Mar 30, 2026 9:31 AM | 6227542172 | CHEMISTRY PANEL | Calcium (EDTA) | 2.41 | 2.07 - 2.64 | mmol/L | ||||||||
| 365 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Mar 30, 2026 9:31 AM | 6227542172 | CHEMISTRY PANEL | Phosphorus | 0.83 | 0.71 - 1.65 | mmol/L | ||||||||
| 366 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Mar 30, 2026 9:31 AM | 6227542172 | CHEMISTRY PANEL | Total Protein | 65 | 61 - 84 | g/L | ||||||||
| 367 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Mar 30, 2026 9:31 AM | 6227542172 | CHEMISTRY PANEL | Albumin-BCG | 45 | 33 - 49 | g/L | ||||||||
| 368 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Mar 30, 2026 9:31 AM | 6227542172 | CHEMISTRY PANEL | Creatine Kinase | 83 | 26 - 192 | U/L | ||||||||
| 369 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Mar 30, 2026 9:31 AM | 6227542172 | CHEMISTRY PANEL | Serum Sodium | 141 | 132 - 147 | mmol/L | ||||||||
| 370 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Mar 30, 2026 9:31 AM | 6227542172 | CHEMISTRY PANEL | Serum Potassium | 4.2 | 3.5 - 5.2 | mmol/L | ||||||||
| 371 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Mar 30, 2026 9:31 AM | 6227542172 | CHEMISTRY PANEL | Serum Bicarbonate | 23.3 | 19.3 - 29.3 | mmol/L | ||||||||
| 372 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Mar 30, 2026 9:31 AM | 6227542172 | CHEMISTRY PANEL | Serum Chloride | 106 | 94 - 112 | mmol/L | ||||||||
| 373 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Mar 30, 2026 9:31 AM | 6227542172 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 121 | 116 - 164 | g/L | ||||||||
| 374 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Mar 30, 2026 9:31 AM | 6227542172 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.36 | 0.34 - 0.48 | |||||||||
| 375 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Mar 30, 2026 9:31 AM | 6227542172 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.0 | L | 4.1 - 5.6 | TI/L | |||||||
| 376 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Mar 30, 2026 9:31 AM | 6227542172 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||
| 377 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Mar 30, 2026 9:31 AM | 6227542172 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 91 | 79 - 98 | fL | ||||||||
| 378 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Mar 30, 2026 9:31 AM | 6227542172 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 4.63 | 3.8 - 10.7 | GI/L | ||||||||
| 379 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Mar 30, 2026 9:31 AM | 6227542172 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 2.66 | 1.96 - 7.23 | GI/L | ||||||||
| 380 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Mar 30, 2026 9:31 AM | 6227542172 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.64 | 0.91 - 4.28 | GI/L | ||||||||
| 381 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Mar 30, 2026 9:31 AM | 6227542172 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.20 | 0.12 - 0.92 | GI/L | ||||||||
| 382 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Mar 30, 2026 9:31 AM | 6227542172 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.11 | 0 - 0.57 | GI/L | ||||||||
| 383 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Mar 30, 2026 9:31 AM | 6227542172 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.02 | 0 - 0.2 | GI/L | ||||||||
| 384 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Mar 30, 2026 9:31 AM | 6227542172 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 57.5 | 40.5 - 75 | % | ||||||||
| 385 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Mar 30, 2026 9:31 AM | 6227542172 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 35.3 | 15.4 - 48.5 | % | ||||||||
| 386 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Mar 30, 2026 9:31 AM | 6227542172 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 4.3 | 2.6 - 10.1 | % | ||||||||
| 387 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Mar 30, 2026 9:31 AM | 6227542172 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 2.4 | 0 - 6.8 | % | ||||||||
| 388 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Mar 30, 2026 9:31 AM | 6227542172 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 0.5 | 0 - 2 | % | ||||||||
| 389 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Mar 30, 2026 9:31 AM | 6227542172 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 273 | 140 - 400 | GI/L | ||||||||
| 390 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Mar 30, 2026 9:31 AM | 6227542172 | HEMOGLOBIN A1C | Hemoglobin A1c,NGSP-RM | 5.4 | <6.5 % | |||||||||
| 391 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Mar 30, 2026 9:31 AM | 6227542172 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | 5.32 | 1.9 - 23 | uIU/mL | ||||||||
| 392 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Mar 30, 2026 9:31 AM | 6227542172 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||
| 393 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Mar 30, 2026 9:31 AM | 6227542172 | LIPID PANEL | Direct HDL-C 4th Generation | 1.68 | H | 1.03 - 1.53 | mmol/L | |||||||
| 394 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Mar 30, 2026 9:31 AM | 6227542172 | LIPID PANEL | Triglycerides (GPO) | 0.69 | 0.44 - 1.99 | mmol/L | ||||||||
| 395 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Mar 30, 2026 9:31 AM | 6227542172 | LIPID PANEL | Cholesterol (High Performance) | 4.75 | 3.65 - 6.21 | mmol/L | ||||||||
| 396 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Mar 30, 2026 9:31 AM | 6227542172 | LIPID PANEL | LDL Chol Friedewald 4th | 2.75 | 0 - 3.34 | mmol/L | ||||||||
| 397 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Mar 30, 2026 9:31 AM | 6227542172 | RETICULOCYTES | Reticulocyte Count % | 0.7 | 0.6 - 2.5 | % | ||||||||
| 398 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Mar 30, 2026 9:31 AM | 6227542172 | TSH | TSH 3rd IS-QT | 1.607 | 0.45 - 5.33 | mIU/L | ||||||||
| 399 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Mar 30, 2026 9:31 AM | 6227542172 | URINE MACRO PANEL | Ur Specific Gravity | 1.027 | 1 - 1.04 | |||||||||
| 400 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Mar 30, 2026 9:31 AM | 6227542172 | URINE MACRO PANEL | Ur pH | 6.0 | 5 - 8 | |||||||||
| 401 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Mar 30, 2026 9:31 AM | 6227542172 | URINE MACRO PANEL | Ur Protein | Negative | Ref Rng:Negative | |||||||||
| 402 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Mar 30, 2026 9:31 AM | 6227542172 | URINE MACRO PANEL | Ur Glucose | Normal | Ref Rng:Normal | |||||||||
| 403 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Mar 30, 2026 9:31 AM | 6227542172 | URINE MACRO PANEL | Ur Ketones | Negative | Ref Rng:Negative | |||||||||
| 404 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Mar 30, 2026 9:31 AM | 6227542172 | URINE MACRO PANEL | Ur Bilirubin | Negative | Ref Rng:Negative | |||||||||
| 405 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Mar 30, 2026 9:31 AM | 6227542172 | URINE MACRO PANEL | Ur Urobilinogen | Normal | Ref Rng:Normal | |||||||||
| 406 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Mar 30, 2026 9:31 AM | 6227542172 | URINE MACRO PANEL | Ur Blood | Negative | Ref Rng:$Negative-Trace | |||||||||
| 407 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Mar 30, 2026 9:31 AM | 6227542172 | URINE MACRO PANEL | Ur Nitrite | Negative | Ref Rng:Negative | |||||||||
| 408 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Mar 30, 2026 9:31 AM | 6227542172 | URINE MACRO PANEL | Ur Leukocyte Esterase | Negative | Ref Rng:Negative | |||||||||
| 409 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | C-REACTIVE PROTEIN | C Reactive Protein HS | 1.2 | 0 - 5 | mg/L | ||||||||
| 410 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | CELLULAR ELEMENTS | Ur WBC/HPF | 1 | 0 - 12 | /HPF | ||||||||
| 411 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | CHEMISTRY PANEL | Total Bilirubin | 6 | 3 - 21 | umol/L | ||||||||
| 412 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 2.3 | 0 - 6.2 | umol/L | ||||||||
| 413 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | CHEMISTRY PANEL | Alkaline Phosphatase | 64 | 35 - 104 | U/L | ||||||||
| 414 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | CHEMISTRY PANEL | ALT (SGPT) | 21 | 4 - 43 | U/L | ||||||||
| 415 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | CHEMISTRY PANEL | AST (SGOT) | 24 | 8 - 40 | U/L | ||||||||
| 416 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | CHEMISTRY PANEL | GGT | 30 | 4 - 49 | U/L | ||||||||
| 417 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | CHEMISTRY PANEL | LDH | 164 | 53 - 234 | U/L | ||||||||
| 418 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | CHEMISTRY PANEL | Urea Nitrogen | 4.5 | 1.4 - 8.6 | mmol/L | ||||||||
| 419 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 76 | 31 - 101 | umol/L | ||||||||
| 420 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | CHEMISTRY PANEL | Glucose Fasting | 4.7 | 3.9 - 5.6 | mmol/L | ||||||||
| 421 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | CHEMISTRY PANEL | Serum Uric Acid | 315 | 149 - 446 | umol/L | ||||||||
| 422 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | CHEMISTRY PANEL | Calcium (EDTA) | 2.42 | 2.07 - 2.64 | mmol/L | ||||||||
| 423 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | CHEMISTRY PANEL | Phosphorus | 1.08 | 0.71 - 1.65 | mmol/L | ||||||||
| 424 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | CHEMISTRY PANEL | Total Protein | 71 | 61 - 84 | g/L | ||||||||
| 425 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | CHEMISTRY PANEL | Albumin-BCG | 45 | 33 - 49 | g/L | ||||||||
| 426 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | CHEMISTRY PANEL | Creatine Kinase | 151 | 26 - 192 | U/L | ||||||||
| 427 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | CHEMISTRY PANEL | Serum Sodium | 138 | 132 - 147 | mmol/L | ||||||||
| 428 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | CHEMISTRY PANEL | Serum Potassium | 4.9 | 3.5 - 5.2 | mmol/L | ||||||||
| 429 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | CHEMISTRY PANEL | Serum Bicarbonate | 24.8 | 19.3 - 29.3 | mmol/L | ||||||||
| 430 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | CHEMISTRY PANEL | Serum Chloride | 100 | 94 - 112 | mmol/L | ||||||||
| 431 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 135 | 116 - 164 | g/L | ||||||||
| 432 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.40 | 0.34 - 0.48 | |||||||||
| 433 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.4 | 4.1 - 5.6 | TI/L | ||||||||
| 434 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||
| 435 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 91 | 79 - 98 | fL | ||||||||
| 436 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 7.44 | 3.8 - 10.7 | GI/L | ||||||||
| 437 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 3.89 | 1.96 - 7.23 | GI/L | ||||||||
| 438 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 3.02 | 0.91 - 4.28 | GI/L | ||||||||
| 439 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.33 | 0.12 - 0.92 | GI/L | ||||||||
| 440 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.14 | 0 - 0.57 | GI/L | ||||||||
| 441 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.06 | 0 - 0.2 | GI/L | ||||||||
| 442 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 52.3 | 40.5 - 75 | % | ||||||||
| 443 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 40.6 | 15.4 - 48.5 | % | ||||||||
| 444 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 4.5 | 2.6 - 10.1 | % | ||||||||
| 445 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 1.9 | 0 - 6.8 | % | ||||||||
| 446 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 0.8 | 0 - 2 | % | ||||||||
| 447 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 307 | 140 - 400 | GI/L | ||||||||
| 448 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | HEMOGLOBIN A1C | Hemoglobin A1c,NGSP-RM | 5.4 | <6.5 % | |||||||||
| 449 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | 2.60 | 1.9 - 23 | uIU/mL | ||||||||
| 450 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||
| 451 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | LIPID PANEL | Direct HDL-C 4th Generation | 1.98 | H | 1.03 - 1.53 | mmol/L | |||||||
| 452 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | LIPID PANEL | Triglycerides (GPO) | 1.32 | 0.59 - 2.96 | mmol/L | ||||||||
| 453 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | LIPID PANEL | Cholesterol (High Performance) | 5.66 | 4.42 - 7.53 | mmol/L | ||||||||
| 454 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | LIPID PANEL | LDL Chol Friedewald 4th | 3.08 | 0 - 3.34 | mmol/L | ||||||||
| 455 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | RETICULOCYTES | Reticulocyte Count % | 1.3 | 0.6 - 2.5 | % | ||||||||
| 456 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | TSH | TSH 3rd IS-QT | 3.912 | 0.45 - 5.33 | mIU/L | ||||||||
| 457 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | URINE MACRO PANEL | Ur Specific Gravity | 1.025 | 1 - 1.04 | |||||||||
| 458 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | URINE MACRO PANEL | Ur pH | 5.5 | 5 - 8 | |||||||||
| 459 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | URINE MACRO PANEL | Ur Protein | Negative | Ref Rng:Negative | |||||||||
| 460 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | URINE MACRO PANEL | Ur Glucose | Normal | Ref Rng:Normal | |||||||||
| 461 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | URINE MACRO PANEL | Ur Ketones | Negative | Ref Rng:Negative | |||||||||
| 462 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | URINE MACRO PANEL | Ur Bilirubin | Negative | Ref Rng:Negative | |||||||||
| 463 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | URINE MACRO PANEL | Ur Urobilinogen | Normal | Ref Rng:Normal | |||||||||
| 464 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | URINE MACRO PANEL | Ur Blood | Negative | Ref Rng:$Negative-Trace | |||||||||
| 465 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | URINE MACRO PANEL | Ur Nitrite | Negative | Ref Rng:Negative | |||||||||
| 466 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | URINE MACRO PANEL | Ur Leukocyte Esterase | Trace | H | Ref Rng:Negative | ||||||||
| 467 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Mar 16, 2026 9:16 AM | 6227542171 | URINE MICRO PANEL | Ur Microscopic | Positive | NEGATIVE$ | NEGATIVE | ||||||||
| 468 | CZ100110010 | 25 | years | Male | Part 1 DB Baseline | Mar 10, 2026 10:21 AM | 6227844725 | C-REACTIVE PROTEIN | C Reactive Protein HS | 0.7 | 0 - 5 | mg/L | ||||||||
| 469 | CZ100110010 | 25 | years | Male | Part 1 DB Baseline | Mar 10, 2026 10:21 AM | 6227844725 | CELLULAR ELEMENTS | Ur WBC/HPF | 1 | 0 - 5 | /HPF | ||||||||
| 470 | CZ100110010 | 25 | years | Male | Part 1 DB Baseline | Mar 10, 2026 10:21 AM | 6227844725 | CHEMISTRY PANEL | Total Bilirubin | 13 | 3 - 21 | umol/L | ||||||||
| 471 | CZ100110010 | 25 | years | Male | Part 1 DB Baseline | Mar 10, 2026 10:21 AM | 6227844725 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 4.2 | 0 - 6.2 | umol/L | ||||||||
| 472 | CZ100110010 | 25 | years | Male | Part 1 DB Baseline | Mar 10, 2026 10:21 AM | 6227844725 | CHEMISTRY PANEL | Alkaline Phosphatase | 91 | 40 - 129 | U/L | ||||||||
| 473 | CZ100110010 | 25 | years | Male | Part 1 DB Baseline | Mar 10, 2026 10:21 AM | 6227844725 | CHEMISTRY PANEL | ALT (SGPT) | 29 | 5 - 48 | U/L | ||||||||
| 474 | CZ100110010 | 25 | years | Male | Part 1 DB Baseline | Mar 10, 2026 10:21 AM | 6227844725 | CHEMISTRY PANEL | AST (SGOT) | 39 | 8 - 40 | U/L | ||||||||
| 475 | CZ100110010 | 25 | years | Male | Part 1 DB Baseline | Mar 10, 2026 10:21 AM | 6227844725 | CHEMISTRY PANEL | GGT | 13 | 10 - 61 | U/L | ||||||||
| 476 | CZ100110010 | 25 | years | Male | Part 1 DB Baseline | Mar 10, 2026 10:21 AM | 6227844725 | CHEMISTRY PANEL | LDH | 206 | 53 - 234 | U/L | ||||||||
| 477 | CZ100110010 | 25 | years | Male | Part 1 DB Baseline | Mar 10, 2026 10:21 AM | 6227844725 | CHEMISTRY PANEL | Urea Nitrogen | 5.5 | 1.4 - 8.6 | mmol/L | ||||||||
| 478 | CZ100110010 | 25 | years | Male | Part 1 DB Baseline | Mar 10, 2026 10:21 AM | 6227844725 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 104 | 40 - 110 | umol/L | ||||||||
| 479 | CZ100110010 | 25 | years | Male | Part 1 DB Baseline | Mar 10, 2026 10:21 AM | 6227844725 | CHEMISTRY PANEL | Glucose Fasting | 5.6 | 3.9 - 5.6 | mmol/L | ||||||||
| 480 | CZ100110010 | 25 | years | Male | Part 1 DB Baseline | Mar 10, 2026 10:21 AM | 6227844725 | CHEMISTRY PANEL | Serum Uric Acid | 223 | 125 - 488 | umol/L | ||||||||
| 481 | CZ100110010 | 25 | years | Male | Part 1 DB Baseline | Mar 10, 2026 10:21 AM | 6227844725 | CHEMISTRY PANEL | Calcium (EDTA) | 2.58 | 2.07 - 2.64 | mmol/L | ||||||||
| 482 | CZ100110010 | 25 | years | Male | Part 1 DB Baseline | Mar 10, 2026 10:21 AM | 6227844725 | CHEMISTRY PANEL | Phosphorus | 1.09 | 0.71 - 1.65 | mmol/L | ||||||||
| 483 | CZ100110010 | 25 | years | Male | Part 1 DB Baseline | Mar 10, 2026 10:21 AM | 6227844725 | CHEMISTRY PANEL | Total Protein | 72 | 61 - 84 | g/L | ||||||||
| 484 | CZ100110010 | 25 | years | Male | Part 1 DB Baseline | Mar 10, 2026 10:21 AM | 6227844725 | CHEMISTRY PANEL | Albumin-BCG | 51 | R | H | 33 - 49 | g/L | ||||||
| 485 | CZ100110010 | 25 | years | Male | Part 1 DB Baseline | Mar 10, 2026 10:21 AM | 6227844725 | CHEMISTRY PANEL | Creatine Kinase | 1857 | R | H SF | Diluted for quantitation | 39 - 308 | U/L | |||||
| 486 | CZ100110010 | 25 | years | Male | Part 1 DB Baseline | Mar 10, 2026 10:21 AM | 6227844725 | CHEMISTRY PANEL | Serum Sodium | 139 | 132 - 147 | mmol/L | ||||||||
| 487 | CZ100110010 | 25 | years | Male | Part 1 DB Baseline | Mar 10, 2026 10:21 AM | 6227844725 | CHEMISTRY PANEL | Serum Potassium | 4.5 | 3.5 - 5.2 | mmol/L | ||||||||
| 488 | CZ100110010 | 25 | years | Male | Part 1 DB Baseline | Mar 10, 2026 10:21 AM | 6227844725 | CHEMISTRY PANEL | Serum Bicarbonate | 23.1 | 19.3 - 29.3 | mmol/L | ||||||||
| 489 | CZ100110010 | 25 | years | Male | Part 1 DB Baseline | Mar 10, 2026 10:21 AM | 6227844725 | CHEMISTRY PANEL | Serum Chloride | 100 | 94 - 112 | mmol/L | ||||||||
| 490 | CZ100110010 | 25 | years | Male | Part 1 DB Baseline | Mar 10, 2026 10:21 AM | 6227844725 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 157 | 127 - 181 | g/L | ||||||||
| 491 | CZ100110010 | 25 | years | Male | Part 1 DB Baseline | Mar 10, 2026 10:21 AM | 6227844725 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.45 | 0.39 - 0.54 | |||||||||
| 492 | CZ100110010 | 25 | years | Male | Part 1 DB Baseline | Mar 10, 2026 10:21 AM | 6227844725 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 5.2 | 4.5 - 6.4 | TI/L | ||||||||
| 493 | CZ100110010 | 25 | years | Male | Part 1 DB Baseline | Mar 10, 2026 10:21 AM | 6227844725 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||
| 494 | CZ100110010 | 25 | years | Male | Part 1 DB Baseline | Mar 10, 2026 10:21 AM | 6227844725 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 87 | 79 - 96 | fL | ||||||||
| 495 | CZ100110010 | 25 | years | Male | Part 1 DB Baseline | Mar 10, 2026 10:21 AM | 6227844725 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 6.41 | 3.8 - 10.7 | GI/L | ||||||||
| 496 | CZ100110010 | 25 | years | Male | Part 1 DB Baseline | Mar 10, 2026 10:21 AM | 6227844725 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 4.57 | 1.96 - 7.23 | GI/L | ||||||||
| 497 | CZ100110010 | 25 | years | Male | Part 1 DB Baseline | Mar 10, 2026 10:21 AM | 6227844725 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.23 | 0.91 - 4.28 | GI/L | ||||||||
| 498 | CZ100110010 | 25 | years | Male | Part 1 DB Baseline | Mar 10, 2026 10:21 AM | 6227844725 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.48 | 0.12 - 0.92 | GI/L | ||||||||
| 499 | CZ100110010 | 25 | years | Male | Part 1 DB Baseline | Mar 10, 2026 10:21 AM | 6227844725 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.08 | 0 - 0.57 | GI/L | ||||||||
| 500 | CZ100110010 | 25 | years | Male | Part 1 DB Baseline | Mar 10, 2026 10:21 AM | 6227844725 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.06 | 0 - 0.2 | GI/L | ||||||||
| 501 | CZ100110010 | 25 | years | Male | Part 1 DB Baseline | Mar 10, 2026 10:21 AM | 6227844725 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 71.3 | 40.5 - 75 | % | ||||||||
| 502 | CZ100110010 | 25 | years | Male | Part 1 DB Baseline | Mar 10, 2026 10:21 AM | 6227844725 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 19.1 | 15.4 - 48.5 | % | ||||||||
| 503 | CZ100110010 | 25 | years | Male | Part 1 DB Baseline | Mar 10, 2026 10:21 AM | 6227844725 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 7.5 | 2.6 - 10.1 | % | ||||||||
| 504 | CZ100110010 | 25 | years | Male | Part 1 DB Baseline | Mar 10, 2026 10:21 AM | 6227844725 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 1.3 | 0 - 6.8 | % | ||||||||
| 505 | CZ100110010 | 25 | years | Male | Part 1 DB Baseline | Mar 10, 2026 10:21 AM | 6227844725 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 0.9 | 0 - 2 | % | ||||||||
| 506 | CZ100110010 | 25 | years | Male | Part 1 DB Baseline | Mar 10, 2026 10:21 AM | 6227844725 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 242 | 140 - 400 | GI/L | ||||||||
| 507 | CZ100110010 | 25 | years | Male | Part 1 DB Baseline | Mar 10, 2026 10:21 AM | 6227844725 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | 6.71 | 1.9 - 23 | uIU/mL | ||||||||
| 508 | CZ100110010 | 25 | years | Male | Part 1 DB Baseline | Mar 10, 2026 10:21 AM | 6227844725 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||
| 509 | CZ100110010 | 25 | years | Male | Part 1 DB Baseline | Mar 10, 2026 10:21 AM | 6227844725 | LIPID PANEL | Direct HDL-C 4th Generation | 1.23 | 1.03 - 1.53 | mmol/L | ||||||||
| 510 | CZ100110010 | 25 | years | Male | Part 1 DB Baseline | Mar 10, 2026 10:21 AM | 6227844725 | LIPID PANEL | Triglycerides (GPO) | 1.12 | 0.5 - 2.81 | mmol/L | ||||||||
| 511 | CZ100110010 | 25 | years | Male | Part 1 DB Baseline | Mar 10, 2026 10:21 AM | 6227844725 | LIPID PANEL | Cholesterol (High Performance) | 3.95 | 3.31 - 6.1 | mmol/L | ||||||||
| 512 | CZ100110010 | 25 | years | Male | Part 1 DB Baseline | Mar 10, 2026 10:21 AM | 6227844725 | LIPID PANEL | LDL Chol Friedewald 4th | 2.21 | 0 - 3.34 | mmol/L | ||||||||
| 513 | CZ100110010 | 25 | years | Male | Part 1 DB Baseline | Mar 10, 2026 10:21 AM | 6227844725 | RETICULOCYTES | Reticulocyte Count % | 0.6 | 0.6 - 2.5 | % | ||||||||
| 514 | CZ100110010 | 25 | years | Male | Part 1 DB Baseline | Mar 10, 2026 10:21 AM | 6227844725 | URINE MACRO PANEL | Ur Specific Gravity | 1.036 | R | H | 1 - 1.04 | |||||||
| 515 | CZ100110010 | 25 | years | Male | Part 1 DB Baseline | Mar 10, 2026 10:21 AM | 6227844725 | URINE MACRO PANEL | Ur pH | 5.5 | 5 - 8 | |||||||||
| 516 | CZ100110010 | 25 | years | Male | Part 1 DB Baseline | Mar 10, 2026 10:21 AM | 6227844725 | URINE MACRO PANEL | Ur Protein | Trace | R | H | Ref Rng:Negative | |||||||
| 517 | CZ100110010 | 25 | years | Male | Part 1 DB Baseline | Mar 10, 2026 10:21 AM | 6227844725 | URINE MACRO PANEL | Ur Glucose | Normal | Ref Rng:Normal | |||||||||
| 518 | CZ100110010 | 25 | years | Male | Part 1 DB Baseline | Mar 10, 2026 10:21 AM | 6227844725 | URINE MACRO PANEL | Ur Ketones | Negative | Ref Rng:Negative | |||||||||
| 519 | CZ100110010 | 25 | years | Male | Part 1 DB Baseline | Mar 10, 2026 10:21 AM | 6227844725 | URINE MACRO PANEL | Ur Bilirubin | Negative | Ref Rng:Negative | |||||||||
| 520 | CZ100110010 | 25 | years | Male | Part 1 DB Baseline | Mar 10, 2026 10:21 AM | 6227844725 | URINE MACRO PANEL | Ur Urobilinogen | Normal | Ref Rng:Normal | |||||||||
| 521 | CZ100110010 | 25 | years | Male | Part 1 DB Baseline | Mar 10, 2026 10:21 AM | 6227844725 | URINE MACRO PANEL | Ur Blood | Negative | Ref Rng:Negative | |||||||||
| 522 | CZ100110010 | 25 | years | Male | Part 1 DB Baseline | Mar 10, 2026 10:21 AM | 6227844725 | URINE MACRO PANEL | Ur Nitrite | Negative | Ref Rng:Negative | |||||||||
| 523 | CZ100110010 | 25 | years | Male | Part 1 DB Baseline | Mar 10, 2026 10:21 AM | 6227844725 | URINE MACRO PANEL | Ur Leukocyte Esterase | Negative | Ref Rng:Negative | |||||||||
| 524 | CZ100110010 | 25 | years | Male | Part 1 DB Baseline | Mar 10, 2026 10:21 AM | 6227844725 | URINE MICRO PANEL | Ur Microscopic | Positive | NEGATIVE$ | NEGATIVE | ||||||||
| 525 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | Mar 10, 2026 9:30 AM | 6227542170 | C-REACTIVE PROTEIN | C Reactive Protein HS | 2.7 | 0 - 5 | mg/L | ||||||||
| 526 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | Mar 10, 2026 9:30 AM | 6227542170 | CHEMISTRY PANEL | Total Bilirubin | 9 | 3 - 21 | umol/L | ||||||||
| 527 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | Mar 10, 2026 9:30 AM | 6227542170 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 3.1 | 0 - 6.2 | umol/L | ||||||||
| 528 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | Mar 10, 2026 9:30 AM | 6227542170 | CHEMISTRY PANEL | Alkaline Phosphatase | 53 | 40 - 129 | U/L | ||||||||
| 529 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | Mar 10, 2026 9:30 AM | 6227542170 | CHEMISTRY PANEL | ALT (SGPT) | 79 | H RX | 5 - 48 | U/L | |||||||
| 530 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | Mar 10, 2026 9:30 AM | 6227542170 | CHEMISTRY PANEL | AST (SGOT) | 46 | H | 8 - 40 | U/L | |||||||
| 531 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | Mar 10, 2026 9:30 AM | 6227542170 | CHEMISTRY PANEL | GGT | 68 | H | 10 - 50 | U/L | |||||||
| 532 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | Mar 10, 2026 9:30 AM | 6227542170 | CHEMISTRY PANEL | LDH | 161 | 53 - 234 | U/L | ||||||||
| 533 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | Mar 10, 2026 9:30 AM | 6227542170 | CHEMISTRY PANEL | Urea Nitrogen | 4.8 | 1.4 - 8.6 | mmol/L | ||||||||
| 534 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | Mar 10, 2026 9:30 AM | 6227542170 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 95 | 40 - 119 | umol/L | ||||||||
| 535 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | Mar 10, 2026 9:30 AM | 6227542170 | CHEMISTRY PANEL | Glucose Fasting | 7.0 | H | 3.9 - 5.6 | mmol/L | |||||||
| 536 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | Mar 10, 2026 9:30 AM | 6227542170 | CHEMISTRY PANEL | Serum Uric Acid | 393 | 149 - 494 | umol/L | ||||||||
| 537 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | Mar 10, 2026 9:30 AM | 6227542170 | CHEMISTRY PANEL | Calcium (EDTA) | 2.28 | 2.07 - 2.64 | mmol/L | ||||||||
| 538 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | Mar 10, 2026 9:30 AM | 6227542170 | CHEMISTRY PANEL | Phosphorus | 0.81 | 0.71 - 1.65 | mmol/L | ||||||||
| 539 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | Mar 10, 2026 9:30 AM | 6227542170 | CHEMISTRY PANEL | Total Protein | 72 | 60 - 80 | g/L | ||||||||
| 540 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | Mar 10, 2026 9:30 AM | 6227542170 | CHEMISTRY PANEL | Albumin-BCG | 46 | 33 - 49 | g/L | ||||||||
| 541 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | Mar 10, 2026 9:30 AM | 6227542170 | CHEMISTRY PANEL | Creatine Kinase | 212 | 39 - 308 | U/L | ||||||||
| 542 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | Mar 10, 2026 9:30 AM | 6227542170 | CHEMISTRY PANEL | Serum Sodium | 139 | 135 - 145 | mmol/L | ||||||||
| 543 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | Mar 10, 2026 9:30 AM | 6227542170 | CHEMISTRY PANEL | Serum Potassium | 4.0 | 3.5 - 5.2 | mmol/L | ||||||||
| 544 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | Mar 10, 2026 9:30 AM | 6227542170 | CHEMISTRY PANEL | Serum Bicarbonate | 22.5 | 19.3 - 29.3 | mmol/L | ||||||||
| 545 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | Mar 10, 2026 9:30 AM | 6227542170 | CHEMISTRY PANEL | Serum Chloride | 102 | 94 - 112 | mmol/L | ||||||||
| 546 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | Mar 10, 2026 9:30 AM | 6227542170 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 132 | 125 - 170 | g/L | ||||||||
| 547 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | Mar 10, 2026 9:30 AM | 6227542170 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.38 | 0.37 - 0.51 | |||||||||
| 548 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | Mar 10, 2026 9:30 AM | 6227542170 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 3.9 | L | 4 - 5.8 | TI/L | |||||||
| 549 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | Mar 10, 2026 9:30 AM | 6227542170 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||
| 550 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | Mar 10, 2026 9:30 AM | 6227542170 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 98 | 80 - 100 | fL | ||||||||
| 551 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | Mar 10, 2026 9:30 AM | 6227542170 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 4.42 | 3.8 - 10.7 | GI/L | ||||||||
| 552 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | Mar 10, 2026 9:30 AM | 6227542170 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 2.42 | 1.96 - 7.23 | GI/L | ||||||||
| 553 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | Mar 10, 2026 9:30 AM | 6227542170 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.61 | 0.8 - 3 | GI/L | ||||||||
| 554 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | Mar 10, 2026 9:30 AM | 6227542170 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.28 | 0.12 - 0.92 | GI/L | ||||||||
| 555 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | Mar 10, 2026 9:30 AM | 6227542170 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.06 | 0 - 0.57 | GI/L | ||||||||
| 556 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | Mar 10, 2026 9:30 AM | 6227542170 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.05 | 0 - 0.2 | GI/L | ||||||||
| 557 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | Mar 10, 2026 9:30 AM | 6227542170 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 54.8 | 40.5 - 75 | % | ||||||||
| 558 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | Mar 10, 2026 9:30 AM | 6227542170 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 36.4 | 15.4 - 48.5 | % | ||||||||
| 559 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | Mar 10, 2026 9:30 AM | 6227542170 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 6.4 | 2.6 - 10.1 | % | ||||||||
| 560 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | Mar 10, 2026 9:30 AM | 6227542170 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 1.3 | 0 - 6.8 | % | ||||||||
| 561 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | Mar 10, 2026 9:30 AM | 6227542170 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 1.2 | 0 - 2 | % | ||||||||
| 562 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | Mar 10, 2026 9:30 AM | 6227542170 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 149 | 140 - 400 | GI/L | ||||||||
| 563 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | Mar 10, 2026 9:30 AM | 6227542170 | HEMOGLOBIN A1C | Hemoglobin A1c,NGSP-RM | 6.2 | <6.5 % | |||||||||
| 564 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | Mar 10, 2026 9:30 AM | 6227542170 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | 33.25 | R | H | 1.9 - 23 | uIU/mL | ||||||
| 565 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | Mar 10, 2026 9:30 AM | 6227542170 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||
| 566 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | Mar 10, 2026 9:30 AM | 6227542170 | LIPID PANEL | Direct HDL-C 4th Generation | 0.79 | L | 1.03 - 1.53 | mmol/L | |||||||
| 567 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | Mar 10, 2026 9:30 AM | 6227542170 | LIPID PANEL | Triglycerides (GPO) | 2.48 | 0.65 - 3.61 | mmol/L | ||||||||
| 568 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | Mar 10, 2026 9:30 AM | 6227542170 | LIPID PANEL | Cholesterol (High Performance) | 4.67 | 4.4 - 7.53 | mmol/L | ||||||||
| 569 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | Mar 10, 2026 9:30 AM | 6227542170 | LIPID PANEL | LDL Chol Friedewald 4th | 2.74 | 0 - 3.34 | mmol/L | ||||||||
| 570 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | Mar 10, 2026 9:30 AM | 6227542170 | RETICULOCYTES | Reticulocyte Count % | 1.8 | 0.6 - 2.5 | % | ||||||||
| 571 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | Mar 10, 2026 9:30 AM | 6227542170 | TSH | TSH 3rd IS-QT | 1.053 | 0.45 - 5.33 | mIU/L | ||||||||
| 572 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | Mar 10, 2026 9:30 AM | 6227542170 | URINE MACRO PANEL | Ur Specific Gravity | 1.017 | 1.01 - 1.03 | |||||||||
| 573 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | Mar 10, 2026 9:30 AM | 6227542170 | URINE MACRO PANEL | Ur pH | 5.5 | 5 - 8 | |||||||||
| 574 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | Mar 10, 2026 9:30 AM | 6227542170 | URINE MACRO PANEL | Ur Protein | Negative | Ref Rng:Negative | |||||||||
| 575 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | Mar 10, 2026 9:30 AM | 6227542170 | URINE MACRO PANEL | Ur Glucose | Normal | Ref Rng:Normal | |||||||||
| 576 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | Mar 10, 2026 9:30 AM | 6227542170 | URINE MACRO PANEL | Ur Ketones | Negative | Ref Rng:Negative | |||||||||
| 577 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | Mar 10, 2026 9:30 AM | 6227542170 | URINE MACRO PANEL | Ur Bilirubin | Negative | Ref Rng:Negative | |||||||||
| 578 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | Mar 10, 2026 9:30 AM | 6227542170 | URINE MACRO PANEL | Ur Urobilinogen | Normal | Ref Rng:Normal | |||||||||
| 579 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | Mar 10, 2026 9:30 AM | 6227542170 | URINE MACRO PANEL | Ur Blood | Negative | Ref Rng:Negative | |||||||||
| 580 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | Mar 10, 2026 9:30 AM | 6227542170 | URINE MACRO PANEL | Ur Nitrite | Negative | Ref Rng:Negative | |||||||||
| 581 | CZ100110008 | 59 | years | Male | End of Phase/Treatment | Mar 10, 2026 9:30 AM | 6227542170 | URINE MACRO PANEL | Ur Leukocyte Esterase | Negative | Ref Rng:Negative | |||||||||
| 582 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | C-REACTIVE PROTEIN | C Reactive Protein HS | 0.7 | 0 - 5 | mg/L | ||||||||
| 583 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | CHEMISTRY PANEL | Total Bilirubin | 10 | 3 - 21 | umol/L | ||||||||
| 584 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 3.2 | 0 - 6.2 | umol/L | ||||||||
| 585 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | CHEMISTRY PANEL | Alkaline Phosphatase | 60 | 40 - 129 | U/L | ||||||||
| 586 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | CHEMISTRY PANEL | ALT (SGPT) | 22 | 5 - 48 | U/L | ||||||||
| 587 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | CHEMISTRY PANEL | AST (SGOT) | 17 | 8 - 40 | U/L | ||||||||
| 588 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | CHEMISTRY PANEL | GGT | 26 | 10 - 61 | U/L | ||||||||
| 589 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | CHEMISTRY PANEL | LDH | 161 | 53 - 234 | U/L | ||||||||
| 590 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | CHEMISTRY PANEL | Urea Nitrogen | 5.2 | 1.4 - 8.6 | mmol/L | ||||||||
| 591 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 86 | 40 - 110 | umol/L | ||||||||
| 592 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | CHEMISTRY PANEL | Glucose Fasting | 5.0 | 3.9 - 5.6 | mmol/L | ||||||||
| 593 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | CHEMISTRY PANEL | Serum Uric Acid | 261 | 125 - 488 | umol/L | ||||||||
| 594 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | CHEMISTRY PANEL | Calcium (EDTA) | 2.52 | 2.07 - 2.64 | mmol/L | ||||||||
| 595 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | CHEMISTRY PANEL | Phosphorus | 1.20 | 0.71 - 1.65 | mmol/L | ||||||||
| 596 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | CHEMISTRY PANEL | Total Protein | 74 | 61 - 84 | g/L | ||||||||
| 597 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | CHEMISTRY PANEL | Albumin-BCG | 53 | H | 33 - 49 | g/L | |||||||
| 598 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | CHEMISTRY PANEL | Creatine Kinase | 70 | 39 - 308 | U/L | ||||||||
| 599 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | CHEMISTRY PANEL | Serum Sodium | 142 | 132 - 147 | mmol/L | ||||||||
| 600 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | CHEMISTRY PANEL | Serum Potassium | 4.4 | 3.5 - 5.2 | mmol/L | ||||||||
| 601 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | CHEMISTRY PANEL | Serum Bicarbonate | 25.3 | 19.3 - 29.3 | mmol/L | ||||||||
| 602 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | CHEMISTRY PANEL | Serum Chloride | 104 | 94 - 112 | mmol/L | ||||||||
| 603 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | CREATININE CLEARANCE CC&G | CreatininClearancCockcrftGault | 1.99 | 1.42 - 2.08 | mL/sec | ||||||||
| 604 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | CREATININE CLEARANCE CC&G | Creatinine(Rate Blanked)-2dp | 86 | 40 - 110 | umol/L | ||||||||
| 605 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | CREATININE CLEARANCE CC&G | Weight (kg,1dec place) | Y | 81.1 | kg | ||||||||
| 606 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | DRUG SCREEN URINE | Amphetamines/MDMA | Neg | Neg;$Cutoff = 1000 ng/mL | |||||||||
| 607 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | DRUG SCREEN URINE | Barbiturates | Neg | Neg;$Cutoff = 200 ng/mL | |||||||||
| 608 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | DRUG SCREEN URINE | Cannabinoids | Neg | Neg;$Cutoff = 50 ng/mL | |||||||||
| 609 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | DRUG SCREEN URINE | Cocaine | Neg | Neg;$Cutoff = 300 ng/mL | |||||||||
| 610 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | DRUG SCREEN URINE | Opiates | Neg | Neg;$Cutoff = 300 ng/mL | |||||||||
| 611 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | DRUG SCREEN URINE | Methadone | Neg | Neg;$Cutoff = 300 ng/mL | |||||||||
| 612 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | DRUG SCREEN URINE BENZO NON-US | Benzodiazepines Gen 2 | Neg | Neg;$Cutoff = 200 ng/mL | |||||||||
| 613 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | GFR | EGFR by MDRD | 87 | mL/min/1.73m^2$No Ref Rng | |||||||||
| 614 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | Test cancelled: Clotted Blood Received | ||||||||||
| 615 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | Test cancelled: Clotted Blood Received | ||||||||||
| 616 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | Test cancelled: Clotted Blood Received | ||||||||||
| 617 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | Test cancelled: Clotted Blood Received | ||||||||||
| 618 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | Test cancelled: Clotted Blood Received | ||||||||||
| 619 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | Test cancelled: Clotted Blood Received | ||||||||||
| 620 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | Test cancelled: Clotted Blood Received | ||||||||||
| 621 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | Test cancelled: Clotted Blood Received | ||||||||||
| 622 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | Test cancelled: Clotted Blood Received | ||||||||||
| 623 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | Test cancelled: Clotted Blood Received | ||||||||||
| 624 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | Test cancelled: Clotted Blood Received | ||||||||||
| 625 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | Test cancelled: Clotted Blood Received | ||||||||||
| 626 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | Test cancelled: Clotted Blood Received | ||||||||||
| 627 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | Test cancelled: Clotted Blood Received | ||||||||||
| 628 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | Test cancelled: Clotted Blood Received | ||||||||||
| 629 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | Test cancelled: Clotted Blood Received | ||||||||||
| 630 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | Test cancelled: Clotted Blood Received | ||||||||||
| 631 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | HEMOGLOBIN A1C | Hemoglobin A1c,NGSP-RM | 5.2 | <6.5 % | |||||||||
| 632 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | 5.94 | 1.9 - 23 | uIU/mL | ||||||||
| 633 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||
| 634 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | IS SUBJECT OF BLACK RACE? | Subject of black race? | Y | No | |||||||||
| 635 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | LIPID PANEL | Direct HDL-C 4th Generation | 0.90 | L | 1.03 - 1.53 | mmol/L | |||||||
| 636 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | LIPID PANEL | Triglycerides (GPO) | 1.55 | 0.56 - 3.62 | mmol/L | ||||||||
| 637 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | LIPID PANEL | Cholesterol (High Performance) | 4.40 | 3.88 - 6.83 | mmol/L | ||||||||
| 638 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | LIPID PANEL | LDL Chol Friedewald 4th | 2.79 | 0 - 3.34 | mmol/L | ||||||||
| 639 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | RETICULOCYTES | Reticulocyte Count % | Test cancelled: Clotted Blood Received | ||||||||||
| 640 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | TSH | TSH 3rd IS-QT | 0.855 | 0.45 - 5.33 | mIU/L | ||||||||
| 641 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | URINE MACRO PANEL | Ur Specific Gravity | 1.017 | 1 - 1.04 | |||||||||
| 642 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | URINE MACRO PANEL | Ur pH | 5.5 | 5 - 8 | |||||||||
| 643 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | URINE MACRO PANEL | Ur Protein | Negative | Ref Rng:Negative | |||||||||
| 644 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | URINE MACRO PANEL | Ur Glucose | Normal | Ref Rng:Normal | |||||||||
| 645 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | URINE MACRO PANEL | Ur Ketones | Negative | Ref Rng:Negative | |||||||||
| 646 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | URINE MACRO PANEL | Ur Bilirubin | Negative | Ref Rng:Negative | |||||||||
| 647 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | URINE MACRO PANEL | Ur Urobilinogen | Normal | Ref Rng:Normal | |||||||||
| 648 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | URINE MACRO PANEL | Ur Blood | Negative | Ref Rng:Negative | |||||||||
| 649 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | URINE MACRO PANEL | Ur Nitrite | Negative | Ref Rng:Negative | |||||||||
| 650 | CZ100110012 | 37 | years | Male | Part 1 Screening | Mar 6, 2026 9:22 AM | 6227797407 | URINE MACRO PANEL | Ur Leukocyte Esterase | Negative | Ref Rng:Negative | |||||||||
| 651 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | C-REACTIVE PROTEIN | C Reactive Protein HS | 12.0 | H | 0 - 5 | mg/L | |||||||
| 652 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | CHEMISTRY PANEL | Total Bilirubin | 8 | 3 - 21 | umol/L | ||||||||
| 653 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 2.7 | 0 - 6.2 | umol/L | ||||||||
| 654 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | CHEMISTRY PANEL | Alkaline Phosphatase | 120 | 40 - 129 | U/L | ||||||||
| 655 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | CHEMISTRY PANEL | ALT (SGPT) | 15 | 5 - 48 | U/L | ||||||||
| 656 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | CHEMISTRY PANEL | AST (SGOT) | 20 | 8 - 40 | U/L | ||||||||
| 657 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | CHEMISTRY PANEL | GGT | 15 | 10 - 50 | U/L | ||||||||
| 658 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | CHEMISTRY PANEL | LDH | 165 | 53 - 234 | U/L | ||||||||
| 659 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | CHEMISTRY PANEL | Urea Nitrogen | 6.1 | 1.4 - 8.6 | mmol/L | ||||||||
| 660 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 108 | 40 - 119 | umol/L | ||||||||
| 661 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | CHEMISTRY PANEL | Glucose Fasting | 5.7 | H | 3.9 - 5.6 | mmol/L | |||||||
| 662 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | CHEMISTRY PANEL | Serum Uric Acid | 237 | 149 - 494 | umol/L | ||||||||
| 663 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | CHEMISTRY PANEL | Calcium (EDTA) | 2.37 | 2.07 - 2.64 | mmol/L | ||||||||
| 664 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | CHEMISTRY PANEL | Phosphorus | 0.98 | 0.71 - 1.65 | mmol/L | ||||||||
| 665 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | CHEMISTRY PANEL | Total Protein | 84 | H | 60 - 80 | g/L | |||||||
| 666 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | CHEMISTRY PANEL | Albumin-BCG | 46 | 33 - 49 | g/L | ||||||||
| 667 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | CHEMISTRY PANEL | Creatine Kinase | 116 | 39 - 308 | U/L | ||||||||
| 668 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | CHEMISTRY PANEL | Serum Sodium | 138 | 135 - 145 | mmol/L | ||||||||
| 669 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | CHEMISTRY PANEL | Serum Potassium | 4.0 | 3.5 - 5.2 | mmol/L | ||||||||
| 670 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | CHEMISTRY PANEL | Serum Bicarbonate | 17.8 | L | 19.3 - 29.3 | mmol/L | |||||||
| 671 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | CHEMISTRY PANEL | Serum Chloride | 102 | 94 - 112 | mmol/L | ||||||||
| 672 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | CREATININE CLEARANCE CC&G | CreatininClearancCockcrftGault | 1.23 | L | 1.42 - 2.08 | mL/sec | |||||||
| 673 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | CREATININE CLEARANCE CC&G | Creatinine(Rate Blanked)-2dp | 108 | 40 - 119 | umol/L | ||||||||
| 674 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | CREATININE CLEARANCE CC&G | Weight (kg,1dec place) | Y | 82.0 | kg | ||||||||
| 675 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | DRUG SCREEN URINE | Amphetamines/MDMA | Neg | Neg;$Cutoff = 1000 ng/mL | |||||||||
| 676 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | DRUG SCREEN URINE | Barbiturates | Neg | Neg;$Cutoff = 200 ng/mL | |||||||||
| 677 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | DRUG SCREEN URINE | Cannabinoids | Neg | Neg;$Cutoff = 50 ng/mL | |||||||||
| 678 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | DRUG SCREEN URINE | Cocaine | Neg | Neg;$Cutoff = 300 ng/mL | |||||||||
| 679 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | DRUG SCREEN URINE | Opiates | Neg | Neg;$Cutoff = 300 ng/mL | |||||||||
| 680 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | DRUG SCREEN URINE | Methadone | Neg | Neg;$Cutoff = 300 ng/mL | |||||||||
| 681 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | DRUG SCREEN URINE BENZO NON-US | Benzodiazepines Gen 2 | Neg | Neg;$Cutoff = 200 ng/mL | |||||||||
| 682 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | GFR | EGFR by MDRD | 60 | mL/min/1.73m^2$No Ref Rng | |||||||||
| 683 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 140 | 125 - 170 | g/L | ||||||||
| 684 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.42 | 0.37 - 0.51 | |||||||||
| 685 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 5.1 | 4 - 5.8 | TI/L | ||||||||
| 686 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||
| 687 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 83 | 80 - 100 | fL | ||||||||
| 688 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 9.37 | 3.8 - 10.7 | GI/L | ||||||||
| 689 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 6.83 | 1.96 - 7.23 | GI/L | ||||||||
| 690 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.79 | 0.8 - 3 | GI/L | ||||||||
| 691 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.61 | 0.12 - 0.92 | GI/L | ||||||||
| 692 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.10 | 0 - 0.57 | GI/L | ||||||||
| 693 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.04 | 0 - 0.2 | GI/L | ||||||||
| 694 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 72.9 | 40.5 - 75 | % | ||||||||
| 695 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 19.1 | 15.4 - 48.5 | % | ||||||||
| 696 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 6.5 | 2.6 - 10.1 | % | ||||||||
| 697 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 1.1 | 0 - 6.8 | % | ||||||||
| 698 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 0.4 | 0 - 2 | % | ||||||||
| 699 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 509 | R | H | 130 - 394 | GI/L | ||||||
| 700 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | HEMOGLOBIN A1C | Hemoglobin A1c,NGSP-RM | 6.5 | H | <6.5 % | ||||||||
| 701 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | 5.10 | 1.9 - 23 | uIU/mL | ||||||||
| 702 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||
| 703 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | IS SUBJECT OF BLACK RACE? | Subject of black race? | Y | No | |||||||||
| 704 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | LIPID PANEL | Direct HDL-C 4th Generation | 1.24 | 1.03 - 1.53 | mmol/L | ||||||||
| 705 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | LIPID PANEL | Triglycerides (GPO) | 1.36 | 0.65 - 2.94 | mmol/L | ||||||||
| 706 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | LIPID PANEL | Cholesterol (High Performance) | 3.73 | L | 4.53 - 7.71 | mmol/L | |||||||
| 707 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | LIPID PANEL | LDL Chol Friedewald 4th | 1.87 | 0 - 3.34 | mmol/L | ||||||||
| 708 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | RETICULOCYTES | Reticulocyte Count % | 0.7 | 0.6 - 2.5 | % | ||||||||
| 709 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | TSH | TSH 3rd IS-QT | 1.311 | 0.45 - 5.33 | mIU/L | ||||||||
| 710 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | URINE MACRO PANEL | Ur Specific Gravity | 1.017 | 1.01 - 1.03 | |||||||||
| 711 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | URINE MACRO PANEL | Ur pH | 5.5 | 5 - 8 | |||||||||
| 712 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | URINE MACRO PANEL | Ur Protein | Negative | Ref Rng:Negative | |||||||||
| 713 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | URINE MACRO PANEL | Ur Glucose | Normal | Ref Rng:Normal | |||||||||
| 714 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | URINE MACRO PANEL | Ur Ketones | Negative | Ref Rng:Negative | |||||||||
| 715 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | URINE MACRO PANEL | Ur Bilirubin | Negative | Ref Rng:Negative | |||||||||
| 716 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | URINE MACRO PANEL | Ur Urobilinogen | Normal | Ref Rng:Normal | |||||||||
| 717 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | URINE MACRO PANEL | Ur Blood | Negative | Ref Rng:Negative | |||||||||
| 718 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | URINE MACRO PANEL | Ur Nitrite | Negative | Ref Rng:Negative | |||||||||
| 719 | CZ100110011 | 61 | years | Male | Part 1 Screening | Mar 2, 2026 9:05 AM | 6227797408 | URINE MACRO PANEL | Ur Leukocyte Esterase | Negative | Ref Rng:Negative | |||||||||
| 720 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | C-REACTIVE PROTEIN | C Reactive Protein HS | 0.5 | 0 - 5 | mg/L | ||||||||
| 721 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | CHEMISTRY PANEL | Total Bilirubin | 15 | 3 - 21 | umol/L | ||||||||
| 722 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 4.7 | 0 - 6.2 | umol/L | ||||||||
| 723 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | CHEMISTRY PANEL | Alkaline Phosphatase | 89 | 40 - 129 | U/L | ||||||||
| 724 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | CHEMISTRY PANEL | ALT (SGPT) | 23 | 5 - 48 | U/L | ||||||||
| 725 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | CHEMISTRY PANEL | AST (SGOT) | 16 | 8 - 40 | U/L | ||||||||
| 726 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | CHEMISTRY PANEL | GGT | 13 | 10 - 61 | U/L | ||||||||
| 727 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | CHEMISTRY PANEL | LDH | 157 | 53 - 234 | U/L | ||||||||
| 728 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | CHEMISTRY PANEL | Urea Nitrogen | 4.9 | 1.4 - 8.6 | mmol/L | ||||||||
| 729 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 90 | 40 - 110 | umol/L | ||||||||
| 730 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | CHEMISTRY PANEL | Glucose Fasting | 4.9 | 3.9 - 5.6 | mmol/L | ||||||||
| 731 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | CHEMISTRY PANEL | Serum Uric Acid | 287 | 125 - 488 | umol/L | ||||||||
| 732 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | CHEMISTRY PANEL | Calcium (EDTA) | 2.55 | 2.07 - 2.64 | mmol/L | ||||||||
| 733 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | CHEMISTRY PANEL | Phosphorus | 1.09 | 0.71 - 1.65 | mmol/L | ||||||||
| 734 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | CHEMISTRY PANEL | Total Protein | 76 | 61 - 84 | g/L | ||||||||
| 735 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | CHEMISTRY PANEL | Albumin-BCG | 51 | H | 33 - 49 | g/L | |||||||
| 736 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | CHEMISTRY PANEL | Creatine Kinase | 332 | H | 39 - 308 | U/L | |||||||
| 737 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | CHEMISTRY PANEL | Serum Sodium | 139 | 132 - 147 | mmol/L | ||||||||
| 738 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | CHEMISTRY PANEL | Serum Potassium | 3.9 | 3.5 - 5.2 | mmol/L | ||||||||
| 739 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | CHEMISTRY PANEL | Serum Bicarbonate | 23.8 | 19.3 - 29.3 | mmol/L | ||||||||
| 740 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | CHEMISTRY PANEL | Serum Chloride | 100 | 94 - 112 | mmol/L | ||||||||
| 741 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | CREATININE CLEARANCE CC&G | CreatininClearancCockcrftGault | 1.60 | 1.42 - 2.08 | mL/sec | ||||||||
| 742 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | CREATININE CLEARANCE CC&G | Creatinine(Rate Blanked)-2dp | 90 | 40 - 110 | umol/L | ||||||||
| 743 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | CREATININE CLEARANCE CC&G | Weight (kg,1dec place) | Y | 61.0 | kg | ||||||||
| 744 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | DRUG SCREEN URINE | Amphetamines/MDMA | Neg | Neg;$Cutoff = 1000 ng/mL | |||||||||
| 745 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | DRUG SCREEN URINE | Barbiturates | Neg | Neg;$Cutoff = 200 ng/mL | |||||||||
| 746 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | DRUG SCREEN URINE | Cannabinoids | Neg | Neg;$Cutoff = 50 ng/mL | |||||||||
| 747 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | DRUG SCREEN URINE | Cocaine | Neg | Neg;$Cutoff = 300 ng/mL | |||||||||
| 748 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | DRUG SCREEN URINE | Opiates | Neg | Neg;$Cutoff = 300 ng/mL | |||||||||
| 749 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | DRUG SCREEN URINE | Methadone | Neg | Neg;$Cutoff = 300 ng/mL | |||||||||
| 750 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | DRUG SCREEN URINE BENZO NON-US | Benzodiazepines Gen 2 | Neg | Neg;$Cutoff = 200 ng/mL | |||||||||
| 751 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | GFR | EGFR by MDRD | 89 | mL/min/1.73m^2$No Ref Rng | |||||||||
| 752 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 149 | 127 - 181 | g/L | ||||||||
| 753 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.43 | 0.39 - 0.54 | |||||||||
| 754 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.9 | 4.5 - 6.4 | TI/L | ||||||||
| 755 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||
| 756 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 86 | 79 - 96 | fL | ||||||||
| 757 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 6.69 | 3.8 - 10.7 | GI/L | ||||||||
| 758 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 4.98 | 1.96 - 7.23 | GI/L | ||||||||
| 759 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.11 | 0.91 - 4.28 | GI/L | ||||||||
| 760 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.45 | 0.12 - 0.92 | GI/L | ||||||||
| 761 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.06 | 0 - 0.57 | GI/L | ||||||||
| 762 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.10 | 0 - 0.2 | GI/L | ||||||||
| 763 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 74.5 | 40.5 - 75 | % | ||||||||
| 764 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 16.5 | 15.4 - 48.5 | % | ||||||||
| 765 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 6.8 | 2.6 - 10.1 | % | ||||||||
| 766 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 0.9 | 0 - 6.8 | % | ||||||||
| 767 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 1.4 | 0 - 2 | % | ||||||||
| 768 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 262 | 140 - 400 | GI/L | ||||||||
| 769 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | HEMOGLOBIN A1C | Hemoglobin A1c,NGSP-RM | 5.1 | <6.5 % | |||||||||
| 770 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | 4.81 | 1.9 - 23 | uIU/mL | ||||||||
| 771 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||
| 772 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | IS SUBJECT OF BLACK RACE? | Subject of black race? | Y | No | |||||||||
| 773 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | LIPID PANEL | Direct HDL-C 4th Generation | 1.32 | 1.03 - 1.53 | mmol/L | ||||||||
| 774 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | LIPID PANEL | Triglycerides (GPO) | 0.69 | 0.5 - 2.81 | mmol/L | ||||||||
| 775 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | LIPID PANEL | Cholesterol (High Performance) | 4.31 | 3.31 - 6.1 | mmol/L | ||||||||
| 776 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | LIPID PANEL | LDL Chol Friedewald 4th | 2.67 | 0 - 3.34 | mmol/L | ||||||||
| 777 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | RETICULOCYTES | Reticulocyte Count % | 1.2 | 0.6 - 2.5 | % | ||||||||
| 778 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | TSH | TSH 3rd IS-QT | 0.928 | 0.45 - 5.33 | mIU/L | ||||||||
| 779 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | URINE MACRO PANEL | Ur Specific Gravity | 1.009 | 1 - 1.04 | |||||||||
| 780 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | URINE MACRO PANEL | Ur pH | 5.5 | 5 - 8 | |||||||||
| 781 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | URINE MACRO PANEL | Ur Protein | Negative | Ref Rng:Negative | |||||||||
| 782 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | URINE MACRO PANEL | Ur Glucose | Normal | Ref Rng:Normal | |||||||||
| 783 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | URINE MACRO PANEL | Ur Ketones | Negative | Ref Rng:Negative | |||||||||
| 784 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | URINE MACRO PANEL | Ur Bilirubin | Negative | Ref Rng:Negative | |||||||||
| 785 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | URINE MACRO PANEL | Ur Urobilinogen | Normal | Ref Rng:Normal | |||||||||
| 786 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | URINE MACRO PANEL | Ur Blood | Negative | Ref Rng:Negative | |||||||||
| 787 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | URINE MACRO PANEL | Ur Nitrite | Negative | Ref Rng:Negative | |||||||||
| 788 | CZ100110010 | 25 | years | Male | Part 1 Screening | Feb 17, 2026 11:03 AM | 6227797406 | URINE MACRO PANEL | Ur Leukocyte Esterase | Negative | Ref Rng:Negative | |||||||||
| 789 | CZ100110007 | 56 | years | Female | Part 2 OL Induction Day 29 | Feb 16, 2026 9:18 AM | 6226550646 | C-REACTIVE PROTEIN | C Reactive Protein HS | 4.4 | 0 - 5 | mg/L | ||||||||
| 790 | CZ100110007 | 56 | years | Female | Part 2 OL Induction Day 29 | Feb 16, 2026 9:18 AM | 6226550646 | CHEMISTRY PANEL | Total Bilirubin | 6 | 3 - 21 | umol/L | ||||||||
| 791 | CZ100110007 | 56 | years | Female | Part 2 OL Induction Day 29 | Feb 16, 2026 9:18 AM | 6226550646 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 2.3 | 0 - 6.2 | umol/L | ||||||||
| 792 | CZ100110007 | 56 | years | Female | Part 2 OL Induction Day 29 | Feb 16, 2026 9:18 AM | 6226550646 | CHEMISTRY PANEL | Alkaline Phosphatase | 67 | 35 - 104 | U/L | ||||||||
| 793 | CZ100110007 | 56 | years | Female | Part 2 OL Induction Day 29 | Feb 16, 2026 9:18 AM | 6226550646 | CHEMISTRY PANEL | ALT (SGPT) | 28 | 4 - 43 | U/L | ||||||||
| 794 | CZ100110007 | 56 | years | Female | Part 2 OL Induction Day 29 | Feb 16, 2026 9:18 AM | 6226550646 | CHEMISTRY PANEL | AST (SGOT) | 30 | 8 - 40 | U/L | ||||||||
| 795 | CZ100110007 | 56 | years | Female | Part 2 OL Induction Day 29 | Feb 16, 2026 9:18 AM | 6226550646 | CHEMISTRY PANEL | GGT | 27 | 4 - 49 | U/L | ||||||||
| 796 | CZ100110007 | 56 | years | Female | Part 2 OL Induction Day 29 | Feb 16, 2026 9:18 AM | 6226550646 | CHEMISTRY PANEL | LDH | 166 | 53 - 234 | U/L | ||||||||
| 797 | CZ100110007 | 56 | years | Female | Part 2 OL Induction Day 29 | Feb 16, 2026 9:18 AM | 6226550646 | CHEMISTRY PANEL | Urea Nitrogen | 4.7 | 1.4 - 8.6 | mmol/L | ||||||||
| 798 | CZ100110007 | 56 | years | Female | Part 2 OL Induction Day 29 | Feb 16, 2026 9:18 AM | 6226550646 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 76 | 31 - 101 | umol/L | ||||||||
| 799 | CZ100110007 | 56 | years | Female | Part 2 OL Induction Day 29 | Feb 16, 2026 9:18 AM | 6226550646 | CHEMISTRY PANEL | Glucose Fasting | 4.8 | 3.9 - 5.6 | mmol/L | ||||||||
| 800 | CZ100110007 | 56 | years | Female | Part 2 OL Induction Day 29 | Feb 16, 2026 9:18 AM | 6226550646 | CHEMISTRY PANEL | Serum Uric Acid | 337 | 149 - 446 | umol/L | ||||||||
| 801 | CZ100110007 | 56 | years | Female | Part 2 OL Induction Day 29 | Feb 16, 2026 9:18 AM | 6226550646 | CHEMISTRY PANEL | Calcium (EDTA) | 2.51 | 2.07 - 2.64 | mmol/L | ||||||||
| 802 | CZ100110007 | 56 | years | Female | Part 2 OL Induction Day 29 | Feb 16, 2026 9:18 AM | 6226550646 | CHEMISTRY PANEL | Phosphorus | 1.16 | 0.71 - 1.65 | mmol/L | ||||||||
| 803 | CZ100110007 | 56 | years | Female | Part 2 OL Induction Day 29 | Feb 16, 2026 9:18 AM | 6226550646 | CHEMISTRY PANEL | Total Protein | 75 | 61 - 84 | g/L | ||||||||
| 804 | CZ100110007 | 56 | years | Female | Part 2 OL Induction Day 29 | Feb 16, 2026 9:18 AM | 6226550646 | CHEMISTRY PANEL | Albumin-BCG | 46 | 33 - 49 | g/L | ||||||||
| 805 | CZ100110007 | 56 | years | Female | Part 2 OL Induction Day 29 | Feb 16, 2026 9:18 AM | 6226550646 | CHEMISTRY PANEL | Creatine Kinase | 148 | 26 - 192 | U/L | ||||||||
| 806 | CZ100110007 | 56 | years | Female | Part 2 OL Induction Day 29 | Feb 16, 2026 9:18 AM | 6226550646 | CHEMISTRY PANEL | Serum Sodium | 138 | 132 - 147 | mmol/L | ||||||||
| 807 | CZ100110007 | 56 | years | Female | Part 2 OL Induction Day 29 | Feb 16, 2026 9:18 AM | 6226550646 | CHEMISTRY PANEL | Serum Potassium | 4.4 | 3.5 - 5.2 | mmol/L | ||||||||
| 808 | CZ100110007 | 56 | years | Female | Part 2 OL Induction Day 29 | Feb 16, 2026 9:18 AM | 6226550646 | CHEMISTRY PANEL | Serum Bicarbonate | 21.7 | 19.3 - 29.3 | mmol/L | ||||||||
| 809 | CZ100110007 | 56 | years | Female | Part 2 OL Induction Day 29 | Feb 16, 2026 9:18 AM | 6226550646 | CHEMISTRY PANEL | Serum Chloride | 102 | 94 - 112 | mmol/L | ||||||||
| 810 | CZ100110007 | 56 | years | Female | Part 2 OL Induction Day 29 | Feb 16, 2026 9:18 AM | 6226550646 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 145 | 116 - 164 | g/L | ||||||||
| 811 | CZ100110007 | 56 | years | Female | Part 2 OL Induction Day 29 | Feb 16, 2026 9:18 AM | 6226550646 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.43 | 0.34 - 0.48 | |||||||||
| 812 | CZ100110007 | 56 | years | Female | Part 2 OL Induction Day 29 | Feb 16, 2026 9:18 AM | 6226550646 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.7 | 4.1 - 5.6 | TI/L | ||||||||
| 813 | CZ100110007 | 56 | years | Female | Part 2 OL Induction Day 29 | Feb 16, 2026 9:18 AM | 6226550646 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||
| 814 | CZ100110007 | 56 | years | Female | Part 2 OL Induction Day 29 | Feb 16, 2026 9:18 AM | 6226550646 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 91 | 79 - 98 | fL | ||||||||
| 815 | CZ100110007 | 56 | years | Female | Part 2 OL Induction Day 29 | Feb 16, 2026 9:18 AM | 6226550646 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 8.09 | 3.8 - 10.7 | GI/L | ||||||||
| 816 | CZ100110007 | 56 | years | Female | Part 2 OL Induction Day 29 | Feb 16, 2026 9:18 AM | 6226550646 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 4.49 | 1.96 - 7.23 | GI/L | ||||||||
| 817 | CZ100110007 | 56 | years | Female | Part 2 OL Induction Day 29 | Feb 16, 2026 9:18 AM | 6226550646 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 3.02 | 0.91 - 4.28 | GI/L | ||||||||
| 818 | CZ100110007 | 56 | years | Female | Part 2 OL Induction Day 29 | Feb 16, 2026 9:18 AM | 6226550646 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.33 | 0.12 - 0.92 | GI/L | ||||||||
| 819 | CZ100110007 | 56 | years | Female | Part 2 OL Induction Day 29 | Feb 16, 2026 9:18 AM | 6226550646 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.16 | 0 - 0.57 | GI/L | ||||||||
| 820 | CZ100110007 | 56 | years | Female | Part 2 OL Induction Day 29 | Feb 16, 2026 9:18 AM | 6226550646 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.08 | 0 - 0.2 | GI/L | ||||||||
| 821 | CZ100110007 | 56 | years | Female | Part 2 OL Induction Day 29 | Feb 16, 2026 9:18 AM | 6226550646 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 55.6 | 40.5 - 75 | % | ||||||||
| 822 | CZ100110007 | 56 | years | Female | Part 2 OL Induction Day 29 | Feb 16, 2026 9:18 AM | 6226550646 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 37.4 | 15.4 - 48.5 | % | ||||||||
| 823 | CZ100110007 | 56 | years | Female | Part 2 OL Induction Day 29 | Feb 16, 2026 9:18 AM | 6226550646 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 4.0 | 2.6 - 10.1 | % | ||||||||
| 824 | CZ100110007 | 56 | years | Female | Part 2 OL Induction Day 29 | Feb 16, 2026 9:18 AM | 6226550646 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 2.0 | 0 - 6.8 | % | ||||||||
| 825 | CZ100110007 | 56 | years | Female | Part 2 OL Induction Day 29 | Feb 16, 2026 9:18 AM | 6226550646 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 1.0 | 0 - 2 | % | ||||||||
| 826 | CZ100110007 | 56 | years | Female | Part 2 OL Induction Day 29 | Feb 16, 2026 9:18 AM | 6226550646 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 316 | 140 - 400 | GI/L | ||||||||
| 827 | CZ100110007 | 56 | years | Female | Part 2 OL Induction Day 29 | Feb 16, 2026 9:18 AM | 6226550646 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | 3.12 | 1.9 - 23 | uIU/mL | ||||||||
| 828 | CZ100110007 | 56 | years | Female | Part 2 OL Induction Day 29 | Feb 16, 2026 9:18 AM | 6226550646 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||
| 829 | CZ100110007 | 56 | years | Female | Part 2 OL Induction Day 29 | Feb 16, 2026 9:18 AM | 6226550646 | LIPID PANEL | Direct HDL-C 4th Generation | 1.96 | H | 1.03 - 1.53 | mmol/L | |||||||
| 830 | CZ100110007 | 56 | years | Female | Part 2 OL Induction Day 29 | Feb 16, 2026 9:18 AM | 6226550646 | LIPID PANEL | Triglycerides (GPO) | 1.32 | 0.59 - 2.96 | mmol/L | ||||||||
| 831 | CZ100110007 | 56 | years | Female | Part 2 OL Induction Day 29 | Feb 16, 2026 9:18 AM | 6226550646 | LIPID PANEL | Cholesterol (High Performance) | 5.64 | 4.42 - 7.53 | mmol/L | ||||||||
| 832 | CZ100110007 | 56 | years | Female | Part 2 OL Induction Day 29 | Feb 16, 2026 9:18 AM | 6226550646 | LIPID PANEL | LDL Chol Friedewald 4th | 3.08 | 0 - 3.34 | mmol/L | ||||||||
| 833 | CZ100110007 | 56 | years | Female | Part 2 OL Induction Day 29 | Feb 16, 2026 9:18 AM | 6226550646 | RETICULOCYTES | Reticulocyte Count % | 0.6 | 0.6 - 2.5 | % | ||||||||
| 834 | CZ100110007 | 56 | years | Female | Part 2 OL Induction Day 29 | Feb 16, 2026 9:18 AM | 6226550646 | URINE MACRO PANEL | Ur Specific Gravity | 1.021 | 1 - 1.04 | |||||||||
| 835 | CZ100110007 | 56 | years | Female | Part 2 OL Induction Day 29 | Feb 16, 2026 9:18 AM | 6226550646 | URINE MACRO PANEL | Ur pH | 5.5 | 5 - 8 | |||||||||
| 836 | CZ100110007 | 56 | years | Female | Part 2 OL Induction Day 29 | Feb 16, 2026 9:18 AM | 6226550646 | URINE MACRO PANEL | Ur Protein | Negative | Ref Rng:Negative | |||||||||
| 837 | CZ100110007 | 56 | years | Female | Part 2 OL Induction Day 29 | Feb 16, 2026 9:18 AM | 6226550646 | URINE MACRO PANEL | Ur Glucose | Normal | Ref Rng:Normal | |||||||||
| 838 | CZ100110007 | 56 | years | Female | Part 2 OL Induction Day 29 | Feb 16, 2026 9:18 AM | 6226550646 | URINE MACRO PANEL | Ur Ketones | Negative | Ref Rng:Negative | |||||||||
| 839 | CZ100110007 | 56 | years | Female | Part 2 OL Induction Day 29 | Feb 16, 2026 9:18 AM | 6226550646 | URINE MACRO PANEL | Ur Bilirubin | Negative | Ref Rng:Negative | |||||||||
| 840 | CZ100110007 | 56 | years | Female | Part 2 OL Induction Day 29 | Feb 16, 2026 9:18 AM | 6226550646 | URINE MACRO PANEL | Ur Urobilinogen | Normal | Ref Rng:Normal | |||||||||
| 841 | CZ100110007 | 56 | years | Female | Part 2 OL Induction Day 29 | Feb 16, 2026 9:18 AM | 6226550646 | URINE MACRO PANEL | Ur Blood | Negative | Ref Rng:$Negative-Trace | |||||||||
| 842 | CZ100110007 | 56 | years | Female | Part 2 OL Induction Day 29 | Feb 16, 2026 9:18 AM | 6226550646 | URINE MACRO PANEL | Ur Nitrite | Negative | Ref Rng:Negative | |||||||||
| 843 | CZ100110007 | 56 | years | Female | Part 2 OL Induction Day 29 | Feb 16, 2026 9:18 AM | 6226550646 | URINE MACRO PANEL | Ur Leukocyte Esterase | Trace | H | Ref Rng:Negative | ||||||||
| 844 | CZ100110007 | 56 | years | Female | Part 2 OL Induction Day 29 | Feb 16, 2026 9:18 AM | 6226550646 | URINE MICRO PANEL | Ur Microscopic | Negative | NEGATIVE$ | NEGATIVE | ||||||||
| 845 | CZ100110006 | 32 | years | Female | Part 2 OL Induction Day 29 | Feb 3, 2026 10:23 AM | 6226561517 | C-REACTIVE PROTEIN | C Reactive Protein HS | 2.0 | 0 - 5 | mg/L | ||||||||
| 846 | CZ100110006 | 32 | years | Female | Part 2 OL Induction Day 29 | Feb 3, 2026 10:23 AM | 6226561517 | CELLULAR ELEMENTS | Ur WBC/HPF | 3 | 0 - 12 | /HPF | ||||||||
| 847 | CZ100110006 | 32 | years | Female | Part 2 OL Induction Day 29 | Feb 3, 2026 10:23 AM | 6226561517 | CHEMISTRY PANEL | Total Bilirubin | 7 | 3 - 21 | umol/L | ||||||||
| 848 | CZ100110006 | 32 | years | Female | Part 2 OL Induction Day 29 | Feb 3, 2026 10:23 AM | 6226561517 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 2.4 | 0 - 6.2 | umol/L | ||||||||
| 849 | CZ100110006 | 32 | years | Female | Part 2 OL Induction Day 29 | Feb 3, 2026 10:23 AM | 6226561517 | CHEMISTRY PANEL | Alkaline Phosphatase | 90 | 35 - 104 | U/L | ||||||||
| 850 | CZ100110006 | 32 | years | Female | Part 2 OL Induction Day 29 | Feb 3, 2026 10:23 AM | 6226561517 | CHEMISTRY PANEL | ALT (SGPT) | 9 | 4 - 43 | U/L | ||||||||
| 851 | CZ100110006 | 32 | years | Female | Part 2 OL Induction Day 29 | Feb 3, 2026 10:23 AM | 6226561517 | CHEMISTRY PANEL | AST (SGOT) | 15 | 8 - 40 | U/L | ||||||||
| 852 | CZ100110006 | 32 | years | Female | Part 2 OL Induction Day 29 | Feb 3, 2026 10:23 AM | 6226561517 | CHEMISTRY PANEL | GGT | 8 | 4 - 49 | U/L | ||||||||
| 853 | CZ100110006 | 32 | years | Female | Part 2 OL Induction Day 29 | Feb 3, 2026 10:23 AM | 6226561517 | CHEMISTRY PANEL | LDH | 150 | 53 - 234 | U/L | ||||||||
| 854 | CZ100110006 | 32 | years | Female | Part 2 OL Induction Day 29 | Feb 3, 2026 10:23 AM | 6226561517 | CHEMISTRY PANEL | Urea Nitrogen | 4.1 | 1.4 - 8.6 | mmol/L | ||||||||
| 855 | CZ100110006 | 32 | years | Female | Part 2 OL Induction Day 29 | Feb 3, 2026 10:23 AM | 6226561517 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 61 | 31 - 101 | umol/L | ||||||||
| 856 | CZ100110006 | 32 | years | Female | Part 2 OL Induction Day 29 | Feb 3, 2026 10:23 AM | 6226561517 | CHEMISTRY PANEL | Glucose Fasting | 4.8 | 3.9 - 5.6 | mmol/L | ||||||||
| 857 | CZ100110006 | 32 | years | Female | Part 2 OL Induction Day 29 | Feb 3, 2026 10:23 AM | 6226561517 | CHEMISTRY PANEL | Serum Uric Acid | 250 | 125 - 428 | umol/L | ||||||||
| 858 | CZ100110006 | 32 | years | Female | Part 2 OL Induction Day 29 | Feb 3, 2026 10:23 AM | 6226561517 | CHEMISTRY PANEL | Calcium (EDTA) | 2.30 | 2.07 - 2.64 | mmol/L | ||||||||
| 859 | CZ100110006 | 32 | years | Female | Part 2 OL Induction Day 29 | Feb 3, 2026 10:23 AM | 6226561517 | CHEMISTRY PANEL | Phosphorus | 1.08 | 0.71 - 1.65 | mmol/L | ||||||||
| 860 | CZ100110006 | 32 | years | Female | Part 2 OL Induction Day 29 | Feb 3, 2026 10:23 AM | 6226561517 | CHEMISTRY PANEL | Total Protein | 77 | 61 - 84 | g/L | ||||||||
| 861 | CZ100110006 | 32 | years | Female | Part 2 OL Induction Day 29 | Feb 3, 2026 10:23 AM | 6226561517 | CHEMISTRY PANEL | Albumin-BCG | 46 | 33 - 49 | g/L | ||||||||
| 862 | CZ100110006 | 32 | years | Female | Part 2 OL Induction Day 29 | Feb 3, 2026 10:23 AM | 6226561517 | CHEMISTRY PANEL | Creatine Kinase | 69 | 26 - 192 | U/L | ||||||||
| 863 | CZ100110006 | 32 | years | Female | Part 2 OL Induction Day 29 | Feb 3, 2026 10:23 AM | 6226561517 | CHEMISTRY PANEL | Serum Sodium | 140 | 132 - 147 | mmol/L | ||||||||
| 864 | CZ100110006 | 32 | years | Female | Part 2 OL Induction Day 29 | Feb 3, 2026 10:23 AM | 6226561517 | CHEMISTRY PANEL | Serum Potassium | 4.9 | 3.5 - 5.2 | mmol/L | ||||||||
| 865 | CZ100110006 | 32 | years | Female | Part 2 OL Induction Day 29 | Feb 3, 2026 10:23 AM | 6226561517 | CHEMISTRY PANEL | Serum Bicarbonate | 23.4 | 19.3 - 29.3 | mmol/L | ||||||||
| 866 | CZ100110006 | 32 | years | Female | Part 2 OL Induction Day 29 | Feb 3, 2026 10:23 AM | 6226561517 | CHEMISTRY PANEL | Serum Chloride | 104 | 94 - 112 | mmol/L | ||||||||
| 867 | CZ100110006 | 32 | years | Female | Part 2 OL Induction Day 29 | Feb 3, 2026 10:23 AM | 6226561517 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 136 | 116 - 164 | g/L | ||||||||
| 868 | CZ100110006 | 32 | years | Female | Part 2 OL Induction Day 29 | Feb 3, 2026 10:23 AM | 6226561517 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.40 | 0.34 - 0.48 | |||||||||
| 869 | CZ100110006 | 32 | years | Female | Part 2 OL Induction Day 29 | Feb 3, 2026 10:23 AM | 6226561517 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.5 | 4.1 - 5.6 | TI/L | ||||||||
| 870 | CZ100110006 | 32 | years | Female | Part 2 OL Induction Day 29 | Feb 3, 2026 10:23 AM | 6226561517 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||
| 871 | CZ100110006 | 32 | years | Female | Part 2 OL Induction Day 29 | Feb 3, 2026 10:23 AM | 6226561517 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 89 | 79 - 98 | fL | ||||||||
| 872 | CZ100110006 | 32 | years | Female | Part 2 OL Induction Day 29 | Feb 3, 2026 10:23 AM | 6226561517 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 7.73 | 3.8 - 10.7 | GI/L | ||||||||
| 873 | CZ100110006 | 32 | years | Female | Part 2 OL Induction Day 29 | Feb 3, 2026 10:23 AM | 6226561517 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 4.57 | 1.96 - 7.23 | GI/L | ||||||||
| 874 | CZ100110006 | 32 | years | Female | Part 2 OL Induction Day 29 | Feb 3, 2026 10:23 AM | 6226561517 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 2.54 | 0.91 - 4.28 | GI/L | ||||||||
| 875 | CZ100110006 | 32 | years | Female | Part 2 OL Induction Day 29 | Feb 3, 2026 10:23 AM | 6226561517 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.42 | 0.12 - 0.92 | GI/L | ||||||||
| 876 | CZ100110006 | 32 | years | Female | Part 2 OL Induction Day 29 | Feb 3, 2026 10:23 AM | 6226561517 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.14 | 0 - 0.57 | GI/L | ||||||||
| 877 | CZ100110006 | 32 | years | Female | Part 2 OL Induction Day 29 | Feb 3, 2026 10:23 AM | 6226561517 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.06 | 0 - 0.2 | GI/L | ||||||||
| 878 | CZ100110006 | 32 | years | Female | Part 2 OL Induction Day 29 | Feb 3, 2026 10:23 AM | 6226561517 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 59.1 | 40.5 - 75 | % | ||||||||
| 879 | CZ100110006 | 32 | years | Female | Part 2 OL Induction Day 29 | Feb 3, 2026 10:23 AM | 6226561517 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 32.9 | 15.4 - 48.5 | % | ||||||||
| 880 | CZ100110006 | 32 | years | Female | Part 2 OL Induction Day 29 | Feb 3, 2026 10:23 AM | 6226561517 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 5.4 | 2.6 - 10.1 | % | ||||||||
| 881 | CZ100110006 | 32 | years | Female | Part 2 OL Induction Day 29 | Feb 3, 2026 10:23 AM | 6226561517 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 1.9 | 0 - 6.8 | % | ||||||||
| 882 | CZ100110006 | 32 | years | Female | Part 2 OL Induction Day 29 | Feb 3, 2026 10:23 AM | 6226561517 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 0.7 | 0 - 2 | % | ||||||||
| 883 | CZ100110006 | 32 | years | Female | Part 2 OL Induction Day 29 | Feb 3, 2026 10:23 AM | 6226561517 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 348 | 140 - 400 | GI/L | ||||||||
| 884 | CZ100110006 | 32 | years | Female | Part 2 OL Induction Day 29 | Feb 3, 2026 10:23 AM | 6226561517 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | 4.60 | 1.9 - 23 | uIU/mL | ||||||||
| 885 | CZ100110006 | 32 | years | Female | Part 2 OL Induction Day 29 | Feb 3, 2026 10:23 AM | 6226561517 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||
| 886 | CZ100110006 | 32 | years | Female | Part 2 OL Induction Day 29 | Feb 3, 2026 10:23 AM | 6226561517 | LIPID PANEL | Direct HDL-C 4th Generation | 1.10 | 1.03 - 1.53 | mmol/L | ||||||||
| 887 | CZ100110006 | 32 | years | Female | Part 2 OL Induction Day 29 | Feb 3, 2026 10:23 AM | 6226561517 | LIPID PANEL | Triglycerides (GPO) | 1.17 | 0.44 - 1.99 | mmol/L | ||||||||
| 888 | CZ100110006 | 32 | years | Female | Part 2 OL Induction Day 29 | Feb 3, 2026 10:23 AM | 6226561517 | LIPID PANEL | Cholesterol (High Performance) | 4.41 | 3.65 - 6.21 | mmol/L | ||||||||
| 889 | CZ100110006 | 32 | years | Female | Part 2 OL Induction Day 29 | Feb 3, 2026 10:23 AM | 6226561517 | LIPID PANEL | LDL Chol Friedewald 4th | 2.77 | 0 - 3.34 | mmol/L | ||||||||
| 890 | CZ100110006 | 32 | years | Female | Part 2 OL Induction Day 29 | Feb 3, 2026 10:23 AM | 6226561517 | RETICULOCYTES | Reticulocyte Count % | 1.9 | 0.6 - 2.5 | % | ||||||||
| 891 | CZ100110006 | 32 | years | Female | Part 2 OL Induction Day 29 | Feb 3, 2026 10:23 AM | 6226561517 | URINE MACRO PANEL | Ur Specific Gravity | 1.026 | 1 - 1.04 | |||||||||
| 892 | CZ100110006 | 32 | years | Female | Part 2 OL Induction Day 29 | Feb 3, 2026 10:23 AM | 6226561517 | URINE MACRO PANEL | Ur pH | 6.0 | 5 - 8 | |||||||||
| 893 | CZ100110006 | 32 | years | Female | Part 2 OL Induction Day 29 | Feb 3, 2026 10:23 AM | 6226561517 | URINE MACRO PANEL | Ur Protein | Negative | Ref Rng:Negative | |||||||||
| 894 | CZ100110006 | 32 | years | Female | Part 2 OL Induction Day 29 | Feb 3, 2026 10:23 AM | 6226561517 | URINE MACRO PANEL | Ur Glucose | Normal | Ref Rng:Normal | |||||||||
| 895 | CZ100110006 | 32 | years | Female | Part 2 OL Induction Day 29 | Feb 3, 2026 10:23 AM | 6226561517 | URINE MACRO PANEL | Ur Ketones | Negative | Ref Rng:Negative | |||||||||
| 896 | CZ100110006 | 32 | years | Female | Part 2 OL Induction Day 29 | Feb 3, 2026 10:23 AM | 6226561517 | URINE MACRO PANEL | Ur Bilirubin | Negative | Ref Rng:Negative | |||||||||
| 897 | CZ100110006 | 32 | years | Female | Part 2 OL Induction Day 29 | Feb 3, 2026 10:23 AM | 6226561517 | URINE MACRO PANEL | Ur Urobilinogen | Normal | Ref Rng:Normal | |||||||||
| 898 | CZ100110006 | 32 | years | Female | Part 2 OL Induction Day 29 | Feb 3, 2026 10:23 AM | 6226561517 | URINE MACRO PANEL | Ur Blood | Negative | Ref Rng:$Negative-Trace | |||||||||
| 899 | CZ100110006 | 32 | years | Female | Part 2 OL Induction Day 29 | Feb 3, 2026 10:23 AM | 6226561517 | URINE MACRO PANEL | Ur Nitrite | Negative | Ref Rng:Negative | |||||||||
| 900 | CZ100110006 | 32 | years | Female | Part 2 OL Induction Day 29 | Feb 3, 2026 10:23 AM | 6226561517 | URINE MACRO PANEL | Ur Leukocyte Esterase | +1 | H | Ref Rng:Negative | ||||||||
| 901 | CZ100110006 | 32 | years | Female | Part 2 OL Induction Day 29 | Feb 3, 2026 10:23 AM | 6226561517 | URINE MICRO PANEL | Ur Microscopic | Positive | NEGATIVE$ | NEGATIVE | ||||||||
| 902 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | C-REACTIVE PROTEIN | C Reactive Protein HS | 1.2 | 0 - 5 | mg/L | ||||||||
| 903 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | CELLULAR ELEMENTS | Ur WBC/HPF | 4 | 0 - 12 | /HPF | ||||||||
| 904 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | CHEMISTRY PANEL | Total Bilirubin | <3 | L | Result verified by repeat analysis | 3 - 21 | umol/L | ||||||
| 905 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 1.5 | 0 - 6.2 | umol/L | ||||||||
| 906 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | CHEMISTRY PANEL | Alkaline Phosphatase | 60 | 35 - 104 | U/L | ||||||||
| 907 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | CHEMISTRY PANEL | ALT (SGPT) | 11 | 4 - 43 | U/L | ||||||||
| 908 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | CHEMISTRY PANEL | AST (SGOT) | 13 | 8 - 40 | U/L | ||||||||
| 909 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | CHEMISTRY PANEL | GGT | 16 | 4 - 49 | U/L | ||||||||
| 910 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | CHEMISTRY PANEL | LDH | 128 | 53 - 234 | U/L | ||||||||
| 911 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | CHEMISTRY PANEL | Urea Nitrogen | 7.9 | 1.4 - 8.6 | mmol/L | ||||||||
| 912 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 84 | 31 - 101 | umol/L | ||||||||
| 913 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | CHEMISTRY PANEL | Glucose Fasting | 4.9 | 3.9 - 5.6 | mmol/L | ||||||||
| 914 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | CHEMISTRY PANEL | Serum Uric Acid | 250 | 125 - 428 | umol/L | ||||||||
| 915 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | CHEMISTRY PANEL | Calcium (EDTA) | 2.33 | 2.07 - 2.64 | mmol/L | ||||||||
| 916 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | CHEMISTRY PANEL | Phosphorus | 0.97 | 0.71 - 1.65 | mmol/L | ||||||||
| 917 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | CHEMISTRY PANEL | Total Protein | 66 | 61 - 84 | g/L | ||||||||
| 918 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | CHEMISTRY PANEL | Albumin-BCG | 45 | 33 - 49 | g/L | ||||||||
| 919 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | CHEMISTRY PANEL | Creatine Kinase | 79 | 26 - 192 | U/L | ||||||||
| 920 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | CHEMISTRY PANEL | Serum Sodium | 139 | 132 - 147 | mmol/L | ||||||||
| 921 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | CHEMISTRY PANEL | Serum Potassium | 4.4 | 3.5 - 5.2 | mmol/L | ||||||||
| 922 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | CHEMISTRY PANEL | Serum Bicarbonate | 22.0 | 19.3 - 29.3 | mmol/L | ||||||||
| 923 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | CHEMISTRY PANEL | Serum Chloride | 105 | 94 - 112 | mmol/L | ||||||||
| 924 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 123 | 116 - 164 | g/L | ||||||||
| 925 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.37 | 0.34 - 0.48 | |||||||||
| 926 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.1 | 4.1 - 5.6 | TI/L | ||||||||
| 927 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||
| 928 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 90 | 79 - 98 | fL | ||||||||
| 929 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 3.99 | 3.8 - 10.7 | GI/L | ||||||||
| 930 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 1.90 | L | 1.96 - 7.23 | GI/L | |||||||
| 931 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.74 | 0.91 - 4.28 | GI/L | ||||||||
| 932 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.18 | 0.12 - 0.92 | GI/L | ||||||||
| 933 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.15 | 0 - 0.57 | GI/L | ||||||||
| 934 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.02 | 0 - 0.2 | GI/L | ||||||||
| 935 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 47.6 | 40.5 - 75 | % | ||||||||
| 936 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 43.6 | 15.4 - 48.5 | % | ||||||||
| 937 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 4.5 | 2.6 - 10.1 | % | ||||||||
| 938 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 3.8 | 0 - 6.8 | % | ||||||||
| 939 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 0.5 | 0 - 2 | % | ||||||||
| 940 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 301 | 140 - 400 | GI/L | ||||||||
| 941 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | HEMOGLOBIN A1C | Hemoglobin A1c,NGSP-RM | 5.6 | <6.5 % | |||||||||
| 942 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | 3.63 | 1.9 - 23 | uIU/mL | ||||||||
| 943 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||
| 944 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | LIPID PANEL | Direct HDL-C 4th Generation | 1.75 | H | 1.03 - 1.53 | mmol/L | |||||||
| 945 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | LIPID PANEL | Triglycerides (GPO) | 0.50 | 0.44 - 1.99 | mmol/L | ||||||||
| 946 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | LIPID PANEL | Cholesterol (High Performance) | 4.64 | 3.65 - 6.21 | mmol/L | ||||||||
| 947 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | LIPID PANEL | LDL Chol Friedewald 4th | 2.66 | 0 - 3.34 | mmol/L | ||||||||
| 948 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | RETICULOCYTES | Reticulocyte Count % | 0.7 | 0.6 - 2.5 | % | ||||||||
| 949 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | TSH | TSH 3rd IS-QT | 1.963 | 0.45 - 5.33 | mIU/L | ||||||||
| 950 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | URINE MACRO PANEL | Ur Specific Gravity | 1.024 | 1 - 1.04 | |||||||||
| 951 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | URINE MACRO PANEL | Ur pH | 5.5 | 5 - 8 | |||||||||
| 952 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | URINE MACRO PANEL | Ur Protein | Negative | Ref Rng:Negative | |||||||||
| 953 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | URINE MACRO PANEL | Ur Glucose | Normal | Ref Rng:Normal | |||||||||
| 954 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | URINE MACRO PANEL | Ur Ketones | Negative | Ref Rng:Negative | |||||||||
| 955 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | URINE MACRO PANEL | Ur Bilirubin | Negative | Ref Rng:Negative | |||||||||
| 956 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | URINE MACRO PANEL | Ur Urobilinogen | Normal | Ref Rng:Normal | |||||||||
| 957 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | URINE MACRO PANEL | Ur Blood | +1 | H | Ref Rng:$Negative-Trace | ||||||||
| 958 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | URINE MACRO PANEL | Ur Nitrite | Negative | Ref Rng:Negative | |||||||||
| 959 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | URINE MACRO PANEL | Ur Leukocyte Esterase | +1 | H | Ref Rng:Negative | ||||||||
| 960 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Jan 30, 2026 8:36 AM | 6227498380 | URINE MICRO PANEL | Ur Microscopic | Positive | NEGATIVE$ | NEGATIVE | ||||||||
| 961 | CZ100110008 | 59 | years | Male | Part 1 DB Baseline | Jan 27, 2026 8:25 AM | 6227144560 | C-REACTIVE PROTEIN | C Reactive Protein HS | 3.5 | 0 - 5 | mg/L | ||||||||
| 962 | CZ100110008 | 59 | years | Male | Part 1 DB Baseline | Jan 27, 2026 8:25 AM | 6227144560 | CHEMISTRY PANEL | Total Bilirubin | 10 | 3 - 21 | umol/L | ||||||||
| 963 | CZ100110008 | 59 | years | Male | Part 1 DB Baseline | Jan 27, 2026 8:25 AM | 6227144560 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 3.3 | 0 - 6.2 | umol/L | ||||||||
| 964 | CZ100110008 | 59 | years | Male | Part 1 DB Baseline | Jan 27, 2026 8:25 AM | 6227144560 | CHEMISTRY PANEL | Alkaline Phosphatase | 52 | 40 - 129 | U/L | ||||||||
| 965 | CZ100110008 | 59 | years | Male | Part 1 DB Baseline | Jan 27, 2026 8:25 AM | 6227144560 | CHEMISTRY PANEL | ALT (SGPT) | 77 | H RX | 5 - 48 | U/L | |||||||
| 966 | CZ100110008 | 59 | years | Male | Part 1 DB Baseline | Jan 27, 2026 8:25 AM | 6227144560 | CHEMISTRY PANEL | AST (SGOT) | 49 | H | 8 - 40 | U/L | |||||||
| 967 | CZ100110008 | 59 | years | Male | Part 1 DB Baseline | Jan 27, 2026 8:25 AM | 6227144560 | CHEMISTRY PANEL | GGT | 53 | H | 10 - 50 | U/L | |||||||
| 968 | CZ100110008 | 59 | years | Male | Part 1 DB Baseline | Jan 27, 2026 8:25 AM | 6227144560 | CHEMISTRY PANEL | LDH | 139 | 53 - 234 | U/L | ||||||||
| 969 | CZ100110008 | 59 | years | Male | Part 1 DB Baseline | Jan 27, 2026 8:25 AM | 6227144560 | CHEMISTRY PANEL | Urea Nitrogen | 4.0 | 1.4 - 8.6 | mmol/L | ||||||||
| 970 | CZ100110008 | 59 | years | Male | Part 1 DB Baseline | Jan 27, 2026 8:25 AM | 6227144560 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 91 | 40 - 119 | umol/L | ||||||||
| 971 | CZ100110008 | 59 | years | Male | Part 1 DB Baseline | Jan 27, 2026 8:25 AM | 6227144560 | CHEMISTRY PANEL | Glucose Fasting | 6.3 | H | 3.9 - 5.6 | mmol/L | |||||||
| 972 | CZ100110008 | 59 | years | Male | Part 1 DB Baseline | Jan 27, 2026 8:25 AM | 6227144560 | CHEMISTRY PANEL | Serum Uric Acid | 507 | H | 149 - 494 | umol/L | |||||||
| 973 | CZ100110008 | 59 | years | Male | Part 1 DB Baseline | Jan 27, 2026 8:25 AM | 6227144560 | CHEMISTRY PANEL | Calcium (EDTA) | 2.38 | 2.07 - 2.64 | mmol/L | ||||||||
| 974 | CZ100110008 | 59 | years | Male | Part 1 DB Baseline | Jan 27, 2026 8:25 AM | 6227144560 | CHEMISTRY PANEL | Phosphorus | 0.92 | 0.71 - 1.65 | mmol/L | ||||||||
| 975 | CZ100110008 | 59 | years | Male | Part 1 DB Baseline | Jan 27, 2026 8:25 AM | 6227144560 | CHEMISTRY PANEL | Total Protein | 74 | 60 - 80 | g/L | ||||||||
| 976 | CZ100110008 | 59 | years | Male | Part 1 DB Baseline | Jan 27, 2026 8:25 AM | 6227144560 | CHEMISTRY PANEL | Albumin-BCG | 46 | 33 - 49 | g/L | ||||||||
| 977 | CZ100110008 | 59 | years | Male | Part 1 DB Baseline | Jan 27, 2026 8:25 AM | 6227144560 | CHEMISTRY PANEL | Creatine Kinase | 201 | 39 - 308 | U/L | ||||||||
| 978 | CZ100110008 | 59 | years | Male | Part 1 DB Baseline | Jan 27, 2026 8:25 AM | 6227144560 | CHEMISTRY PANEL | Serum Sodium | 140 | 135 - 145 | mmol/L | ||||||||
| 979 | CZ100110008 | 59 | years | Male | Part 1 DB Baseline | Jan 27, 2026 8:25 AM | 6227144560 | CHEMISTRY PANEL | Serum Potassium | 4.0 | 3.5 - 5.2 | mmol/L | ||||||||
| 980 | CZ100110008 | 59 | years | Male | Part 1 DB Baseline | Jan 27, 2026 8:25 AM | 6227144560 | CHEMISTRY PANEL | Serum Bicarbonate | 27.8 | 19.3 - 29.3 | mmol/L | ||||||||
| 981 | CZ100110008 | 59 | years | Male | Part 1 DB Baseline | Jan 27, 2026 8:25 AM | 6227144560 | CHEMISTRY PANEL | Serum Chloride | 100 | 94 - 112 | mmol/L | ||||||||
| 982 | CZ100110008 | 59 | years | Male | Part 1 DB Baseline | Jan 27, 2026 8:25 AM | 6227144560 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 128 | 125 - 170 | g/L | ||||||||
| 983 | CZ100110008 | 59 | years | Male | Part 1 DB Baseline | Jan 27, 2026 8:25 AM | 6227144560 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.37 | 0.37 - 0.51 | |||||||||
| 984 | CZ100110008 | 59 | years | Male | Part 1 DB Baseline | Jan 27, 2026 8:25 AM | 6227144560 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 3.9 | L | 4 - 5.8 | TI/L | |||||||
| 985 | CZ100110008 | 59 | years | Male | Part 1 DB Baseline | Jan 27, 2026 8:25 AM | 6227144560 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||
| 986 | CZ100110008 | 59 | years | Male | Part 1 DB Baseline | Jan 27, 2026 8:25 AM | 6227144560 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 96 | 80 - 100 | fL | ||||||||
| 987 | CZ100110008 | 59 | years | Male | Part 1 DB Baseline | Jan 27, 2026 8:25 AM | 6227144560 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 4.20 | 3.8 - 10.7 | GI/L | ||||||||
| 988 | CZ100110008 | 59 | years | Male | Part 1 DB Baseline | Jan 27, 2026 8:25 AM | 6227144560 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 2.39 | 1.96 - 7.23 | GI/L | ||||||||
| 989 | CZ100110008 | 59 | years | Male | Part 1 DB Baseline | Jan 27, 2026 8:25 AM | 6227144560 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.38 | 0.8 - 3 | GI/L | ||||||||
| 990 | CZ100110008 | 59 | years | Male | Part 1 DB Baseline | Jan 27, 2026 8:25 AM | 6227144560 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.33 | 0.12 - 0.92 | GI/L | ||||||||
| 991 | CZ100110008 | 59 | years | Male | Part 1 DB Baseline | Jan 27, 2026 8:25 AM | 6227144560 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.04 | 0 - 0.57 | GI/L | ||||||||
| 992 | CZ100110008 | 59 | years | Male | Part 1 DB Baseline | Jan 27, 2026 8:25 AM | 6227144560 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.05 | 0 - 0.2 | GI/L | ||||||||
| 993 | CZ100110008 | 59 | years | Male | Part 1 DB Baseline | Jan 27, 2026 8:25 AM | 6227144560 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 57.0 | 40.5 - 75 | % | ||||||||
| 994 | CZ100110008 | 59 | years | Male | Part 1 DB Baseline | Jan 27, 2026 8:25 AM | 6227144560 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 32.9 | 15.4 - 48.5 | % | ||||||||
| 995 | CZ100110008 | 59 | years | Male | Part 1 DB Baseline | Jan 27, 2026 8:25 AM | 6227144560 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 7.8 | 2.6 - 10.1 | % | ||||||||
| 996 | CZ100110008 | 59 | years | Male | Part 1 DB Baseline | Jan 27, 2026 8:25 AM | 6227144560 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 1.1 | 0 - 6.8 | % | ||||||||
| 997 | CZ100110008 | 59 | years | Male | Part 1 DB Baseline | Jan 27, 2026 8:25 AM | 6227144560 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 1.2 | 0 - 2 | % | ||||||||
| 998 | CZ100110008 | 59 | years | Male | Part 1 DB Baseline | Jan 27, 2026 8:25 AM | 6227144560 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 144 | 140 - 400 | GI/L | ||||||||
| 999 | CZ100110008 | 59 | years | Male | Part 1 DB Baseline | Jan 27, 2026 8:25 AM | 6227144560 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | 22.36 | 1.9 - 23 | uIU/mL | ||||||||
| 1000 | CZ100110008 | 59 | years | Male | Part 1 DB Baseline | Jan 27, 2026 8:25 AM | 6227144560 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||
| 1001 | CZ100110008 | 59 | years | Male | Part 1 DB Baseline | Jan 27, 2026 8:25 AM | 6227144560 | LIPID PANEL | Direct HDL-C 4th Generation | 0.75 | L | 1.03 - 1.53 | mmol/L | |||||||
| 1002 | CZ100110008 | 59 | years | Male | Part 1 DB Baseline | Jan 27, 2026 8:25 AM | 6227144560 | LIPID PANEL | Triglycerides (GPO) | 3.00 | 0.65 - 3.61 | mmol/L | ||||||||
| 1003 | CZ100110008 | 59 | years | Male | Part 1 DB Baseline | Jan 27, 2026 8:25 AM | 6227144560 | LIPID PANEL | Cholesterol (High Performance) | 4.63 | 4.4 - 7.53 | mmol/L | ||||||||
| 1004 | CZ100110008 | 59 | years | Male | Part 1 DB Baseline | Jan 27, 2026 8:25 AM | 6227144560 | LIPID PANEL | LDL Chol Friedewald 4th | 2.51 | 0 - 3.34 | mmol/L | ||||||||
| 1005 | CZ100110008 | 59 | years | Male | Part 1 DB Baseline | Jan 27, 2026 8:25 AM | 6227144560 | RETICULOCYTES | Reticulocyte Count % | 1.4 | 0.6 - 2.5 | % | ||||||||
| 1006 | CZ100110008 | 59 | years | Male | Part 1 DB Baseline | Jan 27, 2026 8:25 AM | 6227144560 | URINE MACRO PANEL | Ur Specific Gravity | 1.010 | 1.01 - 1.03 | |||||||||
| 1007 | CZ100110008 | 59 | years | Male | Part 1 DB Baseline | Jan 27, 2026 8:25 AM | 6227144560 | URINE MACRO PANEL | Ur pH | 6.0 | 5 - 8 | |||||||||
| 1008 | CZ100110008 | 59 | years | Male | Part 1 DB Baseline | Jan 27, 2026 8:25 AM | 6227144560 | URINE MACRO PANEL | Ur Protein | Negative | Ref Rng:Negative | |||||||||
| 1009 | CZ100110008 | 59 | years | Male | Part 1 DB Baseline | Jan 27, 2026 8:25 AM | 6227144560 | URINE MACRO PANEL | Ur Glucose | Normal | Ref Rng:Normal | |||||||||
| 1010 | CZ100110008 | 59 | years | Male | Part 1 DB Baseline | Jan 27, 2026 8:25 AM | 6227144560 | URINE MACRO PANEL | Ur Ketones | Negative | Ref Rng:Negative | |||||||||
| 1011 | CZ100110008 | 59 | years | Male | Part 1 DB Baseline | Jan 27, 2026 8:25 AM | 6227144560 | URINE MACRO PANEL | Ur Bilirubin | Negative | Ref Rng:Negative | |||||||||
| 1012 | CZ100110008 | 59 | years | Male | Part 1 DB Baseline | Jan 27, 2026 8:25 AM | 6227144560 | URINE MACRO PANEL | Ur Urobilinogen | Normal | Ref Rng:Normal | |||||||||
| 1013 | CZ100110008 | 59 | years | Male | Part 1 DB Baseline | Jan 27, 2026 8:25 AM | 6227144560 | URINE MACRO PANEL | Ur Blood | Negative | Ref Rng:Negative | |||||||||
| 1014 | CZ100110008 | 59 | years | Male | Part 1 DB Baseline | Jan 27, 2026 8:25 AM | 6227144560 | URINE MACRO PANEL | Ur Nitrite | Negative | Ref Rng:Negative | |||||||||
| 1015 | CZ100110008 | 59 | years | Male | Part 1 DB Baseline | Jan 27, 2026 8:25 AM | 6227144560 | URINE MACRO PANEL | Ur Leukocyte Esterase | Negative | Ref Rng:Negative | |||||||||
| 1016 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | C-REACTIVE PROTEIN | C Reactive Protein HS | 0.2 | Result verified by repeat analysis | 0 - 5 | mg/L | |||||||
| 1017 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | CHEMISTRY PANEL | Total Bilirubin | 7 | 3 - 21 | umol/L | ||||||||
| 1018 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 2.4 | 0 - 6.2 | umol/L | ||||||||
| 1019 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | CHEMISTRY PANEL | Alkaline Phosphatase | 39 | 35 - 104 | U/L | ||||||||
| 1020 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | CHEMISTRY PANEL | ALT (SGPT) | 7 | 4 - 43 | U/L | ||||||||
| 1021 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | CHEMISTRY PANEL | AST (SGOT) | 13 | 8 - 40 | U/L | ||||||||
| 1022 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | CHEMISTRY PANEL | GGT | 10 | 4 - 49 | U/L | ||||||||
| 1023 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | CHEMISTRY PANEL | LDH | 144 | 53 - 234 | U/L | ||||||||
| 1024 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | CHEMISTRY PANEL | Urea Nitrogen | 2.9 | 1.4 - 8.6 | mmol/L | ||||||||
| 1025 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 63 | 31 - 101 | umol/L | ||||||||
| 1026 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | CHEMISTRY PANEL | Glucose Fasting | 4.9 | 3.9 - 5.6 | mmol/L | ||||||||
| 1027 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | CHEMISTRY PANEL | Serum Uric Acid | 162 | 125 - 428 | umol/L | ||||||||
| 1028 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | CHEMISTRY PANEL | Calcium (EDTA) | 2.41 | 2.07 - 2.64 | mmol/L | ||||||||
| 1029 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | CHEMISTRY PANEL | Phosphorus | 0.94 | 0.71 - 1.65 | mmol/L | ||||||||
| 1030 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | CHEMISTRY PANEL | Total Protein | 69 | 61 - 84 | g/L | ||||||||
| 1031 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | CHEMISTRY PANEL | Albumin-BCG | 44 | 33 - 49 | g/L | ||||||||
| 1032 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | CHEMISTRY PANEL | Creatine Kinase | 56 | 26 - 192 | U/L | ||||||||
| 1033 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | CHEMISTRY PANEL | Serum Sodium | 142 | 132 - 147 | mmol/L | ||||||||
| 1034 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | CHEMISTRY PANEL | Serum Potassium | 4.7 | 3.5 - 5.2 | mmol/L | ||||||||
| 1035 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | CHEMISTRY PANEL | Serum Bicarbonate | 26.3 | 19.3 - 29.3 | mmol/L | ||||||||
| 1036 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | CHEMISTRY PANEL | Serum Chloride | 104 | 94 - 112 | mmol/L | ||||||||
| 1037 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | CREATININE CLEARANCE CC&G | CreatininClearancCockcrftGault | 1.79 | 1.25 - 1.92 | mL/sec | ||||||||
| 1038 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | CREATININE CLEARANCE CC&G | Creatinine(Rate Blanked)-2dp | 63 | 31 - 101 | umol/L | ||||||||
| 1039 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | CREATININE CLEARANCE CC&G | Weight (kg,1dec place) | Y | 70.3 | kg | ||||||||
| 1040 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | DRUG SCREEN URINE | Amphetamines/MDMA | Neg | Neg;$Cutoff = 1000 ng/mL | |||||||||
| 1041 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | DRUG SCREEN URINE | Barbiturates | Neg | Neg;$Cutoff = 200 ng/mL | |||||||||
| 1042 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | DRUG SCREEN URINE | Cannabinoids | Neg | Neg;$Cutoff = 50 ng/mL | |||||||||
| 1043 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | DRUG SCREEN URINE | Cocaine | Neg | Neg;$Cutoff = 300 ng/mL | |||||||||
| 1044 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | DRUG SCREEN URINE | Opiates | Neg | Neg;$Cutoff = 300 ng/mL | |||||||||
| 1045 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | DRUG SCREEN URINE | Methadone | Neg | Neg;$Cutoff = 300 ng/mL | |||||||||
| 1046 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | DRUG SCREEN URINE BENZO NON-US | Benzodiazepines Gen 2 | Neg | Neg;$Cutoff = 200 ng/mL | |||||||||
| 1047 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | FEMALE OF CHILDBEARING POT? | Female/of Childbearing pot.? | Y | Yes | |||||||||
| 1048 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | GFR | EGFR by MDRD | 88 | mL/min/1.73m^2$No Ref Rng | |||||||||
| 1049 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 140 | Result verified by repeat analysis | 116 - 164 | g/L | |||||||
| 1050 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.41 | 0.34 - 0.48 | |||||||||
| 1051 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.5 | Result verified by repeat analysis | 4.1 - 5.6 | TI/L | |||||||
| 1052 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||
| 1053 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 90 | 79 - 98 | fL | ||||||||
| 1054 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 4.80 | Result verified by repeat analysis | 3.8 - 10.7 | GI/L | |||||||
| 1055 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 2.45 | Result verified by repeat analysis | 1.96 - 7.23 | GI/L | |||||||
| 1056 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.67 | 0.91 - 4.28 | GI/L | ||||||||
| 1057 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.43 | Result verified by repeat analysis | 0.12 - 0.92 | GI/L | |||||||
| 1058 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.21 | Result verified by repeat analysis | 0 - 0.57 | GI/L | |||||||
| 1059 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.04 | Result verified by repeat analysis | 0 - 0.2 | GI/L | |||||||
| 1060 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 51.1 | Result verified by repeat analysis | 40.5 - 75 | % | |||||||
| 1061 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 34.7 | Result verified by repeat analysis | 15.4 - 48.5 | % | |||||||
| 1062 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 9.0 | Result verified by repeat analysis | 2.6 - 10.1 | % | |||||||
| 1063 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 4.4 | Result verified by repeat analysis | 0 - 6.8 | % | |||||||
| 1064 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 0.8 | Result verified by repeat analysis | 0 - 2 | % | |||||||
| 1065 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 254 | Result verified by repeat analysis | 140 - 400 | GI/L | |||||||
| 1066 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | HEMOGLOBIN A1C | Hemoglobin A1c,NGSP-RM | 5.5 | <6.5 % | |||||||||
| 1067 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | 6.02 | 1.9 - 23 | uIU/mL | ||||||||
| 1068 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||
| 1069 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | IS SUBJECT OF BLACK RACE? | Subject of black race? | Y | No | |||||||||
| 1070 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | LIPID PANEL | Direct HDL-C 4th Generation | 1.67 | H | 1.03 - 1.53 | mmol/L | |||||||
| 1071 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | LIPID PANEL | Triglycerides (GPO) | 0.69 | 0.51 - 2.42 | mmol/L | ||||||||
| 1072 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | LIPID PANEL | Cholesterol (High Performance) | 5.79 | 4.01 - 6.85 | mmol/L | ||||||||
| 1073 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | LIPID PANEL | LDL Chol Friedewald 4th | 3.80 | H | 0 - 3.34 | mmol/L | |||||||
| 1074 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | POSTMENOPAUSAL FEMALE? | <40yrs & amenorrhea >/= 12mo | No | ||||||||||
| 1075 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | RETICULOCYTES | Reticulocyte Count % | 1.2 | 0.6 - 2.5 | % | ||||||||
| 1076 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | SERUM BETA HCG | B-hCG, Qualitative | Negative | Ref Rng: Negative | |||||||||
| 1077 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | SERUM BETA HCG | B-hCG, Quantitative | <0.6 | Units: mIU/mL$Pre-menopausal$<5.0: Negative$5.0-24.9:Borderline$>/= 25.0: Positive | |||||||||
| 1078 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | TSH | TSH 3rd IS-QT | 1.837 | 0.45 - 5.33 | mIU/L | ||||||||
| 1079 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | URINE MACRO PANEL | Ur Specific Gravity | 1.005 | 1 - 1.04 | |||||||||
| 1080 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | URINE MACRO PANEL | Ur pH | 5.5 | 5 - 8 | |||||||||
| 1081 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | URINE MACRO PANEL | Ur Protein | Negative | Ref Rng:Negative | |||||||||
| 1082 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | URINE MACRO PANEL | Ur Glucose | Normal | Ref Rng:Normal | |||||||||
| 1083 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | URINE MACRO PANEL | Ur Ketones | Negative | Ref Rng:Negative | |||||||||
| 1084 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | URINE MACRO PANEL | Ur Bilirubin | Negative | Ref Rng:Negative | |||||||||
| 1085 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | URINE MACRO PANEL | Ur Urobilinogen | Normal | Ref Rng:Normal | |||||||||
| 1086 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | URINE MACRO PANEL | Ur Blood | Negative | Ref Rng:$Negative-Trace | |||||||||
| 1087 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | URINE MACRO PANEL | Ur Nitrite | Negative | Ref Rng:Negative | |||||||||
| 1088 | CZ100110009 | 48 | years | Female | Part 1 Screening | Jan 21, 2026 10:11 AM | 6227542160 | URINE MACRO PANEL | Ur Leukocyte Esterase | Negative | Ref Rng:Negative | |||||||||
| 1089 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | C-REACTIVE PROTEIN | C Reactive Protein HS | 0.9 | 0 - 5 | mg/L | ||||||||
| 1090 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | CELLULAR ELEMENTS | Ur RBC/HPF | 3 | 0 - 8 | /HPF | ||||||||
| 1091 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | CELLULAR ELEMENTS | Ur WBC/HPF | 1 | 0 - 12 | /HPF | ||||||||
| 1092 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | CHEMISTRY PANEL | Total Bilirubin | 10 | 3 - 21 | umol/L | ||||||||
| 1093 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 3.4 | 0 - 6.2 | umol/L | ||||||||
| 1094 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | CHEMISTRY PANEL | Alkaline Phosphatase | 60 | 35 - 104 | U/L | ||||||||
| 1095 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | CHEMISTRY PANEL | ALT (SGPT) | 23 | 4 - 43 | U/L | ||||||||
| 1096 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | CHEMISTRY PANEL | AST (SGOT) | 27 | 8 - 40 | U/L | ||||||||
| 1097 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | CHEMISTRY PANEL | GGT | 21 | 4 - 49 | U/L | ||||||||
| 1098 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | CHEMISTRY PANEL | LDH | 167 | 53 - 234 | U/L | ||||||||
| 1099 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | CHEMISTRY PANEL | Urea Nitrogen | 3.7 | 1.4 - 8.6 | mmol/L | ||||||||
| 1100 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 79 | 31 - 101 | umol/L | ||||||||
| 1101 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | CHEMISTRY PANEL | Glucose Fasting | 4.9 | 3.9 - 5.6 | mmol/L | ||||||||
| 1102 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | CHEMISTRY PANEL | Serum Uric Acid | 286 | 149 - 446 | umol/L | ||||||||
| 1103 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | CHEMISTRY PANEL | Calcium (EDTA) | 2.43 | 2.07 - 2.64 | mmol/L | ||||||||
| 1104 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | CHEMISTRY PANEL | Phosphorus | 1.01 | 0.71 - 1.65 | mmol/L | ||||||||
| 1105 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | CHEMISTRY PANEL | Total Protein | 76 | 61 - 84 | g/L | ||||||||
| 1106 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | CHEMISTRY PANEL | Albumin-BCG | 47 | 33 - 49 | g/L | ||||||||
| 1107 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | CHEMISTRY PANEL | Creatine Kinase | 147 | 26 - 192 | U/L | ||||||||
| 1108 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | CHEMISTRY PANEL | Serum Sodium | 138 | 132 - 147 | mmol/L | ||||||||
| 1109 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | CHEMISTRY PANEL | Serum Potassium | 4.4 | 3.5 - 5.2 | mmol/L | ||||||||
| 1110 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | CHEMISTRY PANEL | Serum Bicarbonate | 22.4 | 19.3 - 29.3 | mmol/L | ||||||||
| 1111 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | CHEMISTRY PANEL | Serum Chloride | 100 | 94 - 112 | mmol/L | ||||||||
| 1112 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | FREE T4 | Free Thyroxine-QT | 9 | 8 - 14 | pmol/L | ||||||||
| 1113 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 143 | 116 - 164 | g/L | ||||||||
| 1114 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.42 | 0.34 - 0.48 | |||||||||
| 1115 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.6 | 4.1 - 5.6 | TI/L | ||||||||
| 1116 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||
| 1117 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 92 | 79 - 98 | fL | ||||||||
| 1118 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 7.42 | 3.8 - 10.7 | GI/L | ||||||||
| 1119 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 3.84 | 1.96 - 7.23 | GI/L | ||||||||
| 1120 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 3.08 | 0.91 - 4.28 | GI/L | ||||||||
| 1121 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.29 | 0.12 - 0.92 | GI/L | ||||||||
| 1122 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.13 | 0 - 0.57 | GI/L | ||||||||
| 1123 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.07 | 0 - 0.2 | GI/L | ||||||||
| 1124 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 51.8 | 40.5 - 75 | % | ||||||||
| 1125 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 41.6 | 15.4 - 48.5 | % | ||||||||
| 1126 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 3.9 | 2.6 - 10.1 | % | ||||||||
| 1127 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 1.8 | 0 - 6.8 | % | ||||||||
| 1128 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 0.9 | 0 - 2 | % | ||||||||
| 1129 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 332 | 140 - 400 | GI/L | ||||||||
| 1130 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | HEMOGLOBIN A1C | Hemoglobin A1c,NGSP-RM | 5.2 | <6.5 % | |||||||||
| 1131 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | 3.98 | 1.9 - 23 | uIU/mL | ||||||||
| 1132 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||
| 1133 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | LIPID PANEL | Direct HDL-C 4th Generation | 2.01 | H | 1.03 - 1.53 | mmol/L | |||||||
| 1134 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | LIPID PANEL | Triglycerides (GPO) | 1.43 | 0.59 - 2.96 | mmol/L | ||||||||
| 1135 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | LIPID PANEL | Cholesterol (High Performance) | 5.46 | 4.42 - 7.53 | mmol/L | ||||||||
| 1136 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | LIPID PANEL | LDL Chol Friedewald 4th | 2.80 | 0 - 3.34 | mmol/L | ||||||||
| 1137 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | RETICULOCYTES | Reticulocyte Count % | 0.9 | 0.6 - 2.5 | % | ||||||||
| 1138 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | TSH | TSH 3rd IS-QT | 6.224 | H SF | 0.45 - 5.33 | mIU/L | |||||||
| 1139 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | URINE MACRO PANEL | Ur Specific Gravity | 1.033 | 1 - 1.04 | |||||||||
| 1140 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | URINE MACRO PANEL | Ur pH | 6.5 | 5 - 8 | |||||||||
| 1141 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | URINE MACRO PANEL | Ur Protein | Trace | H | Ref Rng:Negative | ||||||||
| 1142 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | URINE MACRO PANEL | Ur Glucose | Normal | Ref Rng:Normal | |||||||||
| 1143 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | URINE MACRO PANEL | Ur Ketones | Negative | Ref Rng:Negative | |||||||||
| 1144 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | URINE MACRO PANEL | Ur Bilirubin | Negative | Ref Rng:Negative | |||||||||
| 1145 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | URINE MACRO PANEL | Ur Urobilinogen | Normal | Ref Rng:Normal | |||||||||
| 1146 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | URINE MACRO PANEL | Ur Blood | Negative | Ref Rng:$Negative-Trace | |||||||||
| 1147 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | URINE MACRO PANEL | Ur Nitrite | Negative | Ref Rng:Negative | |||||||||
| 1148 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | URINE MACRO PANEL | Ur Leukocyte Esterase | Negative | Ref Rng:Negative | |||||||||
| 1149 | CZ100110007 | 56 | years | Female | End of Phase/Treatment | Jan 16, 2026 8:48 AM | 6227542173 | URINE MICRO PANEL | Ur Microscopic | Positive | NEGATIVE$ | NEGATIVE | ||||||||
| 1150 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | R | Jan 6, 2026 10:11 AM | 6227261836 | C-REACTIVE PROTEIN | C Reactive Protein HS | 1.2 | 0 - 5 | mg/L | |||||||
| 1151 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | R | Jan 6, 2026 10:11 AM | 6227261836 | CHEMISTRY PANEL | Total Bilirubin | 10 | 3 - 21 | umol/L | |||||||
| 1152 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | R | Jan 6, 2026 10:11 AM | 6227261836 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 3.0 | 0 - 6.2 | umol/L | |||||||
| 1153 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | R | Jan 6, 2026 10:11 AM | 6227261836 | CHEMISTRY PANEL | Alkaline Phosphatase | 73 | 35 - 104 | U/L | |||||||
| 1154 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | R | Jan 6, 2026 10:11 AM | 6227261836 | CHEMISTRY PANEL | ALT (SGPT) | 9 | 4 - 43 | U/L | |||||||
| 1155 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | R | Jan 6, 2026 10:11 AM | 6227261836 | CHEMISTRY PANEL | AST (SGOT) | 13 | 8 - 40 | U/L | |||||||
| 1156 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | R | Jan 6, 2026 10:11 AM | 6227261836 | CHEMISTRY PANEL | GGT | 7 | 4 - 49 | U/L | |||||||
| 1157 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | R | Jan 6, 2026 10:11 AM | 6227261836 | CHEMISTRY PANEL | LDH | 145 | 53 - 234 | U/L | |||||||
| 1158 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | R | Jan 6, 2026 10:11 AM | 6227261836 | CHEMISTRY PANEL | Urea Nitrogen | 4.2 | 1.4 - 8.6 | mmol/L | |||||||
| 1159 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | R | Jan 6, 2026 10:11 AM | 6227261836 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 56 | 31 - 101 | umol/L | |||||||
| 1160 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | R | Jan 6, 2026 10:11 AM | 6227261836 | CHEMISTRY PANEL | Glucose Fasting | 4.5 | 3.9 - 5.6 | mmol/L | |||||||
| 1161 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | R | Jan 6, 2026 10:11 AM | 6227261836 | CHEMISTRY PANEL | Serum Uric Acid | 236 | 125 - 428 | umol/L | |||||||
| 1162 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | R | Jan 6, 2026 10:11 AM | 6227261836 | CHEMISTRY PANEL | Calcium (EDTA) | 2.35 | 2.07 - 2.64 | mmol/L | |||||||
| 1163 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | R | Jan 6, 2026 10:11 AM | 6227261836 | CHEMISTRY PANEL | Phosphorus | 1.19 | 0.71 - 1.65 | mmol/L | |||||||
| 1164 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | R | Jan 6, 2026 10:11 AM | 6227261836 | CHEMISTRY PANEL | Total Protein | 73 | 61 - 84 | g/L | |||||||
| 1165 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | R | Jan 6, 2026 10:11 AM | 6227261836 | CHEMISTRY PANEL | Albumin-BCG | 45 | 33 - 49 | g/L | |||||||
| 1166 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | R | Jan 6, 2026 10:11 AM | 6227261836 | CHEMISTRY PANEL | Creatine Kinase | 72 | 26 - 192 | U/L | |||||||
| 1167 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | R | Jan 6, 2026 10:11 AM | 6227261836 | CHEMISTRY PANEL | Serum Sodium | 140 | 132 - 147 | mmol/L | |||||||
| 1168 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | R | Jan 6, 2026 10:11 AM | 6227261836 | CHEMISTRY PANEL | Serum Potassium | 4.1 | 3.5 - 5.2 | mmol/L | |||||||
| 1169 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | R | Jan 6, 2026 10:11 AM | 6227261836 | CHEMISTRY PANEL | Serum Bicarbonate | 23.8 | 19.3 - 29.3 | mmol/L | |||||||
| 1170 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | R | Jan 6, 2026 10:11 AM | 6227261836 | CHEMISTRY PANEL | Serum Chloride | 104 | 94 - 112 | mmol/L | |||||||
| 1171 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | R | Jan 6, 2026 10:11 AM | 6227261836 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 127 | 116 - 164 | g/L | |||||||
| 1172 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | R | Jan 6, 2026 10:11 AM | 6227261836 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.38 | 0.34 - 0.48 | ||||||||
| 1173 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | R | Jan 6, 2026 10:11 AM | 6227261836 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.3 | 4.1 - 5.6 | TI/L | |||||||
| 1174 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | R | Jan 6, 2026 10:11 AM | 6227261836 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | ||||||||
| 1175 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | R | Jan 6, 2026 10:11 AM | 6227261836 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 89 | 79 - 98 | fL | |||||||
| 1176 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | R | Jan 6, 2026 10:11 AM | 6227261836 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 6.59 | 3.8 - 10.7 | GI/L | |||||||
| 1177 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | R | Jan 6, 2026 10:11 AM | 6227261836 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 4.25 | 1.96 - 7.23 | GI/L | |||||||
| 1178 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | R | Jan 6, 2026 10:11 AM | 6227261836 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.64 | 0.91 - 4.28 | GI/L | |||||||
| 1179 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | R | Jan 6, 2026 10:11 AM | 6227261836 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.37 | 0.12 - 0.92 | GI/L | |||||||
| 1180 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | R | Jan 6, 2026 10:11 AM | 6227261836 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.13 | 0 - 0.57 | GI/L | |||||||
| 1181 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | R | Jan 6, 2026 10:11 AM | 6227261836 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.19 | 0 - 0.2 | GI/L | |||||||
| 1182 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | R | Jan 6, 2026 10:11 AM | 6227261836 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 64.5 | 40.5 - 75 | % | |||||||
| 1183 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | R | Jan 6, 2026 10:11 AM | 6227261836 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 24.9 | 15.4 - 48.5 | % | |||||||
| 1184 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | R | Jan 6, 2026 10:11 AM | 6227261836 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 5.6 | 2.6 - 10.1 | % | |||||||
| 1185 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | R | Jan 6, 2026 10:11 AM | 6227261836 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 2.0 | 0 - 6.8 | % | |||||||
| 1186 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | R | Jan 6, 2026 10:11 AM | 6227261836 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 2.9 | H | 0 - 2 | % | ||||||
| 1187 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | R | Jan 6, 2026 10:11 AM | 6227261836 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 300 | 140 - 400 | GI/L | |||||||
| 1188 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | R | Jan 6, 2026 10:11 AM | 6227261836 | HEMOGLOBIN A1C | Hemoglobin A1c,NGSP-RM | 4.9 | <6.5 % | ||||||||
| 1189 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | R | Jan 6, 2026 10:11 AM | 6227261836 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | 2.92 | 1.9 - 23 | uIU/mL | |||||||
| 1190 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | R | Jan 6, 2026 10:11 AM | 6227261836 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | ||||||||
| 1191 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | R | Jan 6, 2026 10:11 AM | 6227261836 | LIPID PANEL | Direct HDL-C 4th Generation | 1.01 | L | 1.03 - 1.53 | mmol/L | ||||||
| 1192 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | R | Jan 6, 2026 10:11 AM | 6227261836 | LIPID PANEL | Triglycerides (GPO) | 1.05 | 0.44 - 1.99 | mmol/L | |||||||
| 1193 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | R | Jan 6, 2026 10:11 AM | 6227261836 | LIPID PANEL | Cholesterol (High Performance) | 3.68 | 3.65 - 6.21 | mmol/L | |||||||
| 1194 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | R | Jan 6, 2026 10:11 AM | 6227261836 | LIPID PANEL | LDL Chol Friedewald 4th | 2.19 | 0 - 3.34 | mmol/L | |||||||
| 1195 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | R | Jan 6, 2026 10:11 AM | 6227261836 | RETICULOCYTES | Reticulocyte Count % | 1.8 | 0.6 - 2.5 | % | |||||||
| 1196 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | R | Jan 6, 2026 10:11 AM | 6227261836 | TSH | TSH 3rd IS-QT | 1.385 | 0.45 - 5.33 | mIU/L | |||||||
| 1197 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | R | Jan 6, 2026 10:11 AM | 6227261836 | URINE MACRO PANEL | Ur Specific Gravity | 1.024 | 1 - 1.04 | ||||||||
| 1198 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | R | Jan 6, 2026 10:11 AM | 6227261836 | URINE MACRO PANEL | Ur pH | 5.5 | 5 - 8 | ||||||||
| 1199 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | R | Jan 6, 2026 10:11 AM | 6227261836 | URINE MACRO PANEL | Ur Protein | Negative | Ref Rng:Negative | ||||||||
| 1200 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | R | Jan 6, 2026 10:11 AM | 6227261836 | URINE MACRO PANEL | Ur Glucose | Normal | Ref Rng:Normal | ||||||||
| 1201 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | R | Jan 6, 2026 10:11 AM | 6227261836 | URINE MACRO PANEL | Ur Ketones | Negative | Ref Rng:Negative | ||||||||
| 1202 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | R | Jan 6, 2026 10:11 AM | 6227261836 | URINE MACRO PANEL | Ur Bilirubin | Negative | Ref Rng:Negative | ||||||||
| 1203 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | R | Jan 6, 2026 10:11 AM | 6227261836 | URINE MACRO PANEL | Ur Urobilinogen | Normal | Ref Rng:Normal | ||||||||
| 1204 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | R | Jan 6, 2026 10:11 AM | 6227261836 | URINE MACRO PANEL | Ur Blood | Negative | Ref Rng:$Negative-Trace | ||||||||
| 1205 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | R | Jan 6, 2026 10:11 AM | 6227261836 | URINE MACRO PANEL | Ur Nitrite | Negative | Ref Rng:Negative | ||||||||
| 1206 | CZ100110006 | 32 | years | Female | End of Phase/Treatment | R | Jan 6, 2026 10:11 AM | 6227261836 | URINE MACRO PANEL | Ur Leukocyte Esterase | Negative | Ref Rng:Negative | ||||||||
| 1207 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | C-REACTIVE PROTEIN | C Reactive Protein HS | 8.1 | H | 0 - 5 | mg/L | |||||||
| 1208 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | CHEMISTRY PANEL | Total Bilirubin | 9 | 3 - 21 | umol/L | ||||||||
| 1209 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 3.3 | 0 - 6.2 | umol/L | ||||||||
| 1210 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | CHEMISTRY PANEL | Alkaline Phosphatase | 51 | 40 - 129 | U/L | ||||||||
| 1211 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | CHEMISTRY PANEL | ALT (SGPT) | 79 | H RX | 5 - 48 | U/L | |||||||
| 1212 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | CHEMISTRY PANEL | AST (SGOT) | 51 | H | 8 - 40 | U/L | |||||||
| 1213 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | CHEMISTRY PANEL | GGT | 52 | H | 10 - 50 | U/L | |||||||
| 1214 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | CHEMISTRY PANEL | LDH | 160 | 53 - 234 | U/L | ||||||||
| 1215 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | CHEMISTRY PANEL | Urea Nitrogen | 4.5 | 1.4 - 8.6 | mmol/L | ||||||||
| 1216 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 92 | 40 - 119 | umol/L | ||||||||
| 1217 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | CHEMISTRY PANEL | Glucose Fasting | 6.1 | H | 3.9 - 5.6 | mmol/L | |||||||
| 1218 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | CHEMISTRY PANEL | Serum Uric Acid | 521 | H | 149 - 494 | umol/L | |||||||
| 1219 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | CHEMISTRY PANEL | Calcium (EDTA) | 2.37 | 2.07 - 2.64 | mmol/L | ||||||||
| 1220 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | CHEMISTRY PANEL | Phosphorus | 1.00 | 0.71 - 1.65 | mmol/L | ||||||||
| 1221 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | CHEMISTRY PANEL | Total Protein | 75 | 60 - 80 | g/L | ||||||||
| 1222 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | CHEMISTRY PANEL | Albumin-BCG | 47 | 33 - 49 | g/L | ||||||||
| 1223 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | CHEMISTRY PANEL | Creatine Kinase | 206 | 39 - 308 | U/L | ||||||||
| 1224 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | CHEMISTRY PANEL | Serum Sodium | 139 | 135 - 145 | mmol/L | ||||||||
| 1225 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | CHEMISTRY PANEL | Serum Potassium | 4.3 | 3.5 - 5.2 | mmol/L | ||||||||
| 1226 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | CHEMISTRY PANEL | Serum Bicarbonate | 25.6 | 19.3 - 29.3 | mmol/L | ||||||||
| 1227 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | CHEMISTRY PANEL | Serum Chloride | 100 | 94 - 112 | mmol/L | ||||||||
| 1228 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | CREATININE CLEARANCE CC&G | CreatininClearancCockcrftGault | 1.95 | 1.42 - 2.08 | mL/sec | ||||||||
| 1229 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | CREATININE CLEARANCE CC&G | Creatinine(Rate Blanked)-2dp | 92 | 40 - 119 | umol/L | ||||||||
| 1230 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | CREATININE CLEARANCE CC&G | Weight (kg,1dec place) | Y | 108.0 | kg | ||||||||
| 1231 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | DRUG SCREEN URINE | Amphetamines/MDMA | Neg | Neg;$Cutoff = 1000 ng/mL | |||||||||
| 1232 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | DRUG SCREEN URINE | Barbiturates | Neg | Neg;$Cutoff = 200 ng/mL | |||||||||
| 1233 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | DRUG SCREEN URINE | Cannabinoids | Neg | Neg;$Cutoff = 50 ng/mL | |||||||||
| 1234 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | DRUG SCREEN URINE | Cocaine | Neg | Neg;$Cutoff = 300 ng/mL | |||||||||
| 1235 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | DRUG SCREEN URINE | Opiates | Neg | Neg;$Cutoff = 300 ng/mL | |||||||||
| 1236 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | DRUG SCREEN URINE | Methadone | Neg | Neg;$Cutoff = 300 ng/mL | |||||||||
| 1237 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | DRUG SCREEN URINE BENZO NON-US | Benzodiazepines Gen 2 | Neg | Neg;$Cutoff = 200 ng/mL | |||||||||
| 1238 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | GFR | EGFR by MDRD | 73 | mL/min/1.73m^2$No Ref Rng | |||||||||
| 1239 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 132 | 125 - 170 | g/L | ||||||||
| 1240 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.39 | 0.37 - 0.51 | |||||||||
| 1241 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.0 | 4 - 5.8 | TI/L | ||||||||
| 1242 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||
| 1243 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 97 | 80 - 100 | fL | ||||||||
| 1244 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 6.10 | 3.8 - 10.7 | GI/L | ||||||||
| 1245 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 3.77 | 1.96 - 7.23 | GI/L | ||||||||
| 1246 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.71 | 0.8 - 3 | GI/L | ||||||||
| 1247 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.52 | 0.12 - 0.92 | GI/L | ||||||||
| 1248 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.05 | 0 - 0.57 | GI/L | ||||||||
| 1249 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.05 | 0 - 0.2 | GI/L | ||||||||
| 1250 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 61.7 | 40.5 - 75 | % | ||||||||
| 1251 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 28.1 | 15.4 - 48.5 | % | ||||||||
| 1252 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 8.5 | 2.6 - 10.1 | % | ||||||||
| 1253 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 0.9 | 0 - 6.8 | % | ||||||||
| 1254 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 0.8 | 0 - 2 | % | ||||||||
| 1255 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 178 | 140 - 400 | GI/L | ||||||||
| 1256 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | HEMOGLOBIN A1C | Hemoglobin A1c,NGSP-RM | 6.2 | <6.5 % | |||||||||
| 1257 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | 15.17 | 1.9 - 23 | uIU/mL | ||||||||
| 1258 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||
| 1259 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | IS SUBJECT OF BLACK RACE? | Subject of black race? | Y | No | |||||||||
| 1260 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | LIPID PANEL | Direct HDL-C 4th Generation | 0.74 | L | 1.03 - 1.53 | mmol/L | |||||||
| 1261 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | LIPID PANEL | Triglycerides (GPO) | 2.04 | 0.65 - 3.61 | mmol/L | ||||||||
| 1262 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | LIPID PANEL | Cholesterol (High Performance) | 4.38 | L | 4.4 - 7.53 | mmol/L | |||||||
| 1263 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | LIPID PANEL | LDL Chol Friedewald 4th | 2.71 | 0 - 3.34 | mmol/L | ||||||||
| 1264 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | RETICULOCYTES | Reticulocyte Count % | 1.9 | 0.6 - 2.5 | % | ||||||||
| 1265 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | TSH | TSH 3rd IS-QT | 1.243 | 0.45 - 5.33 | mIU/L | ||||||||
| 1266 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | URINE MACRO PANEL | Ur Specific Gravity | 1.013 | 1.01 - 1.03 | |||||||||
| 1267 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | URINE MACRO PANEL | Ur pH | 5.0 | 5 - 8 | |||||||||
| 1268 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | URINE MACRO PANEL | Ur Protein | Negative | Ref Rng:Negative | |||||||||
| 1269 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | URINE MACRO PANEL | Ur Glucose | Normal | Ref Rng:Normal | |||||||||
| 1270 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | URINE MACRO PANEL | Ur Ketones | Negative | Ref Rng:Negative | |||||||||
| 1271 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | URINE MACRO PANEL | Ur Bilirubin | Negative | Ref Rng:Negative | |||||||||
| 1272 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | URINE MACRO PANEL | Ur Urobilinogen | Normal | Ref Rng:Normal | |||||||||
| 1273 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | URINE MACRO PANEL | Ur Blood | Negative | Ref Rng:Negative | |||||||||
| 1274 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | URINE MACRO PANEL | Ur Nitrite | Negative | Ref Rng:Negative | |||||||||
| 1275 | CZ100110008 | 59 | years | Male | Part 1 Screening | Jan 5, 2026 10:58 AM | 6227542161 | URINE MACRO PANEL | Ur Leukocyte Esterase | Negative | Ref Rng:Negative | |||||||||
| 1276 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Jan 2, 2026 9:28 AM | 6227498379 | C-REACTIVE PROTEIN | C Reactive Protein HS | 0.2 | Result verified by repeat analysis | 0 - 5 | mg/L | |||||||
| 1277 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Jan 2, 2026 9:28 AM | 6227498379 | CHEMISTRY PANEL | Total Bilirubin | 8 | 3 - 21 | umol/L | ||||||||
| 1278 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Jan 2, 2026 9:28 AM | 6227498379 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 2.6 | 0 - 6.2 | umol/L | ||||||||
| 1279 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Jan 2, 2026 9:28 AM | 6227498379 | CHEMISTRY PANEL | Alkaline Phosphatase | 93 | 40 - 129 | U/L | ||||||||
| 1280 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Jan 2, 2026 9:28 AM | 6227498379 | CHEMISTRY PANEL | ALT (SGPT) | 128 | H RX | 5 - 48 | U/L | |||||||
| 1281 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Jan 2, 2026 9:28 AM | 6227498379 | CHEMISTRY PANEL | AST (SGOT) | 54 | H | 8 - 40 | U/L | |||||||
| 1282 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Jan 2, 2026 9:28 AM | 6227498379 | CHEMISTRY PANEL | GGT | 247 | H | Result verified by repeat analysis | 10 - 61 | U/L | ||||||
| 1283 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Jan 2, 2026 9:28 AM | 6227498379 | CHEMISTRY PANEL | LDH | 161 | 53 - 234 | U/L | ||||||||
| 1284 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Jan 2, 2026 9:28 AM | 6227498379 | CHEMISTRY PANEL | Urea Nitrogen | 6.0 | 1.4 - 8.6 | mmol/L | ||||||||
| 1285 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Jan 2, 2026 9:28 AM | 6227498379 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 89 | 40 - 110 | umol/L | ||||||||
| 1286 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Jan 2, 2026 9:28 AM | 6227498379 | CHEMISTRY PANEL | Glucose Fasting | 4.6 | 3.9 - 5.6 | mmol/L | ||||||||
| 1287 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Jan 2, 2026 9:28 AM | 6227498379 | CHEMISTRY PANEL | Serum Uric Acid | 430 | 125 - 488 | umol/L | ||||||||
| 1288 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Jan 2, 2026 9:28 AM | 6227498379 | CHEMISTRY PANEL | Calcium (EDTA) | 2.56 | 2.07 - 2.64 | mmol/L | ||||||||
| 1289 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Jan 2, 2026 9:28 AM | 6227498379 | CHEMISTRY PANEL | Phosphorus | 1.25 | 0.71 - 1.65 | mmol/L | ||||||||
| 1290 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Jan 2, 2026 9:28 AM | 6227498379 | CHEMISTRY PANEL | Total Protein | 77 | 61 - 84 | g/L | ||||||||
| 1291 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Jan 2, 2026 9:28 AM | 6227498379 | CHEMISTRY PANEL | Albumin-BCG | 48 | 33 - 49 | g/L | ||||||||
| 1292 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Jan 2, 2026 9:28 AM | 6227498379 | CHEMISTRY PANEL | Creatine Kinase | 127 | 39 - 308 | U/L | ||||||||
| 1293 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Jan 2, 2026 9:28 AM | 6227498379 | CHEMISTRY PANEL | Serum Sodium | 141 | 132 - 147 | mmol/L | ||||||||
| 1294 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Jan 2, 2026 9:28 AM | 6227498379 | CHEMISTRY PANEL | Serum Potassium | 4.7 | 3.5 - 5.2 | mmol/L | ||||||||
| 1295 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Jan 2, 2026 9:28 AM | 6227498379 | CHEMISTRY PANEL | Serum Bicarbonate | 24.5 | 19.3 - 29.3 | mmol/L | ||||||||
| 1296 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Jan 2, 2026 9:28 AM | 6227498379 | CHEMISTRY PANEL | Serum Chloride | 103 | 94 - 112 | mmol/L | ||||||||
| 1297 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Jan 2, 2026 9:28 AM | 6227498379 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 162 | 127 - 181 | g/L | ||||||||
| 1298 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Jan 2, 2026 9:28 AM | 6227498379 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.47 | 0.39 - 0.54 | |||||||||
| 1299 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Jan 2, 2026 9:28 AM | 6227498379 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 5.4 | 4.5 - 6.4 | TI/L | ||||||||
| 1300 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Jan 2, 2026 9:28 AM | 6227498379 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||
| 1301 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Jan 2, 2026 9:28 AM | 6227498379 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 88 | 79 - 96 | fL | ||||||||
| 1302 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Jan 2, 2026 9:28 AM | 6227498379 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 4.78 | 3.8 - 10.7 | GI/L | ||||||||
| 1303 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Jan 2, 2026 9:28 AM | 6227498379 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 3.00 | 1.96 - 7.23 | GI/L | ||||||||
| 1304 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Jan 2, 2026 9:28 AM | 6227498379 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.31 | 0.91 - 4.28 | GI/L | ||||||||
| 1305 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Jan 2, 2026 9:28 AM | 6227498379 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.26 | 0.12 - 0.92 | GI/L | ||||||||
| 1306 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Jan 2, 2026 9:28 AM | 6227498379 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.16 | 0 - 0.57 | GI/L | ||||||||
| 1307 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Jan 2, 2026 9:28 AM | 6227498379 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.04 | 0 - 0.2 | GI/L | ||||||||
| 1308 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Jan 2, 2026 9:28 AM | 6227498379 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 62.8 | 40.5 - 75 | % | ||||||||
| 1309 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Jan 2, 2026 9:28 AM | 6227498379 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 27.5 | 15.4 - 48.5 | % | ||||||||
| 1310 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Jan 2, 2026 9:28 AM | 6227498379 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 5.4 | 2.6 - 10.1 | % | ||||||||
| 1311 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Jan 2, 2026 9:28 AM | 6227498379 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 3.4 | 0 - 6.8 | % | ||||||||
| 1312 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Jan 2, 2026 9:28 AM | 6227498379 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 0.9 | 0 - 2 | % | ||||||||
| 1313 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Jan 2, 2026 9:28 AM | 6227498379 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 271 | 140 - 400 | GI/L | ||||||||
| 1314 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Jan 2, 2026 9:28 AM | 6227498379 | HEMOGLOBIN A1C | Hemoglobin A1c,NGSP-RM | 5.1 | <6.5 % | |||||||||
| 1315 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Jan 2, 2026 9:28 AM | 6227498379 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | 8.27 | 1.9 - 23 | uIU/mL | ||||||||
| 1316 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Jan 2, 2026 9:28 AM | 6227498379 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||
| 1317 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Jan 2, 2026 9:28 AM | 6227498379 | LIPID PANEL | Direct HDL-C 4th Generation | 1.32 | Result verified by repeat analysis | 1.03 - 1.53 | mmol/L | |||||||
| 1318 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Jan 2, 2026 9:28 AM | 6227498379 | LIPID PANEL | Triglycerides (GPO) | 2.24 | 0.5 - 2.81 | mmol/L | ||||||||
| 1319 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Jan 2, 2026 9:28 AM | 6227498379 | LIPID PANEL | Cholesterol (High Performance) | 5.39 | 3.31 - 6.1 | mmol/L | ||||||||
| 1320 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Jan 2, 2026 9:28 AM | 6227498379 | LIPID PANEL | LDL Chol Friedewald 4th | 3.04 | 0 - 3.34 | mmol/L | ||||||||
| 1321 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Jan 2, 2026 9:28 AM | 6227498379 | RETICULOCYTES | Reticulocyte Count % | 1.1 | 0.6 - 2.5 | % | ||||||||
| 1322 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Jan 2, 2026 9:28 AM | 6227498379 | TSH | TSH 3rd IS-QT | 1.417 | 0.45 - 5.33 | mIU/L | ||||||||
| 1323 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Jan 2, 2026 9:28 AM | 6227498379 | URINE MACRO PANEL | Ur Specific Gravity | 1.023 | 1 - 1.04 | |||||||||
| 1324 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Jan 2, 2026 9:28 AM | 6227498379 | URINE MACRO PANEL | Ur pH | 5.5 | 5 - 8 | |||||||||
| 1325 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Jan 2, 2026 9:28 AM | 6227498379 | URINE MACRO PANEL | Ur Protein | Negative | Ref Rng:Negative | |||||||||
| 1326 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Jan 2, 2026 9:28 AM | 6227498379 | URINE MACRO PANEL | Ur Glucose | Normal | Ref Rng:Normal | |||||||||
| 1327 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Jan 2, 2026 9:28 AM | 6227498379 | URINE MACRO PANEL | Ur Ketones | Negative | Ref Rng:Negative | |||||||||
| 1328 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Jan 2, 2026 9:28 AM | 6227498379 | URINE MACRO PANEL | Ur Bilirubin | Negative | Ref Rng:Negative | |||||||||
| 1329 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Jan 2, 2026 9:28 AM | 6227498379 | URINE MACRO PANEL | Ur Urobilinogen | Normal | Ref Rng:Normal | |||||||||
| 1330 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Jan 2, 2026 9:28 AM | 6227498379 | URINE MACRO PANEL | Ur Blood | Negative | Ref Rng:Negative | |||||||||
| 1331 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Jan 2, 2026 9:28 AM | 6227498379 | URINE MACRO PANEL | Ur Nitrite | Negative | Ref Rng:Negative | |||||||||
| 1332 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Jan 2, 2026 9:28 AM | 6227498379 | URINE MACRO PANEL | Ur Leukocyte Esterase | Negative | Ref Rng:Negative | |||||||||
| 1333 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | C-REACTIVE PROTEIN | C Reactive Protein HS | 1.0 | 0 - 5 | mg/L | |||||||
| 1334 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | CHEMISTRY PANEL | Total Bilirubin | 9 | 3 - 21 | umol/L | |||||||
| 1335 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 3.4 | 0 - 6.2 | umol/L | |||||||
| 1336 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | CHEMISTRY PANEL | Alkaline Phosphatase | 63 | 35 - 104 | U/L | |||||||
| 1337 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | CHEMISTRY PANEL | ALT (SGPT) | 18 | 4 - 43 | U/L | |||||||
| 1338 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | CHEMISTRY PANEL | AST (SGOT) | 21 | 8 - 40 | U/L | |||||||
| 1339 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | CHEMISTRY PANEL | GGT | 15 | 4 - 49 | U/L | |||||||
| 1340 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | CHEMISTRY PANEL | LDH | 142 | 53 - 234 | U/L | |||||||
| 1341 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | CHEMISTRY PANEL | Urea Nitrogen | 4.2 | 1.4 - 8.6 | mmol/L | |||||||
| 1342 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 81 | 31 - 101 | umol/L | |||||||
| 1343 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | CHEMISTRY PANEL | Glucose Fasting | 5.2 | 3.9 - 5.6 | mmol/L | |||||||
| 1344 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | CHEMISTRY PANEL | Serum Uric Acid | 291 | 125 - 428 | umol/L | |||||||
| 1345 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | CHEMISTRY PANEL | Calcium (EDTA) | 2.40 | 2.07 - 2.64 | mmol/L | |||||||
| 1346 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | CHEMISTRY PANEL | Phosphorus | 1.15 | 0.71 - 1.65 | mmol/L | |||||||
| 1347 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | CHEMISTRY PANEL | Total Protein | 70 | 61 - 84 | g/L | |||||||
| 1348 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | CHEMISTRY PANEL | Albumin-BCG | 45 | 33 - 49 | g/L | |||||||
| 1349 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | CHEMISTRY PANEL | Creatine Kinase | 109 | 26 - 192 | U/L | |||||||
| 1350 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | CHEMISTRY PANEL | Serum Sodium | 140 | 132 - 147 | mmol/L | |||||||
| 1351 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | CHEMISTRY PANEL | Serum Potassium | 4.1 | 3.5 - 5.2 | mmol/L | |||||||
| 1352 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | CHEMISTRY PANEL | Serum Bicarbonate | 21.7 | 19.3 - 29.3 | mmol/L | |||||||
| 1353 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | CHEMISTRY PANEL | Serum Chloride | 102 | 94 - 112 | mmol/L | |||||||
| 1354 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | CREATININE CLEARANCE CC&G | CreatininClearancCockcrftGault | 1.55 | 1.25 - 1.92 | mL/sec | |||||||
| 1355 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | CREATININE CLEARANCE CC&G | Creatinine(Rate Blanked)-2dp | 81 | 31 - 101 | umol/L | |||||||
| 1356 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | CREATININE CLEARANCE CC&G | Weight (kg,1dec place) | Y | 68.0 | kg | |||||||
| 1357 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | FSH | Follicle Stimulating Hormone | 1.95 | RX | Follicular:$3.90-8.80 IU/L$Midcycle:$4.50-22.50 IU/L$Luteal:$1.80-5.10 IU/L$Postmenopausal:$16.70-113.60 IU/L | |||||||
| 1358 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 124 | 116 - 164 | g/L | |||||||
| 1359 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.37 | 0.34 - 0.48 | ||||||||
| 1360 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.2 | 4.1 - 5.6 | TI/L | |||||||
| 1361 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | ||||||||
| 1362 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 89 | 79 - 98 | fL | |||||||
| 1363 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 5.35 | 3.8 - 10.7 | GI/L | |||||||
| 1364 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 3.19 | 1.96 - 7.23 | GI/L | |||||||
| 1365 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.57 | 0.91 - 4.28 | GI/L | |||||||
| 1366 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.39 | 0.12 - 0.92 | GI/L | |||||||
| 1367 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.11 | 0 - 0.57 | GI/L | |||||||
| 1368 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.08 | 0 - 0.2 | GI/L | |||||||
| 1369 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 59.6 | 40.5 - 75 | % | |||||||
| 1370 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 29.4 | 15.4 - 48.5 | % | |||||||
| 1371 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 7.3 | 2.6 - 10.1 | % | |||||||
| 1372 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 2.1 | 0 - 6.8 | % | |||||||
| 1373 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 1.6 | 0 - 2 | % | |||||||
| 1374 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 340 | 140 - 400 | GI/L | |||||||
| 1375 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | HEMOGLOBIN A1C | Hemoglobin A1c,NGSP-RM | 5.7 | <6.5 % | ||||||||
| 1376 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | 4.35 | 1.9 - 23 | uIU/mL | |||||||
| 1377 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | ||||||||
| 1378 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | LIPID PANEL | Direct HDL-C 4th Generation | 1.82 | H | 1.03 - 1.53 | mmol/L | ||||||
| 1379 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | LIPID PANEL | Triglycerides (GPO) | 0.63 | 0.44 - 1.99 | mmol/L | |||||||
| 1380 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | LIPID PANEL | Cholesterol (High Performance) | 5.11 | 3.65 - 6.21 | mmol/L | |||||||
| 1381 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | LIPID PANEL | LDL Chol Friedewald 4th | 3.00 | 0 - 3.34 | mmol/L | |||||||
| 1382 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | RETICULOCYTES | Reticulocyte Count % | 0.7 | 0.6 - 2.5 | % | |||||||
| 1383 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | SERUM BETA HCG | B-hCG, Qualitative | Negative | Ref Rng: Negative | ||||||||
| 1384 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | SERUM BETA HCG | B-hCG, Quantitative | <0.6 | Units: mIU/mL$Pre-menopausal$<5.0: Negative$5.0-24.9:Borderline$>/= 25.0: Positive | ||||||||
| 1385 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | TSH | TSH 3rd IS-QT | 2.024 | 0.45 - 5.33 | mIU/L | |||||||
| 1386 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | URINE MACRO PANEL | Ur Specific Gravity | 1.017 | 1 - 1.04 | ||||||||
| 1387 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | URINE MACRO PANEL | Ur pH | 5.5 | 5 - 8 | ||||||||
| 1388 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | URINE MACRO PANEL | Ur Protein | Negative | Ref Rng:Negative | ||||||||
| 1389 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | URINE MACRO PANEL | Ur Glucose | Normal | Ref Rng:Normal | ||||||||
| 1390 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | URINE MACRO PANEL | Ur Ketones | Negative | Ref Rng:Negative | ||||||||
| 1391 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | URINE MACRO PANEL | Ur Bilirubin | Negative | Ref Rng:Negative | ||||||||
| 1392 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | URINE MACRO PANEL | Ur Urobilinogen | Normal | Ref Rng:Normal | ||||||||
| 1393 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | URINE MACRO PANEL | Ur Blood | Negative | Ref Rng:$Negative-Trace | ||||||||
| 1394 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | URINE MACRO PANEL | Ur Nitrite | Negative | Ref Rng:Negative | ||||||||
| 1395 | CZ100110003 | 35 | years | Female | Retest | R | Dec 11, 2025 9:05 AM | 6226935606 | URINE MACRO PANEL | Ur Leukocyte Esterase | Negative | Ref Rng:Negative | ||||||||
| 1396 | CZ100110007 | 56 | years | Female | Part 1 DB Baseline | Dec 11, 2025 8:13 AM | 6227144562 | C-REACTIVE PROTEIN | C Reactive Protein HS | 0.7 | 0 - 5 | mg/L | ||||||||
| 1397 | CZ100110007 | 56 | years | Female | Part 1 DB Baseline | Dec 11, 2025 8:13 AM | 6227144562 | CHEMISTRY PANEL | Total Bilirubin | 7 | 3 - 21 | umol/L | ||||||||
| 1398 | CZ100110007 | 56 | years | Female | Part 1 DB Baseline | Dec 11, 2025 8:13 AM | 6227144562 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 2.9 | 0 - 6.2 | umol/L | ||||||||
| 1399 | CZ100110007 | 56 | years | Female | Part 1 DB Baseline | Dec 11, 2025 8:13 AM | 6227144562 | CHEMISTRY PANEL | Alkaline Phosphatase | 62 | 35 - 104 | U/L | ||||||||
| 1400 | CZ100110007 | 56 | years | Female | Part 1 DB Baseline | Dec 11, 2025 8:13 AM | 6227144562 | CHEMISTRY PANEL | ALT (SGPT) | 21 | 4 - 43 | U/L | ||||||||
| 1401 | CZ100110007 | 56 | years | Female | Part 1 DB Baseline | Dec 11, 2025 8:13 AM | 6227144562 | CHEMISTRY PANEL | AST (SGOT) | 24 | 8 - 40 | U/L | ||||||||
| 1402 | CZ100110007 | 56 | years | Female | Part 1 DB Baseline | Dec 11, 2025 8:13 AM | 6227144562 | CHEMISTRY PANEL | GGT | 33 | 4 - 49 | U/L | ||||||||
| 1403 | CZ100110007 | 56 | years | Female | Part 1 DB Baseline | Dec 11, 2025 8:13 AM | 6227144562 | CHEMISTRY PANEL | LDH | 158 | 53 - 234 | U/L | ||||||||
| 1404 | CZ100110007 | 56 | years | Female | Part 1 DB Baseline | Dec 11, 2025 8:13 AM | 6227144562 | CHEMISTRY PANEL | Urea Nitrogen | 4.1 | 1.4 - 8.6 | mmol/L | ||||||||
| 1405 | CZ100110007 | 56 | years | Female | Part 1 DB Baseline | Dec 11, 2025 8:13 AM | 6227144562 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 73 | 31 - 101 | umol/L | ||||||||
| 1406 | CZ100110007 | 56 | years | Female | Part 1 DB Baseline | Dec 11, 2025 8:13 AM | 6227144562 | CHEMISTRY PANEL | Glucose Fasting | 4.2 | 3.9 - 5.6 | mmol/L | ||||||||
| 1407 | CZ100110007 | 56 | years | Female | Part 1 DB Baseline | Dec 11, 2025 8:13 AM | 6227144562 | CHEMISTRY PANEL | Serum Uric Acid | 307 | 149 - 446 | umol/L | ||||||||
| 1408 | CZ100110007 | 56 | years | Female | Part 1 DB Baseline | Dec 11, 2025 8:13 AM | 6227144562 | CHEMISTRY PANEL | Calcium (EDTA) | 2.34 | 2.07 - 2.64 | mmol/L | ||||||||
| 1409 | CZ100110007 | 56 | years | Female | Part 1 DB Baseline | Dec 11, 2025 8:13 AM | 6227144562 | CHEMISTRY PANEL | Phosphorus | 1.07 | 0.71 - 1.65 | mmol/L | ||||||||
| 1410 | CZ100110007 | 56 | years | Female | Part 1 DB Baseline | Dec 11, 2025 8:13 AM | 6227144562 | CHEMISTRY PANEL | Total Protein | 71 | 61 - 84 | g/L | ||||||||
| 1411 | CZ100110007 | 56 | years | Female | Part 1 DB Baseline | Dec 11, 2025 8:13 AM | 6227144562 | CHEMISTRY PANEL | Albumin-BCG | 44 | 33 - 49 | g/L | ||||||||
| 1412 | CZ100110007 | 56 | years | Female | Part 1 DB Baseline | Dec 11, 2025 8:13 AM | 6227144562 | CHEMISTRY PANEL | Creatine Kinase | 203 | H | 26 - 192 | U/L | |||||||
| 1413 | CZ100110007 | 56 | years | Female | Part 1 DB Baseline | Dec 11, 2025 8:13 AM | 6227144562 | CHEMISTRY PANEL | Serum Sodium | 139 | 132 - 147 | mmol/L | ||||||||
| 1414 | CZ100110007 | 56 | years | Female | Part 1 DB Baseline | Dec 11, 2025 8:13 AM | 6227144562 | CHEMISTRY PANEL | Serum Potassium | 4.3 | 3.5 - 5.2 | mmol/L | ||||||||
| 1415 | CZ100110007 | 56 | years | Female | Part 1 DB Baseline | Dec 11, 2025 8:13 AM | 6227144562 | CHEMISTRY PANEL | Serum Bicarbonate | 22.0 | 19.3 - 29.3 | mmol/L | ||||||||
| 1416 | CZ100110007 | 56 | years | Female | Part 1 DB Baseline | Dec 11, 2025 8:13 AM | 6227144562 | CHEMISTRY PANEL | Serum Chloride | 103 | 94 - 112 | mmol/L | ||||||||
| 1417 | CZ100110007 | 56 | years | Female | Part 1 DB Baseline | Dec 11, 2025 8:13 AM | 6227144562 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 136 | 116 - 164 | g/L | ||||||||
| 1418 | CZ100110007 | 56 | years | Female | Part 1 DB Baseline | Dec 11, 2025 8:13 AM | 6227144562 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.41 | 0.34 - 0.48 | |||||||||
| 1419 | CZ100110007 | 56 | years | Female | Part 1 DB Baseline | Dec 11, 2025 8:13 AM | 6227144562 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.5 | 4.1 - 5.6 | TI/L | ||||||||
| 1420 | CZ100110007 | 56 | years | Female | Part 1 DB Baseline | Dec 11, 2025 8:13 AM | 6227144562 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||
| 1421 | CZ100110007 | 56 | years | Female | Part 1 DB Baseline | Dec 11, 2025 8:13 AM | 6227144562 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 90 | 79 - 98 | fL | ||||||||
| 1422 | CZ100110007 | 56 | years | Female | Part 1 DB Baseline | Dec 11, 2025 8:13 AM | 6227144562 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 6.49 | 3.8 - 10.7 | GI/L | ||||||||
| 1423 | CZ100110007 | 56 | years | Female | Part 1 DB Baseline | Dec 11, 2025 8:13 AM | 6227144562 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 2.93 | 1.96 - 7.23 | GI/L | ||||||||
| 1424 | CZ100110007 | 56 | years | Female | Part 1 DB Baseline | Dec 11, 2025 8:13 AM | 6227144562 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 2.72 | 0.91 - 4.28 | GI/L | ||||||||
| 1425 | CZ100110007 | 56 | years | Female | Part 1 DB Baseline | Dec 11, 2025 8:13 AM | 6227144562 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.34 | 0.12 - 0.92 | GI/L | ||||||||
| 1426 | CZ100110007 | 56 | years | Female | Part 1 DB Baseline | Dec 11, 2025 8:13 AM | 6227144562 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.32 | 0 - 0.57 | GI/L | ||||||||
| 1427 | CZ100110007 | 56 | years | Female | Part 1 DB Baseline | Dec 11, 2025 8:13 AM | 6227144562 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.17 | 0 - 0.2 | GI/L | ||||||||
| 1428 | CZ100110007 | 56 | years | Female | Part 1 DB Baseline | Dec 11, 2025 8:13 AM | 6227144562 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 45.2 | 40.5 - 75 | % | ||||||||
| 1429 | CZ100110007 | 56 | years | Female | Part 1 DB Baseline | Dec 11, 2025 8:13 AM | 6227144562 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 41.9 | 15.4 - 48.5 | % | ||||||||
| 1430 | CZ100110007 | 56 | years | Female | Part 1 DB Baseline | Dec 11, 2025 8:13 AM | 6227144562 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 5.3 | 2.6 - 10.1 | % | ||||||||
| 1431 | CZ100110007 | 56 | years | Female | Part 1 DB Baseline | Dec 11, 2025 8:13 AM | 6227144562 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 4.9 | 0 - 6.8 | % | ||||||||
| 1432 | CZ100110007 | 56 | years | Female | Part 1 DB Baseline | Dec 11, 2025 8:13 AM | 6227144562 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 2.7 | R | H | 0 - 2 | % | ||||||
| 1433 | CZ100110007 | 56 | years | Female | Part 1 DB Baseline | Dec 11, 2025 8:13 AM | 6227144562 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 332 | 140 - 400 | GI/L | ||||||||
| 1434 | CZ100110007 | 56 | years | Female | Part 1 DB Baseline | Dec 11, 2025 8:13 AM | 6227144562 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | 3.15 | 1.9 - 23 | uIU/mL | ||||||||
| 1435 | CZ100110007 | 56 | years | Female | Part 1 DB Baseline | Dec 11, 2025 8:13 AM | 6227144562 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||
| 1436 | CZ100110007 | 56 | years | Female | Part 1 DB Baseline | Dec 11, 2025 8:13 AM | 6227144562 | LIPID PANEL | Direct HDL-C 4th Generation | 1.91 | H | 1.03 - 1.53 | mmol/L | |||||||
| 1437 | CZ100110007 | 56 | years | Female | Part 1 DB Baseline | Dec 11, 2025 8:13 AM | 6227144562 | LIPID PANEL | Triglycerides (GPO) | 1.28 | 0.59 - 2.96 | mmol/L | ||||||||
| 1438 | CZ100110007 | 56 | years | Female | Part 1 DB Baseline | Dec 11, 2025 8:13 AM | 6227144562 | LIPID PANEL | Cholesterol (High Performance) | 5.21 | 4.42 - 7.53 | mmol/L | ||||||||
| 1439 | CZ100110007 | 56 | years | Female | Part 1 DB Baseline | Dec 11, 2025 8:13 AM | 6227144562 | LIPID PANEL | LDL Chol Friedewald 4th | 2.71 | 0 - 3.34 | mmol/L | ||||||||
| 1440 | CZ100110007 | 56 | years | Female | Part 1 DB Baseline | Dec 11, 2025 8:13 AM | 6227144562 | RETICULOCYTES | Reticulocyte Count % | 1.1 | 0.6 - 2.5 | % | ||||||||
| 1441 | CZ100110007 | 56 | years | Female | Part 1 DB Baseline | Dec 11, 2025 8:13 AM | 6227144562 | URINE MACRO PANEL | Ur Specific Gravity | 1.024 | 1 - 1.04 | |||||||||
| 1442 | CZ100110007 | 56 | years | Female | Part 1 DB Baseline | Dec 11, 2025 8:13 AM | 6227144562 | URINE MACRO PANEL | Ur pH | 6.0 | 5 - 8 | |||||||||
| 1443 | CZ100110007 | 56 | years | Female | Part 1 DB Baseline | Dec 11, 2025 8:13 AM | 6227144562 | URINE MACRO PANEL | Ur Protein | Negative | Ref Rng:Negative | |||||||||
| 1444 | CZ100110007 | 56 | years | Female | Part 1 DB Baseline | Dec 11, 2025 8:13 AM | 6227144562 | URINE MACRO PANEL | Ur Glucose | Normal | Ref Rng:Normal | |||||||||
| 1445 | CZ100110007 | 56 | years | Female | Part 1 DB Baseline | Dec 11, 2025 8:13 AM | 6227144562 | URINE MACRO PANEL | Ur Ketones | Negative | Ref Rng:Negative | |||||||||
| 1446 | CZ100110007 | 56 | years | Female | Part 1 DB Baseline | Dec 11, 2025 8:13 AM | 6227144562 | URINE MACRO PANEL | Ur Bilirubin | Negative | Ref Rng:Negative | |||||||||
| 1447 | CZ100110007 | 56 | years | Female | Part 1 DB Baseline | Dec 11, 2025 8:13 AM | 6227144562 | URINE MACRO PANEL | Ur Urobilinogen | Normal | Ref Rng:Normal | |||||||||
| 1448 | CZ100110007 | 56 | years | Female | Part 1 DB Baseline | Dec 11, 2025 8:13 AM | 6227144562 | URINE MACRO PANEL | Ur Blood | Negative | Ref Rng:$Negative-Trace | |||||||||
| 1449 | CZ100110007 | 56 | years | Female | Part 1 DB Baseline | Dec 11, 2025 8:13 AM | 6227144562 | URINE MACRO PANEL | Ur Nitrite | Negative | Ref Rng:Negative | |||||||||
| 1450 | CZ100110007 | 56 | years | Female | Part 1 DB Baseline | Dec 11, 2025 8:13 AM | 6227144562 | URINE MACRO PANEL | Ur Leukocyte Esterase | Negative | Ref Rng:Negative | |||||||||
| 1451 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Dec 5, 2025 9:23 AM | 6225351093 | C-REACTIVE PROTEIN | C Reactive Protein HS | Test cancelled: Expired contain, test cancel | ||||||||||
| 1452 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Dec 5, 2025 9:23 AM | 6225351093 | CHEMISTRY PANEL | Total Bilirubin | Test cancelled: Expired contain, test cancel | ||||||||||
| 1453 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Dec 5, 2025 9:23 AM | 6225351093 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | Test cancelled: Expired contain, test cancel | ||||||||||
| 1454 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Dec 5, 2025 9:23 AM | 6225351093 | CHEMISTRY PANEL | Alkaline Phosphatase | Test cancelled: Expired contain, test cancel | ||||||||||
| 1455 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Dec 5, 2025 9:23 AM | 6225351093 | CHEMISTRY PANEL | ALT (SGPT) | Test cancelled: Expired contain, test cancel | ||||||||||
| 1456 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Dec 5, 2025 9:23 AM | 6225351093 | CHEMISTRY PANEL | AST (SGOT) | Test cancelled: Expired contain, test cancel | ||||||||||
| 1457 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Dec 5, 2025 9:23 AM | 6225351093 | CHEMISTRY PANEL | GGT | Test cancelled: Expired contain, test cancel | ||||||||||
| 1458 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Dec 5, 2025 9:23 AM | 6225351093 | CHEMISTRY PANEL | LDH | Test cancelled: Expired contain, test cancel | ||||||||||
| 1459 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Dec 5, 2025 9:23 AM | 6225351093 | CHEMISTRY PANEL | Urea Nitrogen | Test cancelled: Expired contain, test cancel | ||||||||||
| 1460 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Dec 5, 2025 9:23 AM | 6225351093 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | Test cancelled: Expired contain, test cancel | ||||||||||
| 1461 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Dec 5, 2025 9:23 AM | 6225351093 | CHEMISTRY PANEL | Glucose Fasting | Test cancelled: Expired contain, test cancel | ||||||||||
| 1462 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Dec 5, 2025 9:23 AM | 6225351093 | CHEMISTRY PANEL | Serum Uric Acid | Test cancelled: Expired contain, test cancel | ||||||||||
| 1463 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Dec 5, 2025 9:23 AM | 6225351093 | CHEMISTRY PANEL | Calcium (EDTA) | Test cancelled: Expired contain, test cancel | ||||||||||
| 1464 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Dec 5, 2025 9:23 AM | 6225351093 | CHEMISTRY PANEL | Phosphorus | Test cancelled: Expired contain, test cancel | ||||||||||
| 1465 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Dec 5, 2025 9:23 AM | 6225351093 | CHEMISTRY PANEL | Total Protein | Test cancelled: Expired contain, test cancel | ||||||||||
| 1466 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Dec 5, 2025 9:23 AM | 6225351093 | CHEMISTRY PANEL | Albumin-BCG | Test cancelled: Expired contain, test cancel | ||||||||||
| 1467 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Dec 5, 2025 9:23 AM | 6225351093 | CHEMISTRY PANEL | Creatine Kinase | Test cancelled: Expired contain, test cancel | ||||||||||
| 1468 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Dec 5, 2025 9:23 AM | 6225351093 | CHEMISTRY PANEL | Serum Sodium | Test cancelled: Expired contain, test cancel | ||||||||||
| 1469 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Dec 5, 2025 9:23 AM | 6225351093 | CHEMISTRY PANEL | Serum Potassium | Test cancelled: Expired contain, test cancel | ||||||||||
| 1470 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Dec 5, 2025 9:23 AM | 6225351093 | CHEMISTRY PANEL | Serum Bicarbonate | Test cancelled: Expired contain, test cancel | ||||||||||
| 1471 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Dec 5, 2025 9:23 AM | 6225351093 | CHEMISTRY PANEL | Serum Chloride | Test cancelled: Expired contain, test cancel | ||||||||||
| 1472 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Dec 5, 2025 9:23 AM | 6225351093 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 126 | 116 - 164 | g/L | ||||||||
| 1473 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Dec 5, 2025 9:23 AM | 6225351093 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.38 | 0.34 - 0.48 | |||||||||
| 1474 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Dec 5, 2025 9:23 AM | 6225351093 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.3 | 4.1 - 5.6 | TI/L | ||||||||
| 1475 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Dec 5, 2025 9:23 AM | 6225351093 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||
| 1476 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Dec 5, 2025 9:23 AM | 6225351093 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 89 | 79 - 98 | fL | ||||||||
| 1477 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Dec 5, 2025 9:23 AM | 6225351093 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 4.49 | 3.8 - 10.7 | GI/L | ||||||||
| 1478 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Dec 5, 2025 9:23 AM | 6225351093 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 2.37 | 1.96 - 7.23 | GI/L | ||||||||
| 1479 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Dec 5, 2025 9:23 AM | 6225351093 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.74 | 0.91 - 4.28 | GI/L | ||||||||
| 1480 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Dec 5, 2025 9:23 AM | 6225351093 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.29 | 0.12 - 0.92 | GI/L | ||||||||
| 1481 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Dec 5, 2025 9:23 AM | 6225351093 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.07 | 0 - 0.57 | GI/L | ||||||||
| 1482 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Dec 5, 2025 9:23 AM | 6225351093 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.02 | 0 - 0.2 | GI/L | ||||||||
| 1483 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Dec 5, 2025 9:23 AM | 6225351093 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 52.8 | 40.5 - 75 | % | ||||||||
| 1484 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Dec 5, 2025 9:23 AM | 6225351093 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 38.7 | 15.4 - 48.5 | % | ||||||||
| 1485 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Dec 5, 2025 9:23 AM | 6225351093 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 6.5 | 2.6 - 10.1 | % | ||||||||
| 1486 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Dec 5, 2025 9:23 AM | 6225351093 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 1.6 | 0 - 6.8 | % | ||||||||
| 1487 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Dec 5, 2025 9:23 AM | 6225351093 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 0.5 | 0 - 2 | % | ||||||||
| 1488 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Dec 5, 2025 9:23 AM | 6225351093 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 299 | 140 - 400 | GI/L | ||||||||
| 1489 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Dec 5, 2025 9:23 AM | 6225351093 | HEMOGLOBIN A1C | Hemoglobin A1c,NGSP-RM | 5.5 | <6.5 % | |||||||||
| 1490 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Dec 5, 2025 9:23 AM | 6225351093 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | 2.65 | 1.9 - 23 | uIU/mL | ||||||||
| 1491 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Dec 5, 2025 9:23 AM | 6225351093 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||
| 1492 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Dec 5, 2025 9:23 AM | 6225351093 | LIPID PANEL | Direct HDL-C 4th Generation | Test cancelled: Expired contain, test cancel | ||||||||||
| 1493 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Dec 5, 2025 9:23 AM | 6225351093 | LIPID PANEL | Triglycerides (GPO) | Test cancelled: Expired contain, test cancel | ||||||||||
| 1494 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Dec 5, 2025 9:23 AM | 6225351093 | LIPID PANEL | Cholesterol (High Performance) | Test cancelled: Expired contain, test cancel | ||||||||||
| 1495 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Dec 5, 2025 9:23 AM | 6225351093 | LIPID PANEL | LDL Chol Friedewald 4th | Required testing unavailable | 0 - 3.34 | mmol/L | ||||||||
| 1496 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Dec 5, 2025 9:23 AM | 6225351093 | RETICULOCYTES | Reticulocyte Count % | 1.0 | 0.6 - 2.5 | % | ||||||||
| 1497 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Dec 5, 2025 9:23 AM | 6225351093 | TSH | TSH 3rd IS-QT | Test cancelled: Expired contain, test cancel | ||||||||||
| 1498 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Dec 5, 2025 9:23 AM | 6225351093 | URINE MACRO PANEL | Ur Specific Gravity | 1.011 | 1 - 1.04 | |||||||||
| 1499 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Dec 5, 2025 9:23 AM | 6225351093 | URINE MACRO PANEL | Ur pH | 6.5 | 5 - 8 | |||||||||
| 1500 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Dec 5, 2025 9:23 AM | 6225351093 | URINE MACRO PANEL | Ur Protein | Negative | Ref Rng:Negative | |||||||||
| 1501 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Dec 5, 2025 9:23 AM | 6225351093 | URINE MACRO PANEL | Ur Glucose | Normal | Ref Rng:Normal | |||||||||
| 1502 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Dec 5, 2025 9:23 AM | 6225351093 | URINE MACRO PANEL | Ur Ketones | Negative | Ref Rng:Negative | |||||||||
| 1503 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Dec 5, 2025 9:23 AM | 6225351093 | URINE MACRO PANEL | Ur Bilirubin | Negative | Ref Rng:Negative | |||||||||
| 1504 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Dec 5, 2025 9:23 AM | 6225351093 | URINE MACRO PANEL | Ur Urobilinogen | Normal | Ref Rng:Normal | |||||||||
| 1505 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Dec 5, 2025 9:23 AM | 6225351093 | URINE MACRO PANEL | Ur Blood | Negative | Ref Rng:$Negative-Trace | |||||||||
| 1506 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Dec 5, 2025 9:23 AM | 6225351093 | URINE MACRO PANEL | Ur Nitrite | Negative | Ref Rng:Negative | |||||||||
| 1507 | CZ100110003 | 35 | years | Female | End of Phase/Treatment | Dec 5, 2025 9:23 AM | 6225351093 | URINE MACRO PANEL | Ur Leukocyte Esterase | Negative | Ref Rng:Negative | |||||||||
| 1508 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | C-REACTIVE PROTEIN | C Reactive Protein HS | 2.1 | 0 - 5 | mg/L | ||||||||
| 1509 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | CELLULAR ELEMENTS | Ur WBC/HPF | 5 | 0 - 12 | /HPF | ||||||||
| 1510 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | CELLULAR ELEMENTS | Ur Squamous Epithelial Cells | 80 | 0 - 3 | /HPF | ||||||||
| 1511 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | CHEMISTRY PANEL | Total Bilirubin | 6 | 3 - 21 | umol/L | ||||||||
| 1512 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 2.5 | 0 - 6.2 | umol/L | ||||||||
| 1513 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | CHEMISTRY PANEL | Alkaline Phosphatase | 98 | 35 - 104 | U/L | ||||||||
| 1514 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | CHEMISTRY PANEL | ALT (SGPT) | 8 | 4 - 43 | U/L | ||||||||
| 1515 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | CHEMISTRY PANEL | AST (SGOT) | 10 | 8 - 40 | U/L | ||||||||
| 1516 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | CHEMISTRY PANEL | GGT | 8 | 4 - 49 | U/L | ||||||||
| 1517 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | CHEMISTRY PANEL | LDH | 142 | 53 - 234 | U/L | ||||||||
| 1518 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | CHEMISTRY PANEL | Urea Nitrogen | 4.8 | 1.4 - 8.6 | mmol/L | ||||||||
| 1519 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 62 | 31 - 101 | umol/L | ||||||||
| 1520 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | CHEMISTRY PANEL | Glucose Fasting | 4.9 | 3.9 - 5.6 | mmol/L | ||||||||
| 1521 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | CHEMISTRY PANEL | Serum Uric Acid | 261 | 125 - 428 | umol/L | ||||||||
| 1522 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | CHEMISTRY PANEL | Calcium (EDTA) | 2.34 | 2.07 - 2.64 | mmol/L | ||||||||
| 1523 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | CHEMISTRY PANEL | Phosphorus | 1.10 | 0.71 - 1.65 | mmol/L | ||||||||
| 1524 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | CHEMISTRY PANEL | Total Protein | 78 | 61 - 84 | g/L | ||||||||
| 1525 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | CHEMISTRY PANEL | Albumin-BCG | 49 | 33 - 49 | g/L | ||||||||
| 1526 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | CHEMISTRY PANEL | Creatine Kinase | 42 | 26 - 192 | U/L | ||||||||
| 1527 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | CHEMISTRY PANEL | Serum Sodium | 139 | 132 - 147 | mmol/L | ||||||||
| 1528 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | CHEMISTRY PANEL | Serum Potassium | 4.4 | 3.5 - 5.2 | mmol/L | ||||||||
| 1529 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | CHEMISTRY PANEL | Serum Bicarbonate | 21.8 | 19.3 - 29.3 | mmol/L | ||||||||
| 1530 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | CHEMISTRY PANEL | Serum Chloride | 102 | 94 - 112 | mmol/L | ||||||||
| 1531 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | CRYSTALS | Ur Calcium Oxalate Crystals | Present | Ref Rng:Not present | |||||||||
| 1532 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 136 | 116 - 164 | g/L | ||||||||
| 1533 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.41 | 0.34 - 0.48 | |||||||||
| 1534 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.5 | 4.1 - 5.6 | TI/L | ||||||||
| 1535 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||
| 1536 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 91 | 79 - 98 | fL | ||||||||
| 1537 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 7.82 | 3.8 - 10.7 | GI/L | ||||||||
| 1538 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 5.12 | 1.96 - 7.23 | GI/L | ||||||||
| 1539 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 2.07 | 0.91 - 4.28 | GI/L | ||||||||
| 1540 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.39 | 0.12 - 0.92 | GI/L | ||||||||
| 1541 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.17 | 0 - 0.57 | GI/L | ||||||||
| 1542 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.08 | 0 - 0.2 | GI/L | ||||||||
| 1543 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 65.4 | 40.5 - 75 | % | ||||||||
| 1544 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 26.4 | 15.4 - 48.5 | % | ||||||||
| 1545 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 5.0 | 2.6 - 10.1 | % | ||||||||
| 1546 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 2.1 | 0 - 6.8 | % | ||||||||
| 1547 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 1.0 | 0 - 2 | % | ||||||||
| 1548 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 322 | 140 - 400 | GI/L | ||||||||
| 1549 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | 4.28 | 1.9 - 23 | uIU/mL | ||||||||
| 1550 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||
| 1551 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | LIPID PANEL | Direct HDL-C 4th Generation | 1.25 | Result verified by repeat analysis | 1.03 - 1.53 | mmol/L | |||||||
| 1552 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | LIPID PANEL | Triglycerides (GPO) | 0.86 | 0.44 - 1.99 | mmol/L | ||||||||
| 1553 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | LIPID PANEL | Cholesterol (High Performance) | 4.48 | 3.65 - 6.21 | mmol/L | ||||||||
| 1554 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | LIPID PANEL | LDL Chol Friedewald 4th | 2.84 | 0 - 3.34 | mmol/L | ||||||||
| 1555 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | MICROORGANISMS | Ur Bacteria | Present | Ref Rng:Not present | |||||||||
| 1556 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | MISCELLANEOUS ELEMENTS | Ur Mucous | Present | Ref Rng:Not present | |||||||||
| 1557 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | RETICULOCYTES | Reticulocyte Count % | 2.1 | 0.6 - 2.5 | % | ||||||||
| 1558 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | URINE MACRO PANEL | Ur Specific Gravity | 1.037 | H | 1 - 1.04 | ||||||||
| 1559 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | URINE MACRO PANEL | Ur pH | 5.5 | 5 - 8 | |||||||||
| 1560 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | URINE MACRO PANEL | Ur Protein | Trace | H | Ref Rng:Negative | ||||||||
| 1561 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | URINE MACRO PANEL | Ur Glucose | Normal | Ref Rng:Normal | |||||||||
| 1562 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | URINE MACRO PANEL | Ur Ketones | Negative | Ref Rng:Negative | |||||||||
| 1563 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | URINE MACRO PANEL | Ur Bilirubin | Negative | Ref Rng:Negative | |||||||||
| 1564 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | URINE MACRO PANEL | Ur Urobilinogen | Normal | Ref Rng:Normal | |||||||||
| 1565 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | URINE MACRO PANEL | Ur Blood | Negative | Ref Rng:$Negative-Trace | |||||||||
| 1566 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | URINE MACRO PANEL | Ur Nitrite | Negative | Ref Rng:Negative | |||||||||
| 1567 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | URINE MACRO PANEL | Ur Leukocyte Esterase | +1 | H | Ref Rng:Negative | ||||||||
| 1568 | CZ100110006 | 32 | years | Female | Part 1 DB Baseline | Nov 25, 2025 10:04 AM | 6227144561 | URINE MICRO PANEL | Ur Microscopic | Positive | NEGATIVE$ | NEGATIVE | ||||||||
| 1569 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | C-REACTIVE PROTEIN | C Reactive Protein HS | 0.4 | 0 - 5 | mg/L | ||||||||
| 1570 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | CHEMISTRY PANEL | Total Bilirubin | 10 | 3 - 21 | umol/L | ||||||||
| 1571 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 3.6 | 0 - 6.2 | umol/L | ||||||||
| 1572 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | CHEMISTRY PANEL | Alkaline Phosphatase | 100 | 35 - 104 | U/L | ||||||||
| 1573 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | CHEMISTRY PANEL | ALT (SGPT) | 20 | 4 - 43 | U/L | ||||||||
| 1574 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | CHEMISTRY PANEL | AST (SGOT) | 25 | 8 - 40 | U/L | ||||||||
| 1575 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | CHEMISTRY PANEL | GGT | 63 | H | 4 - 49 | U/L | |||||||
| 1576 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | CHEMISTRY PANEL | LDH | 174 | 53 - 234 | U/L | ||||||||
| 1577 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | CHEMISTRY PANEL | Urea Nitrogen | 3.7 | 1.4 - 8.6 | mmol/L | ||||||||
| 1578 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 75 | 31 - 101 | umol/L | ||||||||
| 1579 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | CHEMISTRY PANEL | Glucose Fasting | 4.6 | 3.9 - 5.6 | mmol/L | ||||||||
| 1580 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | CHEMISTRY PANEL | Serum Uric Acid | 291 | 149 - 446 | umol/L | ||||||||
| 1581 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | CHEMISTRY PANEL | Calcium (EDTA) | 2.42 | 2.07 - 2.64 | mmol/L | ||||||||
| 1582 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | CHEMISTRY PANEL | Phosphorus | 1.02 | 0.71 - 1.65 | mmol/L | ||||||||
| 1583 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | CHEMISTRY PANEL | Total Protein | 78 | 61 - 84 | g/L | ||||||||
| 1584 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | CHEMISTRY PANEL | Albumin-BCG | 47 | 33 - 49 | g/L | ||||||||
| 1585 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | CHEMISTRY PANEL | Creatine Kinase | 141 | 26 - 192 | U/L | ||||||||
| 1586 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | CHEMISTRY PANEL | Serum Sodium | 140 | 132 - 147 | mmol/L | ||||||||
| 1587 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | CHEMISTRY PANEL | Serum Potassium | 4.3 | 3.5 - 5.2 | mmol/L | ||||||||
| 1588 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | CHEMISTRY PANEL | Serum Bicarbonate | 21.3 | 19.3 - 29.3 | mmol/L | ||||||||
| 1589 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | CHEMISTRY PANEL | Serum Chloride | 102 | 94 - 112 | mmol/L | ||||||||
| 1590 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | CREATININE CLEARANCE CC&G | CreatininClearancCockcrftGault | 1.17 | L | 1.25 - 1.92 | mL/sec | |||||||
| 1591 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | CREATININE CLEARANCE CC&G | Creatinine(Rate Blanked)-2dp | 75 | 31 - 101 | umol/L | ||||||||
| 1592 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | CREATININE CLEARANCE CC&G | Weight (kg,1dec place) | Y | 59.2 | kg | ||||||||
| 1593 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | DRUG SCREEN URINE | Amphetamines/MDMA | Neg | Neg;$Cutoff = 1000 ng/mL | |||||||||
| 1594 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | DRUG SCREEN URINE | Barbiturates | Neg | Neg;$Cutoff = 200 ng/mL | |||||||||
| 1595 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | DRUG SCREEN URINE | Cannabinoids | Neg | Neg;$Cutoff = 50 ng/mL | |||||||||
| 1596 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | DRUG SCREEN URINE | Cocaine | Neg | Neg;$Cutoff = 300 ng/mL | |||||||||
| 1597 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | DRUG SCREEN URINE | Opiates | Neg | Neg;$Cutoff = 300 ng/mL | |||||||||
| 1598 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | DRUG SCREEN URINE | Methadone | Neg | Neg;$Cutoff = 300 ng/mL | |||||||||
| 1599 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | DRUG SCREEN URINE BENZO NON-US | Benzodiazepines Gen 2 | Neg | Neg;$Cutoff = 200 ng/mL | |||||||||
| 1600 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | FEMALE OF CHILDBEARING POT? | Female/of Childbearing pot.? | Y | No | |||||||||
| 1601 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | FREE T4 | Free Thyroxine-QT | 9 | 8 - 14 | pmol/L | ||||||||
| 1602 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | GFR | EGFR by MDRD | 69 | mL/min/1.73m^2$No Ref Rng | |||||||||
| 1603 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 140 | 116 - 164 | g/L | ||||||||
| 1604 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.41 | 0.34 - 0.48 | |||||||||
| 1605 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.6 | 4.1 - 5.6 | TI/L | ||||||||
| 1606 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||
| 1607 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 88 | 79 - 98 | fL | ||||||||
| 1608 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 7.44 | 3.8 - 10.7 | GI/L | ||||||||
| 1609 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 2.83 | 1.96 - 7.23 | GI/L | ||||||||
| 1610 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 4.07 | 0.91 - 4.28 | GI/L | ||||||||
| 1611 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.29 | 0.12 - 0.92 | GI/L | ||||||||
| 1612 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.21 | 0 - 0.57 | GI/L | ||||||||
| 1613 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.05 | 0 - 0.2 | GI/L | ||||||||
| 1614 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 38.0 | R | L | 40.5 - 75 | % | ||||||
| 1615 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 54.7 | R | H | 15.4 - 48.5 | % | ||||||
| 1616 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 3.8 | 2.6 - 10.1 | % | ||||||||
| 1617 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 2.8 | 0 - 6.8 | % | ||||||||
| 1618 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 0.6 | 0 - 2 | % | ||||||||
| 1619 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 295 | 140 - 400 | GI/L | ||||||||
| 1620 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | HEMOGLOBIN A1C | Hemoglobin A1c,Variant(-70)-QT | 5.3 | <6.5% | |||||||||
| 1621 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | 2.96 | 1.9 - 23 | uIU/mL | ||||||||
| 1622 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||
| 1623 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | IS SUBJECT OF BLACK RACE? | Subject of black race? | Y | No | |||||||||
| 1624 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | LIPID PANEL | Direct HDL-C 4th Generation | 1.84 | H | 1.03 - 1.53 | mmol/L | |||||||
| 1625 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | LIPID PANEL | Triglycerides (GPO) | 1.42 | 0.59 - 2.96 | mmol/L | ||||||||
| 1626 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | LIPID PANEL | Cholesterol (High Performance) | 5.78 | 4.42 - 7.53 | mmol/L | ||||||||
| 1627 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | LIPID PANEL | LDL Chol Friedewald 4th | 3.29 | 0 - 3.34 | mmol/L | ||||||||
| 1628 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | POSTMENOPAUSAL FEMALE? | <40yrs & amenorrhea >/= 12mo | No | ||||||||||
| 1629 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | RETICULOCYTES | Reticulocyte Count % | 1.1 | 0.6 - 2.5 | % | ||||||||
| 1630 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | TSH | TSH 3rd IS-QT | 5.438 | R | H SF | 0.45 - 5.33 | mIU/L | ||||||
| 1631 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | URINE MACRO PANEL | Ur Specific Gravity | 1.017 | 1 - 1.04 | |||||||||
| 1632 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | URINE MACRO PANEL | Ur pH | 5.0 | 5 - 8 | |||||||||
| 1633 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | URINE MACRO PANEL | Ur Protein | Negative | Ref Rng:Negative | |||||||||
| 1634 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | URINE MACRO PANEL | Ur Glucose | Normal | Ref Rng:Normal | |||||||||
| 1635 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | URINE MACRO PANEL | Ur Ketones | Negative | Ref Rng:Negative | |||||||||
| 1636 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | URINE MACRO PANEL | Ur Bilirubin | Negative | Ref Rng:Negative | |||||||||
| 1637 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | URINE MACRO PANEL | Ur Urobilinogen | Normal | Ref Rng:Normal | |||||||||
| 1638 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | URINE MACRO PANEL | Ur Blood | Negative | Ref Rng:$Negative-Trace | |||||||||
| 1639 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | URINE MACRO PANEL | Ur Nitrite | Negative | Ref Rng:Negative | |||||||||
| 1640 | CZ100110007 | 56 | years | Female | Part 1 Screening | Nov 14, 2025 10:22 AM | 6225351078 | URINE MACRO PANEL | Ur Leukocyte Esterase | Negative | Ref Rng:Negative | |||||||||
| 1641 | CZ100110002 | 25 | years | Male | Part 2 OL Induction Day 29 | Nov 6, 2025 8:14 AM | 6226991311 | C-REACTIVE PROTEIN | C Reactive Protein HS | 0.4 | 0 - 5 | mg/L | ||||||||
| 1642 | CZ100110002 | 25 | years | Male | Part 2 OL Induction Day 29 | Nov 6, 2025 8:14 AM | 6226991311 | CHEMISTRY PANEL | Total Bilirubin | 9 | 3 - 21 | umol/L | ||||||||
| 1643 | CZ100110002 | 25 | years | Male | Part 2 OL Induction Day 29 | Nov 6, 2025 8:14 AM | 6226991311 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 2.9 | 0 - 6.2 | umol/L | ||||||||
| 1644 | CZ100110002 | 25 | years | Male | Part 2 OL Induction Day 29 | Nov 6, 2025 8:14 AM | 6226991311 | CHEMISTRY PANEL | Alkaline Phosphatase | 84 | 40 - 129 | U/L | ||||||||
| 1645 | CZ100110002 | 25 | years | Male | Part 2 OL Induction Day 29 | Nov 6, 2025 8:14 AM | 6226991311 | CHEMISTRY PANEL | ALT (SGPT) | 64 | H | 5 - 48 | U/L | |||||||
| 1646 | CZ100110002 | 25 | years | Male | Part 2 OL Induction Day 29 | Nov 6, 2025 8:14 AM | 6226991311 | CHEMISTRY PANEL | AST (SGOT) | 27 | 8 - 40 | U/L | ||||||||
| 1647 | CZ100110002 | 25 | years | Male | Part 2 OL Induction Day 29 | Nov 6, 2025 8:14 AM | 6226991311 | CHEMISTRY PANEL | GGT | 123 | H | 10 - 61 | U/L | |||||||
| 1648 | CZ100110002 | 25 | years | Male | Part 2 OL Induction Day 29 | Nov 6, 2025 8:14 AM | 6226991311 | CHEMISTRY PANEL | LDH | 159 | 53 - 234 | U/L | ||||||||
| 1649 | CZ100110002 | 25 | years | Male | Part 2 OL Induction Day 29 | Nov 6, 2025 8:14 AM | 6226991311 | CHEMISTRY PANEL | Urea Nitrogen | 6.3 | 1.4 - 8.6 | mmol/L | ||||||||
| 1650 | CZ100110002 | 25 | years | Male | Part 2 OL Induction Day 29 | Nov 6, 2025 8:14 AM | 6226991311 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 91 | 40 - 110 | umol/L | ||||||||
| 1651 | CZ100110002 | 25 | years | Male | Part 2 OL Induction Day 29 | Nov 6, 2025 8:14 AM | 6226991311 | CHEMISTRY PANEL | Glucose Fasting | 4.8 | 3.9 - 5.6 | mmol/L | ||||||||
| 1652 | CZ100110002 | 25 | years | Male | Part 2 OL Induction Day 29 | Nov 6, 2025 8:14 AM | 6226991311 | CHEMISTRY PANEL | Serum Uric Acid | 419 | 125 - 488 | umol/L | ||||||||
| 1653 | CZ100110002 | 25 | years | Male | Part 2 OL Induction Day 29 | Nov 6, 2025 8:14 AM | 6226991311 | CHEMISTRY PANEL | Calcium (EDTA) | 2.53 | 2.07 - 2.64 | mmol/L | ||||||||
| 1654 | CZ100110002 | 25 | years | Male | Part 2 OL Induction Day 29 | Nov 6, 2025 8:14 AM | 6226991311 | CHEMISTRY PANEL | Phosphorus | 1.27 | 0.71 - 1.65 | mmol/L | ||||||||
| 1655 | CZ100110002 | 25 | years | Male | Part 2 OL Induction Day 29 | Nov 6, 2025 8:14 AM | 6226991311 | CHEMISTRY PANEL | Total Protein | 73 | 61 - 84 | g/L | ||||||||
| 1656 | CZ100110002 | 25 | years | Male | Part 2 OL Induction Day 29 | Nov 6, 2025 8:14 AM | 6226991311 | CHEMISTRY PANEL | Albumin-BCG | 47 | 33 - 49 | g/L | ||||||||
| 1657 | CZ100110002 | 25 | years | Male | Part 2 OL Induction Day 29 | Nov 6, 2025 8:14 AM | 6226991311 | CHEMISTRY PANEL | Creatine Kinase | 141 | 39 - 308 | U/L | ||||||||
| 1658 | CZ100110002 | 25 | years | Male | Part 2 OL Induction Day 29 | Nov 6, 2025 8:14 AM | 6226991311 | CHEMISTRY PANEL | Serum Sodium | 139 | 132 - 147 | mmol/L | ||||||||
| 1659 | CZ100110002 | 25 | years | Male | Part 2 OL Induction Day 29 | Nov 6, 2025 8:14 AM | 6226991311 | CHEMISTRY PANEL | Serum Potassium | 4.5 | 3.5 - 5.2 | mmol/L | ||||||||
| 1660 | CZ100110002 | 25 | years | Male | Part 2 OL Induction Day 29 | Nov 6, 2025 8:14 AM | 6226991311 | CHEMISTRY PANEL | Serum Bicarbonate | 21.9 | 19.3 - 29.3 | mmol/L | ||||||||
| 1661 | CZ100110002 | 25 | years | Male | Part 2 OL Induction Day 29 | Nov 6, 2025 8:14 AM | 6226991311 | CHEMISTRY PANEL | Serum Chloride | 104 | 94 - 112 | mmol/L | ||||||||
| 1662 | CZ100110002 | 25 | years | Male | Part 2 OL Induction Day 29 | Nov 6, 2025 8:14 AM | 6226991311 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 157 | 127 - 181 | g/L | ||||||||
| 1663 | CZ100110002 | 25 | years | Male | Part 2 OL Induction Day 29 | Nov 6, 2025 8:14 AM | 6226991311 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.44 | 0.39 - 0.54 | |||||||||
| 1664 | CZ100110002 | 25 | years | Male | Part 2 OL Induction Day 29 | Nov 6, 2025 8:14 AM | 6226991311 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 5.0 | 4.5 - 6.4 | TI/L | ||||||||
| 1665 | CZ100110002 | 25 | years | Male | Part 2 OL Induction Day 29 | Nov 6, 2025 8:14 AM | 6226991311 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||
| 1666 | CZ100110002 | 25 | years | Male | Part 2 OL Induction Day 29 | Nov 6, 2025 8:14 AM | 6226991311 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 88 | 79 - 96 | fL | ||||||||
| 1667 | CZ100110002 | 25 | years | Male | Part 2 OL Induction Day 29 | Nov 6, 2025 8:14 AM | 6226991311 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 4.88 | 3.8 - 10.7 | GI/L | ||||||||
| 1668 | CZ100110002 | 25 | years | Male | Part 2 OL Induction Day 29 | Nov 6, 2025 8:14 AM | 6226991311 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 3.07 | 1.96 - 7.23 | GI/L | ||||||||
| 1669 | CZ100110002 | 25 | years | Male | Part 2 OL Induction Day 29 | Nov 6, 2025 8:14 AM | 6226991311 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.32 | 0.91 - 4.28 | GI/L | ||||||||
| 1670 | CZ100110002 | 25 | years | Male | Part 2 OL Induction Day 29 | Nov 6, 2025 8:14 AM | 6226991311 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.29 | 0.12 - 0.92 | GI/L | ||||||||
| 1671 | CZ100110002 | 25 | years | Male | Part 2 OL Induction Day 29 | Nov 6, 2025 8:14 AM | 6226991311 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.15 | 0 - 0.57 | GI/L | ||||||||
| 1672 | CZ100110002 | 25 | years | Male | Part 2 OL Induction Day 29 | Nov 6, 2025 8:14 AM | 6226991311 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.05 | 0 - 0.2 | GI/L | ||||||||
| 1673 | CZ100110002 | 25 | years | Male | Part 2 OL Induction Day 29 | Nov 6, 2025 8:14 AM | 6226991311 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 62.9 | 40.5 - 75 | % | ||||||||
| 1674 | CZ100110002 | 25 | years | Male | Part 2 OL Induction Day 29 | Nov 6, 2025 8:14 AM | 6226991311 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 27.1 | 15.4 - 48.5 | % | ||||||||
| 1675 | CZ100110002 | 25 | years | Male | Part 2 OL Induction Day 29 | Nov 6, 2025 8:14 AM | 6226991311 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 5.9 | 2.6 - 10.1 | % | ||||||||
| 1676 | CZ100110002 | 25 | years | Male | Part 2 OL Induction Day 29 | Nov 6, 2025 8:14 AM | 6226991311 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 3.0 | 0 - 6.8 | % | ||||||||
| 1677 | CZ100110002 | 25 | years | Male | Part 2 OL Induction Day 29 | Nov 6, 2025 8:14 AM | 6226991311 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 1.0 | 0 - 2 | % | ||||||||
| 1678 | CZ100110002 | 25 | years | Male | Part 2 OL Induction Day 29 | Nov 6, 2025 8:14 AM | 6226991311 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 266 | 140 - 400 | GI/L | ||||||||
| 1679 | CZ100110002 | 25 | years | Male | Part 2 OL Induction Day 29 | Nov 6, 2025 8:14 AM | 6226991311 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | 6.45 | 1.9 - 23 | uIU/mL | ||||||||
| 1680 | CZ100110002 | 25 | years | Male | Part 2 OL Induction Day 29 | Nov 6, 2025 8:14 AM | 6226991311 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||
| 1681 | CZ100110002 | 25 | years | Male | Part 2 OL Induction Day 29 | Nov 6, 2025 8:14 AM | 6226991311 | LIPID PANEL | Direct HDL-C 4th Generation | 0.92 | L | 1.03 - 1.53 | mmol/L | |||||||
| 1682 | CZ100110002 | 25 | years | Male | Part 2 OL Induction Day 29 | Nov 6, 2025 8:14 AM | 6226991311 | LIPID PANEL | Triglycerides (GPO) | 1.73 | 0.5 - 2.81 | mmol/L | ||||||||
| 1683 | CZ100110002 | 25 | years | Male | Part 2 OL Induction Day 29 | Nov 6, 2025 8:14 AM | 6226991311 | LIPID PANEL | Cholesterol (High Performance) | 4.62 | 3.31 - 6.1 | mmol/L | ||||||||
| 1684 | CZ100110002 | 25 | years | Male | Part 2 OL Induction Day 29 | Nov 6, 2025 8:14 AM | 6226991311 | LIPID PANEL | LDL Chol Friedewald 4th | 2.91 | 0 - 3.34 | mmol/L | ||||||||
| 1685 | CZ100110002 | 25 | years | Male | Part 2 OL Induction Day 29 | Nov 6, 2025 8:14 AM | 6226991311 | RETICULOCYTES | Reticulocyte Count % | 1.4 | 0.6 - 2.5 | % | ||||||||
| 1686 | CZ100110002 | 25 | years | Male | Part 2 OL Induction Day 29 | Nov 6, 2025 8:14 AM | 6226991311 | URINE MACRO PANEL | Ur Specific Gravity | 1.024 | 1 - 1.04 | |||||||||
| 1687 | CZ100110002 | 25 | years | Male | Part 2 OL Induction Day 29 | Nov 6, 2025 8:14 AM | 6226991311 | URINE MACRO PANEL | Ur pH | 5.5 | 5 - 8 | |||||||||
| 1688 | CZ100110002 | 25 | years | Male | Part 2 OL Induction Day 29 | Nov 6, 2025 8:14 AM | 6226991311 | URINE MACRO PANEL | Ur Protein | Negative | Ref Rng:Negative | |||||||||
| 1689 | CZ100110002 | 25 | years | Male | Part 2 OL Induction Day 29 | Nov 6, 2025 8:14 AM | 6226991311 | URINE MACRO PANEL | Ur Glucose | Normal | Ref Rng:Normal | |||||||||
| 1690 | CZ100110002 | 25 | years | Male | Part 2 OL Induction Day 29 | Nov 6, 2025 8:14 AM | 6226991311 | URINE MACRO PANEL | Ur Ketones | Negative | Ref Rng:Negative | |||||||||
| 1691 | CZ100110002 | 25 | years | Male | Part 2 OL Induction Day 29 | Nov 6, 2025 8:14 AM | 6226991311 | URINE MACRO PANEL | Ur Bilirubin | Negative | Ref Rng:Negative | |||||||||
| 1692 | CZ100110002 | 25 | years | Male | Part 2 OL Induction Day 29 | Nov 6, 2025 8:14 AM | 6226991311 | URINE MACRO PANEL | Ur Urobilinogen | Normal | Ref Rng:Normal | |||||||||
| 1693 | CZ100110002 | 25 | years | Male | Part 2 OL Induction Day 29 | Nov 6, 2025 8:14 AM | 6226991311 | URINE MACRO PANEL | Ur Blood | Negative | Ref Rng:Negative | |||||||||
| 1694 | CZ100110002 | 25 | years | Male | Part 2 OL Induction Day 29 | Nov 6, 2025 8:14 AM | 6226991311 | URINE MACRO PANEL | Ur Nitrite | Negative | Ref Rng:Negative | |||||||||
| 1695 | CZ100110002 | 25 | years | Male | Part 2 OL Induction Day 29 | Nov 6, 2025 8:14 AM | 6226991311 | URINE MACRO PANEL | Ur Leukocyte Esterase | Negative | Ref Rng:Negative | |||||||||
| 1696 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | C-REACTIVE PROTEIN | C Reactive Protein HS | 5.3 | H | 0 - 5 | mg/L | |||||||
| 1697 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | CELLULAR ELEMENTS | Ur WBC/HPF | 3 | 0 - 12 | /HPF | ||||||||
| 1698 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | CHEMISTRY PANEL | Total Bilirubin | 8 | 3 - 21 | umol/L | ||||||||
| 1699 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 2.6 | 0 - 6.2 | umol/L | ||||||||
| 1700 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | CHEMISTRY PANEL | Alkaline Phosphatase | 101 | 35 - 104 | U/L | ||||||||
| 1701 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | CHEMISTRY PANEL | ALT (SGPT) | 9 | 4 - 43 | U/L | ||||||||
| 1702 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | CHEMISTRY PANEL | AST (SGOT) | 12 | 8 - 40 | U/L | ||||||||
| 1703 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | CHEMISTRY PANEL | GGT | 6 | 4 - 49 | U/L | ||||||||
| 1704 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | CHEMISTRY PANEL | LDH | 157 | 53 - 234 | U/L | ||||||||
| 1705 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | CHEMISTRY PANEL | Urea Nitrogen | 3.7 | 1.4 - 8.6 | mmol/L | ||||||||
| 1706 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 57 | 31 - 101 | umol/L | ||||||||
| 1707 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | CHEMISTRY PANEL | Glucose Fasting | 4.7 | 3.9 - 5.6 | mmol/L | ||||||||
| 1708 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | CHEMISTRY PANEL | Serum Uric Acid | 232 | 125 - 428 | umol/L | ||||||||
| 1709 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | CHEMISTRY PANEL | Calcium (EDTA) | 2.27 | 2.07 - 2.64 | mmol/L | ||||||||
| 1710 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | CHEMISTRY PANEL | Phosphorus | 1.14 | 0.71 - 1.65 | mmol/L | ||||||||
| 1711 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | CHEMISTRY PANEL | Total Protein | 75 | 61 - 84 | g/L | ||||||||
| 1712 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | CHEMISTRY PANEL | Albumin-BCG | 44 | 33 - 49 | g/L | ||||||||
| 1713 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | CHEMISTRY PANEL | Creatine Kinase | 59 | 26 - 192 | U/L | ||||||||
| 1714 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | CHEMISTRY PANEL | Serum Sodium | 136 | 132 - 147 | mmol/L | ||||||||
| 1715 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | CHEMISTRY PANEL | Serum Potassium | 4.2 | 3.5 - 5.2 | mmol/L | ||||||||
| 1716 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | CHEMISTRY PANEL | Serum Bicarbonate | 21.4 | 19.3 - 29.3 | mmol/L | ||||||||
| 1717 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | CHEMISTRY PANEL | Serum Chloride | 102 | 94 - 112 | mmol/L | ||||||||
| 1718 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | CREATININE CLEARANCE CC&G | CreatininClearancCockcrftGault | 2.50 | H | 1.25 - 1.92 | mL/sec | |||||||
| 1719 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | CREATININE CLEARANCE CC&G | Creatinine(Rate Blanked)-2dp | 57 | 31 - 101 | umol/L | ||||||||
| 1720 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | CREATININE CLEARANCE CC&G | Weight (kg,1dec place) | Y | 75.2 | kg | ||||||||
| 1721 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | DRUG SCREEN URINE | Amphetamines/MDMA | Neg | Neg;$Cutoff = 1000 ng/mL | |||||||||
| 1722 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | DRUG SCREEN URINE | Barbiturates | Neg | Neg;$Cutoff = 200 ng/mL | |||||||||
| 1723 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | DRUG SCREEN URINE | Cannabinoids | Neg | Neg;$Cutoff = 50 ng/mL | |||||||||
| 1724 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | DRUG SCREEN URINE | Cocaine | Neg | Neg;$Cutoff = 300 ng/mL | |||||||||
| 1725 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | DRUG SCREEN URINE | Opiates | Neg | Neg;$Cutoff = 300 ng/mL | |||||||||
| 1726 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | DRUG SCREEN URINE | Methadone | Neg | Neg;$Cutoff = 300 ng/mL | |||||||||
| 1727 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | DRUG SCREEN URINE BENZO NON-US | Benzodiazepines Gen 2 | Neg | Neg;$Cutoff = 200 ng/mL | |||||||||
| 1728 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | FEMALE OF CHILDBEARING POT? | Female/of Childbearing pot.? | Y | Yes | |||||||||
| 1729 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | GFR | EGFR by MDRD | 108 | mL/min/1.73m^2$No Ref Rng | |||||||||
| 1730 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 127 | 116 - 164 | g/L | ||||||||
| 1731 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.39 | 0.34 - 0.48 | |||||||||
| 1732 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.4 | 4.1 - 5.6 | TI/L | ||||||||
| 1733 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||
| 1734 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 89 | 79 - 98 | fL | ||||||||
| 1735 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 7.26 | 3.8 - 10.7 | GI/L | ||||||||
| 1736 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 4.66 | 1.96 - 7.23 | GI/L | ||||||||
| 1737 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.98 | 0.91 - 4.28 | GI/L | ||||||||
| 1738 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.40 | 0.12 - 0.92 | GI/L | ||||||||
| 1739 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.17 | 0 - 0.57 | GI/L | ||||||||
| 1740 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.06 | 0 - 0.2 | GI/L | ||||||||
| 1741 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 64.1 | 40.5 - 75 | % | ||||||||
| 1742 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 27.4 | 15.4 - 48.5 | % | ||||||||
| 1743 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 5.4 | 2.6 - 10.1 | % | ||||||||
| 1744 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 2.3 | 0 - 6.8 | % | ||||||||
| 1745 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 0.8 | 0 - 2 | % | ||||||||
| 1746 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 335 | 140 - 400 | GI/L | ||||||||
| 1747 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | HEMOGLOBIN A1C | Hemoglobin A1c,Variant(-70)-QT | 4.8 | <6.5% | |||||||||
| 1748 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | 4.40 | 1.9 - 23 | uIU/mL | ||||||||
| 1749 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||
| 1750 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | IS SUBJECT OF BLACK RACE? | Subject of black race? | Y | No | |||||||||
| 1751 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | LIPID PANEL | Direct HDL-C 4th Generation | 0.99 | L | 1.03 - 1.53 | mmol/L | |||||||
| 1752 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | LIPID PANEL | Triglycerides (GPO) | 0.76 | 0.44 - 1.99 | mmol/L | ||||||||
| 1753 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | LIPID PANEL | Cholesterol (High Performance) | 4.01 | 3.65 - 6.21 | mmol/L | ||||||||
| 1754 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | LIPID PANEL | LDL Chol Friedewald 4th | 2.67 | 0 - 3.34 | mmol/L | ||||||||
| 1755 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | MICROORGANISMS | Ur Bacteria | Present | Ref Rng:Not present | |||||||||
| 1756 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | POSTMENOPAUSAL FEMALE? | <40yrs & amenorrhea >/= 12mo | No | ||||||||||
| 1757 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | RETICULOCYTES | Reticulocyte Count % | 2.4 | 0.6 - 2.5 | % | ||||||||
| 1758 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | SERUM BETA HCG | B-hCG, Qualitative | Negative | Ref Rng: Negative | |||||||||
| 1759 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | SERUM BETA HCG | B-hCG, Quantitative | <0.6 | Units: mIU/mL$Pre-menopausal$<5.0: Negative$5.0-24.9:Borderline$>/= 25.0: Positive | |||||||||
| 1760 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | TSH | TSH 3rd IS-QT | 1.593 | 0.45 - 5.33 | mIU/L | ||||||||
| 1761 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | URINE MACRO PANEL | Ur Specific Gravity | 1.029 | 1 - 1.04 | |||||||||
| 1762 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | URINE MACRO PANEL | Ur pH | 5.5 | 5 - 8 | |||||||||
| 1763 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | URINE MACRO PANEL | Ur Protein | Negative | Ref Rng:Negative | |||||||||
| 1764 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | URINE MACRO PANEL | Ur Glucose | Normal | Ref Rng:Normal | |||||||||
| 1765 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | URINE MACRO PANEL | Ur Ketones | Negative | Ref Rng:Negative | |||||||||
| 1766 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | URINE MACRO PANEL | Ur Bilirubin | Negative | Ref Rng:Negative | |||||||||
| 1767 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | URINE MACRO PANEL | Ur Urobilinogen | Normal | Ref Rng:Normal | |||||||||
| 1768 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | URINE MACRO PANEL | Ur Blood | Negative | Ref Rng:$Negative-Trace | |||||||||
| 1769 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | URINE MACRO PANEL | Ur Nitrite | Negative | Ref Rng:Negative | |||||||||
| 1770 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | URINE MACRO PANEL | Ur Leukocyte Esterase | +1 | H | Ref Rng:Negative | ||||||||
| 1771 | CZ100110006 | 32 | years | Female | Part 1 Screening | Nov 4, 2025 7:03 AM | 6225351080 | URINE MICRO PANEL | Ur Microscopic | Positive | NEGATIVE$ | NEGATIVE | ||||||||
| 1772 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | BENZODIAZEPINE CONFIRM. UR | BenzodiazepineConf-LCMSMS-LDT | Oxazepam (Confirmed) | R | RX | No Ref Rng | |||||||
| 1773 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | C-REACTIVE PROTEIN | C Reactive Protein HS | 1.2 | 0 - 5 | mg/L | ||||||||
| 1774 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | CHEMISTRY PANEL | Total Bilirubin | 4 | 3 - 21 | umol/L | ||||||||
| 1775 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 1.6 | 0 - 6.2 | umol/L | ||||||||
| 1776 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | CHEMISTRY PANEL | Alkaline Phosphatase | 94 | 40 - 129 | U/L | ||||||||
| 1777 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | CHEMISTRY PANEL | ALT (SGPT) | 27 | 5 - 48 | U/L | ||||||||
| 1778 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | CHEMISTRY PANEL | AST (SGOT) | 23 | 8 - 40 | U/L | ||||||||
| 1779 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | CHEMISTRY PANEL | GGT | 17 | 10 - 61 | U/L | ||||||||
| 1780 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | CHEMISTRY PANEL | LDH | 161 | 53 - 234 | U/L | ||||||||
| 1781 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | CHEMISTRY PANEL | Urea Nitrogen | 6.1 | 1.4 - 8.6 | mmol/L | ||||||||
| 1782 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 83 | 40 - 110 | umol/L | ||||||||
| 1783 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | CHEMISTRY PANEL | Glucose Fasting | 5.4 | 3.9 - 5.6 | mmol/L | ||||||||
| 1784 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | CHEMISTRY PANEL | Serum Uric Acid | 344 | 125 - 488 | umol/L | ||||||||
| 1785 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | CHEMISTRY PANEL | Calcium (EDTA) | 2.46 | 2.07 - 2.64 | mmol/L | ||||||||
| 1786 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | CHEMISTRY PANEL | Phosphorus | 1.03 | 0.71 - 1.65 | mmol/L | ||||||||
| 1787 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | CHEMISTRY PANEL | Total Protein | 78 | 61 - 84 | g/L | ||||||||
| 1788 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | CHEMISTRY PANEL | Albumin-BCG | 47 | 33 - 49 | g/L | ||||||||
| 1789 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | CHEMISTRY PANEL | Creatine Kinase | 232 | 39 - 308 | U/L | ||||||||
| 1790 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | CHEMISTRY PANEL | Serum Sodium | 139 | 132 - 147 | mmol/L | ||||||||
| 1791 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | CHEMISTRY PANEL | Serum Potassium | 4.7 | 3.5 - 5.2 | mmol/L | ||||||||
| 1792 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | CHEMISTRY PANEL | Serum Bicarbonate | 21.3 | 19.3 - 29.3 | mmol/L | ||||||||
| 1793 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | CHEMISTRY PANEL | Serum Chloride | 101 | 94 - 112 | mmol/L | ||||||||
| 1794 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | CREATININE CLEARANCE CC&G | CreatininClearancCockcrftGault | 2.37 | H | 1.42 - 2.08 | mL/sec | |||||||
| 1795 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | CREATININE CLEARANCE CC&G | Creatinine(Rate Blanked)-2dp | 83 | 40 - 110 | umol/L | ||||||||
| 1796 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | CREATININE CLEARANCE CC&G | Weight (kg,1dec place) | Y | 89.1 | kg | ||||||||
| 1797 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | DRUG SCREEN URINE | Amphetamines/MDMA | Neg | Neg;$Cutoff = 1000 ng/mL | |||||||||
| 1798 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | DRUG SCREEN URINE | Barbiturates | Neg | Neg;$Cutoff = 200 ng/mL | |||||||||
| 1799 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | DRUG SCREEN URINE | Cannabinoids | Neg | Neg;$Cutoff = 50 ng/mL | |||||||||
| 1800 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | DRUG SCREEN URINE | Cocaine | Neg | Neg;$Cutoff = 300 ng/mL | |||||||||
| 1801 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | DRUG SCREEN URINE | Opiates | Neg | Neg;$Cutoff = 300 ng/mL | |||||||||
| 1802 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | DRUG SCREEN URINE | Methadone | Neg | Neg;$Cutoff = 300 ng/mL | |||||||||
| 1803 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | DRUG SCREEN URINE BENZO NON-US | Benzodiazepines Gen 2 | Detected (unconfirmed) | Neg;$Cutoff = 200 ng/mL | |||||||||
| 1804 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | GFR | EGFR by MDRD | 93 | mL/min/1.73m^2$No Ref Rng | |||||||||
| 1805 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 141 | 127 - 181 | g/L | ||||||||
| 1806 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.40 | 0.39 - 0.54 | |||||||||
| 1807 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.7 | 4.5 - 6.4 | TI/L | ||||||||
| 1808 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||
| 1809 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 86 | 79 - 96 | fL | ||||||||
| 1810 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 6.63 | 3.8 - 10.7 | GI/L | ||||||||
| 1811 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 3.10 | 1.96 - 7.23 | GI/L | ||||||||
| 1812 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 3.01 | 0.91 - 4.28 | GI/L | ||||||||
| 1813 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.37 | 0.12 - 0.92 | GI/L | ||||||||
| 1814 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.11 | 0 - 0.57 | GI/L | ||||||||
| 1815 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.03 | 0 - 0.2 | GI/L | ||||||||
| 1816 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 46.8 | 40.5 - 75 | % | ||||||||
| 1817 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 45.4 | 15.4 - 48.5 | % | ||||||||
| 1818 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 5.6 | 2.6 - 10.1 | % | ||||||||
| 1819 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 1.6 | 0 - 6.8 | % | ||||||||
| 1820 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 0.5 | 0 - 2 | % | ||||||||
| 1821 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 306 | 140 - 400 | GI/L | ||||||||
| 1822 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | HEMOGLOBIN A1C | Hemoglobin A1c,Variant(-70)-QT | 5.3 | <6.5% | |||||||||
| 1823 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | 16.63 | 1.9 - 23 | uIU/mL | ||||||||
| 1824 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||
| 1825 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | IS SUBJECT OF BLACK RACE? | Subject of black race? | Y | No | |||||||||
| 1826 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | LIPID PANEL | Direct HDL-C 4th Generation | 0.95 | R | L | 1.03 - 1.53 | mmol/L | ||||||
| 1827 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | LIPID PANEL | Triglycerides (GPO) | 2.07 | 0.56 - 3.62 | mmol/L | ||||||||
| 1828 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | LIPID PANEL | Cholesterol (High Performance) | 5.65 | 3.88 - 6.83 | mmol/L | ||||||||
| 1829 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | LIPID PANEL | LDL Chol Friedewald 4th | 3.75 | H | 0 - 3.34 | mmol/L | |||||||
| 1830 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | RETICULOCYTES | Reticulocyte Count % | 1.1 | 0.6 - 2.5 | % | ||||||||
| 1831 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | TSH | TSH 3rd IS-QT | 2.249 | 0.45 - 5.33 | mIU/L | ||||||||
| 1832 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | URINE MACRO PANEL | Ur Specific Gravity | 1.006 | 1 - 1.04 | |||||||||
| 1833 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | URINE MACRO PANEL | Ur pH | 5.0 | 5 - 8 | |||||||||
| 1834 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | URINE MACRO PANEL | Ur Protein | Negative | Ref Rng:Negative | |||||||||
| 1835 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | URINE MACRO PANEL | Ur Glucose | Normal | Ref Rng:Normal | |||||||||
| 1836 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | URINE MACRO PANEL | Ur Ketones | Negative | Ref Rng:Negative | |||||||||
| 1837 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | URINE MACRO PANEL | Ur Bilirubin | Negative | Ref Rng:Negative | |||||||||
| 1838 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | URINE MACRO PANEL | Ur Urobilinogen | Normal | Ref Rng:Normal | |||||||||
| 1839 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | URINE MACRO PANEL | Ur Blood | Negative | Ref Rng:Negative | |||||||||
| 1840 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | URINE MACRO PANEL | Ur Nitrite | Negative | Ref Rng:Negative | |||||||||
| 1841 | CZ100110005 | 33 | years | Male | Part 1 Screening | Nov 3, 2025 9:40 AM | 6225351074 | URINE MACRO PANEL | Ur Leukocyte Esterase | Negative | Ref Rng:Negative | |||||||||
| 1842 | CZ100110003 | 35 | years | Female | Part 1 DB Baseline | Oct 22, 2025 8:04 AM | 6225351084 | C-REACTIVE PROTEIN | C Reactive Protein HS | 0.4 | Result verified by repeat analysis | 0 - 5 | mg/L | |||||||
| 1843 | CZ100110003 | 35 | years | Female | Part 1 DB Baseline | Oct 22, 2025 8:04 AM | 6225351084 | CHEMISTRY PANEL | Total Bilirubin | 6 | 3 - 21 | umol/L | ||||||||
| 1844 | CZ100110003 | 35 | years | Female | Part 1 DB Baseline | Oct 22, 2025 8:04 AM | 6225351084 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 2.5 | 0 - 6.2 | umol/L | ||||||||
| 1845 | CZ100110003 | 35 | years | Female | Part 1 DB Baseline | Oct 22, 2025 8:04 AM | 6225351084 | CHEMISTRY PANEL | Alkaline Phosphatase | 60 | 35 - 104 | U/L | ||||||||
| 1846 | CZ100110003 | 35 | years | Female | Part 1 DB Baseline | Oct 22, 2025 8:04 AM | 6225351084 | CHEMISTRY PANEL | ALT (SGPT) | 9 | 4 - 43 | U/L | ||||||||
| 1847 | CZ100110003 | 35 | years | Female | Part 1 DB Baseline | Oct 22, 2025 8:04 AM | 6225351084 | CHEMISTRY PANEL | AST (SGOT) | 11 | 8 - 40 | U/L | ||||||||
| 1848 | CZ100110003 | 35 | years | Female | Part 1 DB Baseline | Oct 22, 2025 8:04 AM | 6225351084 | CHEMISTRY PANEL | GGT | 13 | 4 - 49 | U/L | ||||||||
| 1849 | CZ100110003 | 35 | years | Female | Part 1 DB Baseline | Oct 22, 2025 8:04 AM | 6225351084 | CHEMISTRY PANEL | LDH | 126 | 53 - 234 | U/L | ||||||||
| 1850 | CZ100110003 | 35 | years | Female | Part 1 DB Baseline | Oct 22, 2025 8:04 AM | 6225351084 | CHEMISTRY PANEL | Urea Nitrogen | 3.6 | 1.4 - 8.6 | mmol/L | ||||||||
| 1851 | CZ100110003 | 35 | years | Female | Part 1 DB Baseline | Oct 22, 2025 8:04 AM | 6225351084 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 77 | 31 - 101 | umol/L | ||||||||
| 1852 | CZ100110003 | 35 | years | Female | Part 1 DB Baseline | Oct 22, 2025 8:04 AM | 6225351084 | CHEMISTRY PANEL | Glucose Fasting | 5.0 | 3.9 - 5.6 | mmol/L | ||||||||
| 1853 | CZ100110003 | 35 | years | Female | Part 1 DB Baseline | Oct 22, 2025 8:04 AM | 6225351084 | CHEMISTRY PANEL | Serum Uric Acid | 217 | 125 - 428 | umol/L | ||||||||
| 1854 | CZ100110003 | 35 | years | Female | Part 1 DB Baseline | Oct 22, 2025 8:04 AM | 6225351084 | CHEMISTRY PANEL | Calcium (EDTA) | 2.40 | 2.07 - 2.64 | mmol/L | ||||||||
| 1855 | CZ100110003 | 35 | years | Female | Part 1 DB Baseline | Oct 22, 2025 8:04 AM | 6225351084 | CHEMISTRY PANEL | Phosphorus | 1.01 | 0.71 - 1.65 | mmol/L | ||||||||
| 1856 | CZ100110003 | 35 | years | Female | Part 1 DB Baseline | Oct 22, 2025 8:04 AM | 6225351084 | CHEMISTRY PANEL | Total Protein | 66 | 61 - 84 | g/L | ||||||||
| 1857 | CZ100110003 | 35 | years | Female | Part 1 DB Baseline | Oct 22, 2025 8:04 AM | 6225351084 | CHEMISTRY PANEL | Albumin-BCG | 45 | 33 - 49 | g/L | ||||||||
| 1858 | CZ100110003 | 35 | years | Female | Part 1 DB Baseline | Oct 22, 2025 8:04 AM | 6225351084 | CHEMISTRY PANEL | Creatine Kinase | 66 | 26 - 192 | U/L | ||||||||
| 1859 | CZ100110003 | 35 | years | Female | Part 1 DB Baseline | Oct 22, 2025 8:04 AM | 6225351084 | CHEMISTRY PANEL | Serum Sodium | 141 | 132 - 147 | mmol/L | ||||||||
| 1860 | CZ100110003 | 35 | years | Female | Part 1 DB Baseline | Oct 22, 2025 8:04 AM | 6225351084 | CHEMISTRY PANEL | Serum Potassium | 4.2 | 3.5 - 5.2 | mmol/L | ||||||||
| 1861 | CZ100110003 | 35 | years | Female | Part 1 DB Baseline | Oct 22, 2025 8:04 AM | 6225351084 | CHEMISTRY PANEL | Serum Bicarbonate | 24.5 | 19.3 - 29.3 | mmol/L | ||||||||
| 1862 | CZ100110003 | 35 | years | Female | Part 1 DB Baseline | Oct 22, 2025 8:04 AM | 6225351084 | CHEMISTRY PANEL | Serum Chloride | 103 | 94 - 112 | mmol/L | ||||||||
| 1863 | CZ100110003 | 35 | years | Female | Part 1 DB Baseline | Oct 22, 2025 8:04 AM | 6225351084 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 121 | 116 - 164 | g/L | ||||||||
| 1864 | CZ100110003 | 35 | years | Female | Part 1 DB Baseline | Oct 22, 2025 8:04 AM | 6225351084 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.38 | 0.34 - 0.48 | |||||||||
| 1865 | CZ100110003 | 35 | years | Female | Part 1 DB Baseline | Oct 22, 2025 8:04 AM | 6225351084 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.2 | 4.1 - 5.6 | TI/L | ||||||||
| 1866 | CZ100110003 | 35 | years | Female | Part 1 DB Baseline | Oct 22, 2025 8:04 AM | 6225351084 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||
| 1867 | CZ100110003 | 35 | years | Female | Part 1 DB Baseline | Oct 22, 2025 8:04 AM | 6225351084 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 90 | 79 - 98 | fL | ||||||||
| 1868 | CZ100110003 | 35 | years | Female | Part 1 DB Baseline | Oct 22, 2025 8:04 AM | 6225351084 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 5.05 | 3.8 - 10.7 | GI/L | ||||||||
| 1869 | CZ100110003 | 35 | years | Female | Part 1 DB Baseline | Oct 22, 2025 8:04 AM | 6225351084 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 2.88 | 1.96 - 7.23 | GI/L | ||||||||
| 1870 | CZ100110003 | 35 | years | Female | Part 1 DB Baseline | Oct 22, 2025 8:04 AM | 6225351084 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.73 | 0.91 - 4.28 | GI/L | ||||||||
| 1871 | CZ100110003 | 35 | years | Female | Part 1 DB Baseline | Oct 22, 2025 8:04 AM | 6225351084 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.29 | 0.12 - 0.92 | GI/L | ||||||||
| 1872 | CZ100110003 | 35 | years | Female | Part 1 DB Baseline | Oct 22, 2025 8:04 AM | 6225351084 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.13 | 0 - 0.57 | GI/L | ||||||||
| 1873 | CZ100110003 | 35 | years | Female | Part 1 DB Baseline | Oct 22, 2025 8:04 AM | 6225351084 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.02 | 0 - 0.2 | GI/L | ||||||||
| 1874 | CZ100110003 | 35 | years | Female | Part 1 DB Baseline | Oct 22, 2025 8:04 AM | 6225351084 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 57.1 | 40.5 - 75 | % | ||||||||
| 1875 | CZ100110003 | 35 | years | Female | Part 1 DB Baseline | Oct 22, 2025 8:04 AM | 6225351084 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 34.3 | 15.4 - 48.5 | % | ||||||||
| 1876 | CZ100110003 | 35 | years | Female | Part 1 DB Baseline | Oct 22, 2025 8:04 AM | 6225351084 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 5.7 | 2.6 - 10.1 | % | ||||||||
| 1877 | CZ100110003 | 35 | years | Female | Part 1 DB Baseline | Oct 22, 2025 8:04 AM | 6225351084 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 2.6 | 0 - 6.8 | % | ||||||||
| 1878 | CZ100110003 | 35 | years | Female | Part 1 DB Baseline | Oct 22, 2025 8:04 AM | 6225351084 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 0.4 | 0 - 2 | % | ||||||||
| 1879 | CZ100110003 | 35 | years | Female | Part 1 DB Baseline | Oct 22, 2025 8:04 AM | 6225351084 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 286 | 140 - 400 | GI/L | ||||||||
| 1880 | CZ100110003 | 35 | years | Female | Part 1 DB Baseline | Oct 22, 2025 8:04 AM | 6225351084 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | 4.08 | 1.9 - 23 | uIU/mL | ||||||||
| 1881 | CZ100110003 | 35 | years | Female | Part 1 DB Baseline | Oct 22, 2025 8:04 AM | 6225351084 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||
| 1882 | CZ100110003 | 35 | years | Female | Part 1 DB Baseline | Oct 22, 2025 8:04 AM | 6225351084 | LIPID PANEL | Direct HDL-C 4th Generation | 1.85 | R | H | 1.03 - 1.53 | mmol/L | ||||||
| 1883 | CZ100110003 | 35 | years | Female | Part 1 DB Baseline | Oct 22, 2025 8:04 AM | 6225351084 | LIPID PANEL | Triglycerides (GPO) | 0.57 | 0.44 - 1.99 | mmol/L | ||||||||
| 1884 | CZ100110003 | 35 | years | Female | Part 1 DB Baseline | Oct 22, 2025 8:04 AM | 6225351084 | LIPID PANEL | Cholesterol (High Performance) | 4.35 | 3.65 - 6.21 | mmol/L | ||||||||
| 1885 | CZ100110003 | 35 | years | Female | Part 1 DB Baseline | Oct 22, 2025 8:04 AM | 6225351084 | LIPID PANEL | LDL Chol Friedewald 4th | 2.24 | 0 - 3.34 | mmol/L | ||||||||
| 1886 | CZ100110003 | 35 | years | Female | Part 1 DB Baseline | Oct 22, 2025 8:04 AM | 6225351084 | RETICULOCYTES | Reticulocyte Count % | 0.8 | 0.6 - 2.5 | % | ||||||||
| 1887 | CZ100110003 | 35 | years | Female | Part 1 DB Baseline | Oct 22, 2025 8:04 AM | 6225351084 | URINE MACRO PANEL | Ur Specific Gravity | 1.015 | 1 - 1.04 | |||||||||
| 1888 | CZ100110003 | 35 | years | Female | Part 1 DB Baseline | Oct 22, 2025 8:04 AM | 6225351084 | URINE MACRO PANEL | Ur pH | 5.5 | 5 - 8 | |||||||||
| 1889 | CZ100110003 | 35 | years | Female | Part 1 DB Baseline | Oct 22, 2025 8:04 AM | 6225351084 | URINE MACRO PANEL | Ur Protein | Negative | Ref Rng:Negative | |||||||||
| 1890 | CZ100110003 | 35 | years | Female | Part 1 DB Baseline | Oct 22, 2025 8:04 AM | 6225351084 | URINE MACRO PANEL | Ur Glucose | Normal | Ref Rng:Normal | |||||||||
| 1891 | CZ100110003 | 35 | years | Female | Part 1 DB Baseline | Oct 22, 2025 8:04 AM | 6225351084 | URINE MACRO PANEL | Ur Ketones | Negative | Ref Rng:Negative | |||||||||
| 1892 | CZ100110003 | 35 | years | Female | Part 1 DB Baseline | Oct 22, 2025 8:04 AM | 6225351084 | URINE MACRO PANEL | Ur Bilirubin | Negative | Ref Rng:Negative | |||||||||
| 1893 | CZ100110003 | 35 | years | Female | Part 1 DB Baseline | Oct 22, 2025 8:04 AM | 6225351084 | URINE MACRO PANEL | Ur Urobilinogen | Normal | Ref Rng:Normal | |||||||||
| 1894 | CZ100110003 | 35 | years | Female | Part 1 DB Baseline | Oct 22, 2025 8:04 AM | 6225351084 | URINE MACRO PANEL | Ur Blood | Negative | Ref Rng:$Negative-Trace | |||||||||
| 1895 | CZ100110003 | 35 | years | Female | Part 1 DB Baseline | Oct 22, 2025 8:04 AM | 6225351084 | URINE MACRO PANEL | Ur Nitrite | Negative | Ref Rng:Negative | |||||||||
| 1896 | CZ100110003 | 35 | years | Female | Part 1 DB Baseline | Oct 22, 2025 8:04 AM | 6225351084 | URINE MACRO PANEL | Ur Leukocyte Esterase | Negative | Ref Rng:Negative | |||||||||
| 1897 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Oct 9, 2025 8:45 AM | 6225351095 | C-REACTIVE PROTEIN | C Reactive Protein HS | 0.2 | Result verified by repeat analysis | 0 - 5 | mg/L | |||||||
| 1898 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Oct 9, 2025 8:45 AM | 6225351095 | CHEMISTRY PANEL | Total Bilirubin | 11 | 3 - 21 | umol/L | ||||||||
| 1899 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Oct 9, 2025 8:45 AM | 6225351095 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 3.8 | 0 - 6.2 | umol/L | ||||||||
| 1900 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Oct 9, 2025 8:45 AM | 6225351095 | CHEMISTRY PANEL | Alkaline Phosphatase | 88 | 40 - 129 | U/L | ||||||||
| 1901 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Oct 9, 2025 8:45 AM | 6225351095 | CHEMISTRY PANEL | ALT (SGPT) | 46 | 5 - 48 | U/L | ||||||||
| 1902 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Oct 9, 2025 8:45 AM | 6225351095 | CHEMISTRY PANEL | AST (SGOT) | 21 | 8 - 40 | U/L | ||||||||
| 1903 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Oct 9, 2025 8:45 AM | 6225351095 | CHEMISTRY PANEL | GGT | 129 | H | 10 - 61 | U/L | |||||||
| 1904 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Oct 9, 2025 8:45 AM | 6225351095 | CHEMISTRY PANEL | LDH | 156 | 53 - 234 | U/L | ||||||||
| 1905 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Oct 9, 2025 8:45 AM | 6225351095 | CHEMISTRY PANEL | Urea Nitrogen | 5.2 | 1.4 - 8.6 | mmol/L | ||||||||
| 1906 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Oct 9, 2025 8:45 AM | 6225351095 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 91 | 40 - 110 | umol/L | ||||||||
| 1907 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Oct 9, 2025 8:45 AM | 6225351095 | CHEMISTRY PANEL | Glucose Fasting | 4.6 | 3.9 - 5.6 | mmol/L | ||||||||
| 1908 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Oct 9, 2025 8:45 AM | 6225351095 | CHEMISTRY PANEL | Serum Uric Acid | 429 | 125 - 488 | umol/L | ||||||||
| 1909 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Oct 9, 2025 8:45 AM | 6225351095 | CHEMISTRY PANEL | Calcium (EDTA) | 2.56 | 2.07 - 2.64 | mmol/L | ||||||||
| 1910 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Oct 9, 2025 8:45 AM | 6225351095 | CHEMISTRY PANEL | Phosphorus | 1.13 | 0.71 - 1.65 | mmol/L | ||||||||
| 1911 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Oct 9, 2025 8:45 AM | 6225351095 | CHEMISTRY PANEL | Total Protein | 75 | 61 - 84 | g/L | ||||||||
| 1912 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Oct 9, 2025 8:45 AM | 6225351095 | CHEMISTRY PANEL | Albumin-BCG | 49 | 33 - 49 | g/L | ||||||||
| 1913 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Oct 9, 2025 8:45 AM | 6225351095 | CHEMISTRY PANEL | Creatine Kinase | 131 | 39 - 308 | U/L | ||||||||
| 1914 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Oct 9, 2025 8:45 AM | 6225351095 | CHEMISTRY PANEL | Serum Sodium | 137 | 132 - 147 | mmol/L | ||||||||
| 1915 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Oct 9, 2025 8:45 AM | 6225351095 | CHEMISTRY PANEL | Serum Potassium | 4.3 | 3.5 - 5.2 | mmol/L | ||||||||
| 1916 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Oct 9, 2025 8:45 AM | 6225351095 | CHEMISTRY PANEL | Serum Bicarbonate | 21.4 | 19.3 - 29.3 | mmol/L | ||||||||
| 1917 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Oct 9, 2025 8:45 AM | 6225351095 | CHEMISTRY PANEL | Serum Chloride | 100 | 94 - 112 | mmol/L | ||||||||
| 1918 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Oct 9, 2025 8:45 AM | 6225351095 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 157 | 127 - 181 | g/L | ||||||||
| 1919 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Oct 9, 2025 8:45 AM | 6225351095 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.46 | 0.39 - 0.54 | |||||||||
| 1920 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Oct 9, 2025 8:45 AM | 6225351095 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 5.2 | 4.5 - 6.4 | TI/L | ||||||||
| 1921 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Oct 9, 2025 8:45 AM | 6225351095 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||
| 1922 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Oct 9, 2025 8:45 AM | 6225351095 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 88 | 79 - 96 | fL | ||||||||
| 1923 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Oct 9, 2025 8:45 AM | 6225351095 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 4.79 | 3.8 - 10.7 | GI/L | ||||||||
| 1924 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Oct 9, 2025 8:45 AM | 6225351095 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 2.75 | 1.96 - 7.23 | GI/L | ||||||||
| 1925 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Oct 9, 2025 8:45 AM | 6225351095 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.48 | 0.91 - 4.28 | GI/L | ||||||||
| 1926 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Oct 9, 2025 8:45 AM | 6225351095 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.34 | 0.12 - 0.92 | GI/L | ||||||||
| 1927 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Oct 9, 2025 8:45 AM | 6225351095 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.14 | 0 - 0.57 | GI/L | ||||||||
| 1928 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Oct 9, 2025 8:45 AM | 6225351095 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.07 | 0 - 0.2 | GI/L | ||||||||
| 1929 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Oct 9, 2025 8:45 AM | 6225351095 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 57.5 | 40.5 - 75 | % | ||||||||
| 1930 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Oct 9, 2025 8:45 AM | 6225351095 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 30.9 | 15.4 - 48.5 | % | ||||||||
| 1931 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Oct 9, 2025 8:45 AM | 6225351095 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 7.2 | 2.6 - 10.1 | % | ||||||||
| 1932 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Oct 9, 2025 8:45 AM | 6225351095 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 2.9 | 0 - 6.8 | % | ||||||||
| 1933 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Oct 9, 2025 8:45 AM | 6225351095 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 1.5 | 0 - 2 | % | ||||||||
| 1934 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Oct 9, 2025 8:45 AM | 6225351095 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 280 | 140 - 400 | GI/L | ||||||||
| 1935 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Oct 9, 2025 8:45 AM | 6225351095 | HEMOGLOBIN A1C | Hemoglobin A1c,Variant(-70)-QT | 4.8 | <6.5% | |||||||||
| 1936 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Oct 9, 2025 8:45 AM | 6225351095 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | 10.32 | 1.9 - 23 | uIU/mL | ||||||||
| 1937 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Oct 9, 2025 8:45 AM | 6225351095 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||
| 1938 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Oct 9, 2025 8:45 AM | 6225351095 | LIPID PANEL | Direct HDL-C 4th Generation | 0.92 | L | 1.03 - 1.53 | mmol/L | |||||||
| 1939 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Oct 9, 2025 8:45 AM | 6225351095 | LIPID PANEL | Triglycerides (GPO) | 1.99 | 0.5 - 2.81 | mmol/L | ||||||||
| 1940 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Oct 9, 2025 8:45 AM | 6225351095 | LIPID PANEL | Cholesterol (High Performance) | 4.77 | 3.31 - 6.1 | mmol/L | ||||||||
| 1941 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Oct 9, 2025 8:45 AM | 6225351095 | LIPID PANEL | LDL Chol Friedewald 4th | 2.94 | 0 - 3.34 | mmol/L | ||||||||
| 1942 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Oct 9, 2025 8:45 AM | 6225351095 | RETICULOCYTES | Reticulocyte Count % | 1.3 | 0.6 - 2.5 | % | ||||||||
| 1943 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Oct 9, 2025 8:45 AM | 6225351095 | TSH | TSH 3rd IS-QT | 1.125 | 0.45 - 5.33 | mIU/L | ||||||||
| 1944 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Oct 9, 2025 8:45 AM | 6225351095 | URINE MACRO PANEL | Ur Specific Gravity | 1.023 | 1 - 1.04 | |||||||||
| 1945 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Oct 9, 2025 8:45 AM | 6225351095 | URINE MACRO PANEL | Ur pH | 5.5 | 5 - 8 | |||||||||
| 1946 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Oct 9, 2025 8:45 AM | 6225351095 | URINE MACRO PANEL | Ur Protein | Negative | Ref Rng:Negative | |||||||||
| 1947 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Oct 9, 2025 8:45 AM | 6225351095 | URINE MACRO PANEL | Ur Glucose | Normal | Ref Rng:Normal | |||||||||
| 1948 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Oct 9, 2025 8:45 AM | 6225351095 | URINE MACRO PANEL | Ur Ketones | Negative | Ref Rng:Negative | |||||||||
| 1949 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Oct 9, 2025 8:45 AM | 6225351095 | URINE MACRO PANEL | Ur Bilirubin | Negative | Ref Rng:Negative | |||||||||
| 1950 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Oct 9, 2025 8:45 AM | 6225351095 | URINE MACRO PANEL | Ur Urobilinogen | Normal | Ref Rng:Normal | |||||||||
| 1951 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Oct 9, 2025 8:45 AM | 6225351095 | URINE MACRO PANEL | Ur Blood | Negative | Ref Rng:Negative | |||||||||
| 1952 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Oct 9, 2025 8:45 AM | 6225351095 | URINE MACRO PANEL | Ur Nitrite | Negative | Ref Rng:Negative | |||||||||
| 1953 | CZ100110002 | 25 | years | Male | End of Phase/Treatment | Oct 9, 2025 8:45 AM | 6225351095 | URINE MACRO PANEL | Ur Leukocyte Esterase | Negative | Ref Rng:Negative | |||||||||
| 1954 | CZ100110001 | 31 | years | Female | End of Phase/Treatment | Oct 8, 2025 8:16 AM | 6225351094 | C-REACTIVE PROTEIN | C Reactive Protein HS | 2.4 | 0 - 5 | mg/L | ||||||||
| 1955 | CZ100110001 | 31 | years | Female | End of Phase/Treatment | Oct 8, 2025 8:16 AM | 6225351094 | CHEMISTRY PANEL | Total Bilirubin | 8 | 3 - 21 | umol/L | ||||||||
| 1956 | CZ100110001 | 31 | years | Female | End of Phase/Treatment | Oct 8, 2025 8:16 AM | 6225351094 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 3.2 | 0 - 6.2 | umol/L | ||||||||
| 1957 | CZ100110001 | 31 | years | Female | End of Phase/Treatment | Oct 8, 2025 8:16 AM | 6225351094 | CHEMISTRY PANEL | Alkaline Phosphatase | 89 | 35 - 104 | U/L | ||||||||
| 1958 | CZ100110001 | 31 | years | Female | End of Phase/Treatment | Oct 8, 2025 8:16 AM | 6225351094 | CHEMISTRY PANEL | ALT (SGPT) | 16 | 4 - 43 | U/L | ||||||||
| 1959 | CZ100110001 | 31 | years | Female | End of Phase/Treatment | Oct 8, 2025 8:16 AM | 6225351094 | CHEMISTRY PANEL | AST (SGOT) | 14 | 8 - 40 | U/L | ||||||||
| 1960 | CZ100110001 | 31 | years | Female | End of Phase/Treatment | Oct 8, 2025 8:16 AM | 6225351094 | CHEMISTRY PANEL | GGT | 16 | 4 - 49 | U/L | ||||||||
| 1961 | CZ100110001 | 31 | years | Female | End of Phase/Treatment | Oct 8, 2025 8:16 AM | 6225351094 | CHEMISTRY PANEL | LDH | 124 | 53 - 234 | U/L | ||||||||
| 1962 | CZ100110001 | 31 | years | Female | End of Phase/Treatment | Oct 8, 2025 8:16 AM | 6225351094 | CHEMISTRY PANEL | Urea Nitrogen | 4.5 | 1.4 - 8.6 | mmol/L | ||||||||
| 1963 | CZ100110001 | 31 | years | Female | End of Phase/Treatment | Oct 8, 2025 8:16 AM | 6225351094 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 68 | 31 - 101 | umol/L | ||||||||
| 1964 | CZ100110001 | 31 | years | Female | End of Phase/Treatment | Oct 8, 2025 8:16 AM | 6225351094 | CHEMISTRY PANEL | Glucose Fasting | 4.3 | 3.9 - 5.6 | mmol/L | ||||||||
| 1965 | CZ100110001 | 31 | years | Female | End of Phase/Treatment | Oct 8, 2025 8:16 AM | 6225351094 | CHEMISTRY PANEL | Serum Uric Acid | 303 | 125 - 428 | umol/L | ||||||||
| 1966 | CZ100110001 | 31 | years | Female | End of Phase/Treatment | Oct 8, 2025 8:16 AM | 6225351094 | CHEMISTRY PANEL | Calcium (EDTA) | 2.40 | 2.07 - 2.64 | mmol/L | ||||||||
| 1967 | CZ100110001 | 31 | years | Female | End of Phase/Treatment | Oct 8, 2025 8:16 AM | 6225351094 | CHEMISTRY PANEL | Phosphorus | 1.03 | 0.71 - 1.65 | mmol/L | ||||||||
| 1968 | CZ100110001 | 31 | years | Female | End of Phase/Treatment | Oct 8, 2025 8:16 AM | 6225351094 | CHEMISTRY PANEL | Total Protein | 74 | 61 - 84 | g/L | ||||||||
| 1969 | CZ100110001 | 31 | years | Female | End of Phase/Treatment | Oct 8, 2025 8:16 AM | 6225351094 | CHEMISTRY PANEL | Albumin-BCG | 47 | 33 - 49 | g/L | ||||||||
| 1970 | CZ100110001 | 31 | years | Female | End of Phase/Treatment | Oct 8, 2025 8:16 AM | 6225351094 | CHEMISTRY PANEL | Creatine Kinase | 79 | 26 - 192 | U/L | ||||||||
| 1971 | CZ100110001 | 31 | years | Female | End of Phase/Treatment | Oct 8, 2025 8:16 AM | 6225351094 | CHEMISTRY PANEL | Serum Sodium | 138 | 132 - 147 | mmol/L | ||||||||
| 1972 | CZ100110001 | 31 | years | Female | End of Phase/Treatment | Oct 8, 2025 8:16 AM | 6225351094 | CHEMISTRY PANEL | Serum Potassium | 4.4 | 3.5 - 5.2 | mmol/L | ||||||||
| 1973 | CZ100110001 | 31 | years | Female | End of Phase/Treatment | Oct 8, 2025 8:16 AM | 6225351094 | CHEMISTRY PANEL | Serum Bicarbonate | 23.6 | 19.3 - 29.3 | mmol/L | ||||||||
| 1974 | CZ100110001 | 31 | years | Female | End of Phase/Treatment | Oct 8, 2025 8:16 AM | 6225351094 | CHEMISTRY PANEL | Serum Chloride | 102 | 94 - 112 | mmol/L | ||||||||
| 1975 | CZ100110001 | 31 | years | Female | End of Phase/Treatment | Oct 8, 2025 8:16 AM | 6225351094 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 127 | 116 - 164 | g/L | ||||||||
| 1976 | CZ100110001 | 31 | years | Female | End of Phase/Treatment | Oct 8, 2025 8:16 AM | 6225351094 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.39 | 0.34 - 0.48 | |||||||||
| 1977 | CZ100110001 | 31 | years | Female | End of Phase/Treatment | Oct 8, 2025 8:16 AM | 6225351094 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.7 | 4.1 - 5.6 | TI/L | ||||||||
| 1978 | CZ100110001 | 31 | years | Female | End of Phase/Treatment | Oct 8, 2025 8:16 AM | 6225351094 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||
| 1979 | CZ100110001 | 31 | years | Female | End of Phase/Treatment | Oct 8, 2025 8:16 AM | 6225351094 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 83 | 79 - 98 | fL | ||||||||
| 1980 | CZ100110001 | 31 | years | Female | End of Phase/Treatment | Oct 8, 2025 8:16 AM | 6225351094 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 5.69 | 3.8 - 10.7 | GI/L | ||||||||
| 1981 | CZ100110001 | 31 | years | Female | End of Phase/Treatment | Oct 8, 2025 8:16 AM | 6225351094 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 3.05 | 1.96 - 7.23 | GI/L | ||||||||
| 1982 | CZ100110001 | 31 | years | Female | End of Phase/Treatment | Oct 8, 2025 8:16 AM | 6225351094 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.72 | 0.91 - 4.28 | GI/L | ||||||||
| 1983 | CZ100110001 | 31 | years | Female | End of Phase/Treatment | Oct 8, 2025 8:16 AM | 6225351094 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.49 | 0.12 - 0.92 | GI/L | ||||||||
| 1984 | CZ100110001 | 31 | years | Female | End of Phase/Treatment | Oct 8, 2025 8:16 AM | 6225351094 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.34 | 0 - 0.57 | GI/L | ||||||||
| 1985 | CZ100110001 | 31 | years | Female | End of Phase/Treatment | Oct 8, 2025 8:16 AM | 6225351094 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.09 | 0 - 0.2 | GI/L | ||||||||
| 1986 | CZ100110001 | 31 | years | Female | End of Phase/Treatment | Oct 8, 2025 8:16 AM | 6225351094 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 53.5 | 40.5 - 75 | % | ||||||||
| 1987 | CZ100110001 | 31 | years | Female | End of Phase/Treatment | Oct 8, 2025 8:16 AM | 6225351094 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 30.1 | 15.4 - 48.5 | % | ||||||||
| 1988 | CZ100110001 | 31 | years | Female | End of Phase/Treatment | Oct 8, 2025 8:16 AM | 6225351094 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 8.6 | 2.6 - 10.1 | % | ||||||||
| 1989 | CZ100110001 | 31 | years | Female | End of Phase/Treatment | Oct 8, 2025 8:16 AM | 6225351094 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 6.1 | 0 - 6.8 | % | ||||||||
| 1990 | CZ100110001 | 31 | years | Female | End of Phase/Treatment | Oct 8, 2025 8:16 AM | 6225351094 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 1.6 | 0 - 2 | % | ||||||||
| 1991 | CZ100110001 | 31 | years | Female | End of Phase/Treatment | Oct 8, 2025 8:16 AM | 6225351094 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 274 | 140 - 400 | GI/L | ||||||||
| 1992 | CZ100110001 | 31 | years | Female | End of Phase/Treatment | Oct 8, 2025 8:16 AM | 6225351094 | HEMOGLOBIN A1C | Hemoglobin A1c,Variant(-70)-QT | 5.2 | <6.5% | |||||||||
| 1993 | CZ100110001 | 31 | years | Female | End of Phase/Treatment | Oct 8, 2025 8:16 AM | 6225351094 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | 5.14 | 1.9 - 23 | uIU/mL | ||||||||
| 1994 | CZ100110001 | 31 | years | Female | End of Phase/Treatment | Oct 8, 2025 8:16 AM | 6225351094 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||
| 1995 | CZ100110001 | 31 | years | Female | End of Phase/Treatment | Oct 8, 2025 8:16 AM | 6225351094 | LIPID PANEL | Direct HDL-C 4th Generation | 1.48 | Result verified by repeat analysis | 1.03 - 1.53 | mmol/L | |||||||
| 1996 | CZ100110001 | 31 | years | Female | End of Phase/Treatment | Oct 8, 2025 8:16 AM | 6225351094 | LIPID PANEL | Triglycerides (GPO) | 0.82 | 0.44 - 1.99 | mmol/L | ||||||||
| 1997 | CZ100110001 | 31 | years | Female | End of Phase/Treatment | Oct 8, 2025 8:16 AM | 6225351094 | LIPID PANEL | Cholesterol (High Performance) | 3.76 | 3.65 - 6.21 | mmol/L | ||||||||
| 1998 | CZ100110001 | 31 | years | Female | End of Phase/Treatment | Oct 8, 2025 8:16 AM | 6225351094 | LIPID PANEL | LDL Chol Friedewald 4th | 1.90 | 0 - 3.34 | mmol/L | ||||||||
| 1999 | CZ100110001 | 31 | years | Female | End of Phase/Treatment | Oct 8, 2025 8:16 AM | 6225351094 | RETICULOCYTES | Reticulocyte Count % | 0.9 | 0.6 - 2.5 | % | ||||||||
| 2000 | CZ100110001 | 31 | years | Female | End of Phase/Treatment | Oct 8, 2025 8:16 AM | 6225351094 | TSH | TSH 3rd IS-QT | 1.582 | 0.45 - 5.33 | mIU/L | ||||||||
| 2001 | CZ100110001 | 31 | years | Female | End of Phase/Treatment | Oct 8, 2025 8:16 AM | 6225351094 | URINE MACRO PANEL | Ur Specific Gravity | 1.011 | 1 - 1.04 | |||||||||
| 2002 | CZ100110001 | 31 | years | Female | End of Phase/Treatment | Oct 8, 2025 8:16 AM | 6225351094 | URINE MACRO PANEL | Ur pH | 5.5 | 5 - 8 | |||||||||
| 2003 | CZ100110001 | 31 | years | Female | End of Phase/Treatment | Oct 8, 2025 8:16 AM | 6225351094 | URINE MACRO PANEL | Ur Protein | Negative | Ref Rng:Negative | |||||||||
| 2004 | CZ100110001 | 31 | years | Female | End of Phase/Treatment | Oct 8, 2025 8:16 AM | 6225351094 | URINE MACRO PANEL | Ur Glucose | Normal | Ref Rng:Normal | |||||||||
| 2005 | CZ100110001 | 31 | years | Female | End of Phase/Treatment | Oct 8, 2025 8:16 AM | 6225351094 | URINE MACRO PANEL | Ur Ketones | Negative | Ref Rng:Negative | |||||||||
| 2006 | CZ100110001 | 31 | years | Female | End of Phase/Treatment | Oct 8, 2025 8:16 AM | 6225351094 | URINE MACRO PANEL | Ur Bilirubin | Negative | Ref Rng:Negative | |||||||||
| 2007 | CZ100110001 | 31 | years | Female | End of Phase/Treatment | Oct 8, 2025 8:16 AM | 6225351094 | URINE MACRO PANEL | Ur Urobilinogen | Normal | Ref Rng:Normal | |||||||||
| 2008 | CZ100110001 | 31 | years | Female | End of Phase/Treatment | Oct 8, 2025 8:16 AM | 6225351094 | URINE MACRO PANEL | Ur Blood | Negative | Ref Rng:$Negative-Trace | |||||||||
| 2009 | CZ100110001 | 31 | years | Female | End of Phase/Treatment | Oct 8, 2025 8:16 AM | 6225351094 | URINE MACRO PANEL | Ur Nitrite | Negative | Ref Rng:Negative | |||||||||
| 2010 | CZ100110001 | 31 | years | Female | End of Phase/Treatment | Oct 8, 2025 8:16 AM | 6225351094 | URINE MACRO PANEL | Ur Leukocyte Esterase | Negative | Ref Rng:Negative | |||||||||
| 2011 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | C-REACTIVE PROTEIN | C Reactive Protein HS | 3.4 | 0 - 5 | mg/L | ||||||||
| 2012 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | CHEMISTRY PANEL | Total Bilirubin | 9 | 3 - 21 | umol/L | ||||||||
| 2013 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 3.3 | 0 - 6.2 | umol/L | ||||||||
| 2014 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | CHEMISTRY PANEL | Alkaline Phosphatase | 80 | 35 - 104 | U/L | ||||||||
| 2015 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | CHEMISTRY PANEL | ALT (SGPT) | 32 | 4 - 43 | U/L | ||||||||
| 2016 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | CHEMISTRY PANEL | AST (SGOT) | 34 | 8 - 40 | U/L | ||||||||
| 2017 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | CHEMISTRY PANEL | GGT | 25 | 5 - 50 | U/L | ||||||||
| 2018 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | CHEMISTRY PANEL | LDH | 167 | 53 - 234 | U/L | ||||||||
| 2019 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | CHEMISTRY PANEL | Urea Nitrogen | 4.0 | 1.4 - 8.6 | mmol/L | ||||||||
| 2020 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 58 | 31 - 101 | umol/L | ||||||||
| 2021 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | CHEMISTRY PANEL | Glucose Fasting | 4.8 | 3.9 - 5.6 | mmol/L | ||||||||
| 2022 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | CHEMISTRY PANEL | Serum Uric Acid | 265 | 149 - 446 | umol/L | ||||||||
| 2023 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | CHEMISTRY PANEL | Calcium (EDTA) | 2.34 | 2.07 - 2.64 | mmol/L | ||||||||
| 2024 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | CHEMISTRY PANEL | Phosphorus | 1.18 | 0.71 - 1.65 | mmol/L | ||||||||
| 2025 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | CHEMISTRY PANEL | Total Protein | 63 | 60 - 80 | g/L | ||||||||
| 2026 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | CHEMISTRY PANEL | Albumin-BCG | 43 | 33 - 49 | g/L | ||||||||
| 2027 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | CHEMISTRY PANEL | Creatine Kinase | 46 | 26 - 192 | U/L | ||||||||
| 2028 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | CHEMISTRY PANEL | Serum Sodium | 143 | 135 - 145 | mmol/L | ||||||||
| 2029 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | CHEMISTRY PANEL | Serum Potassium | 4.2 | 3.5 - 5.2 | mmol/L | ||||||||
| 2030 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | CHEMISTRY PANEL | Serum Bicarbonate | 24.9 | 19.3 - 29.3 | mmol/L | ||||||||
| 2031 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | CHEMISTRY PANEL | Serum Chloride | 103 | 94 - 112 | mmol/L | ||||||||
| 2032 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | CREATININE CLEARANCE CC&G | CreatininClearancCockcrftGault | 1.74 | 1.25 - 1.92 | mL/sec | ||||||||
| 2033 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | CREATININE CLEARANCE CC&G | Creatinine(Rate Blanked)-2dp | 58 | 31 - 101 | umol/L | ||||||||
| 2034 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | CREATININE CLEARANCE CC&G | Weight (kg,1dec place) | Y | 75.3 | kg | ||||||||
| 2035 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | DRUG SCREEN URINE | Amphetamines/MDMA | Neg | Neg;$Cutoff = 1000 ng/mL | |||||||||
| 2036 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | DRUG SCREEN URINE | Barbiturates | Neg | Neg;$Cutoff = 200 ng/mL | |||||||||
| 2037 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | DRUG SCREEN URINE | Cannabinoids | Neg | Neg;$Cutoff = 50 ng/mL | |||||||||
| 2038 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | DRUG SCREEN URINE | Cocaine | Neg | Neg;$Cutoff = 300 ng/mL | |||||||||
| 2039 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | DRUG SCREEN URINE | Opiates | Neg | Neg;$Cutoff = 300 ng/mL | |||||||||
| 2040 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | DRUG SCREEN URINE | Methadone | Neg | Neg;$Cutoff = 300 ng/mL | |||||||||
| 2041 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | DRUG SCREEN URINE BENZO NON-US | Benzodiazepines Gen 2 | Neg | Neg;$Cutoff = 200 ng/mL | |||||||||
| 2042 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | FEMALE OF CHILDBEARING POT? | Female/of Childbearing pot.? | Y | No | |||||||||
| 2043 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | GFR | EGFR by MDRD | 90 | mL/min/1.73m^2$No Ref Rng | |||||||||
| 2044 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 146 | 115 - 158 | g/L | ||||||||
| 2045 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.42 | 0.34 - 0.48 | |||||||||
| 2046 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.4 | 3.9 - 5.5 | TI/L | ||||||||
| 2047 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||
| 2048 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 95 | 80 - 100 | fL | ||||||||
| 2049 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 3.39 | R | L | 3.8 - 10.7 | GI/L | ||||||
| 2050 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 1.95 | R | L | 1.96 - 7.23 | GI/L | ||||||
| 2051 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.01 | 0.8 - 3 | GI/L | ||||||||
| 2052 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.24 | 0.12 - 0.92 | GI/L | ||||||||
| 2053 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.16 | 0 - 0.57 | GI/L | ||||||||
| 2054 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.02 | 0 - 0.2 | GI/L | ||||||||
| 2055 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 57.5 | 40.5 - 75 | % | ||||||||
| 2056 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 29.8 | 15.4 - 48.5 | % | ||||||||
| 2057 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 7.1 | 2.6 - 10.1 | % | ||||||||
| 2058 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 4.8 | 0 - 6.8 | % | ||||||||
| 2059 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 0.7 | 0 - 2 | % | ||||||||
| 2060 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 169 | 130 - 394 | GI/L | ||||||||
| 2061 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | HEMOGLOBIN A1C | Hemoglobin A1c,Variant(-70)-QT | 5.6 | <6.5% | |||||||||
| 2062 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | 4.01 | 1.9 - 23 | uIU/mL | ||||||||
| 2063 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||
| 2064 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | IS SUBJECT OF BLACK RACE? | Subject of black race? | Y | No | |||||||||
| 2065 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | LIPID PANEL | Direct HDL-C 4th Generation | 1.49 | 1.03 - 1.53 | mmol/L | ||||||||
| 2066 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | LIPID PANEL | Triglycerides (GPO) | 0.88 | 0.63 - 2.71 | mmol/L | ||||||||
| 2067 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | LIPID PANEL | Cholesterol (High Performance) | 4.46 | R | L | 4.86 - 8.28 | mmol/L | ||||||
| 2068 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | LIPID PANEL | LDL Chol Friedewald 4th | 2.57 | 0 - 3.34 | mmol/L | ||||||||
| 2069 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | POSTMENOPAUSAL FEMALE? | <40yrs & amenorrhea >/= 12mo | No | ||||||||||
| 2070 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | RETICULOCYTES | Reticulocyte Count % | 0.9 | 0.6 - 2.5 | % | ||||||||
| 2071 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | TSH | TSH 3rd IS-QT | 2.205 | 0.45 - 5.33 | mIU/L | ||||||||
| 2072 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | URINE MACRO PANEL | Ur Specific Gravity | 1.006 | 1.01 - 1.03 | |||||||||
| 2073 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | URINE MACRO PANEL | Ur pH | 5.5 | 5 - 8 | |||||||||
| 2074 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | URINE MACRO PANEL | Ur Protein | Negative | Ref Rng:Negative | |||||||||
| 2075 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | URINE MACRO PANEL | Ur Glucose | Normal | Ref Rng:Normal | |||||||||
| 2076 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | URINE MACRO PANEL | Ur Ketones | Negative | Ref Rng:Negative | |||||||||
| 2077 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | URINE MACRO PANEL | Ur Bilirubin | Negative | Ref Rng:Negative | |||||||||
| 2078 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | URINE MACRO PANEL | Ur Urobilinogen | Normal | Ref Rng:Normal | |||||||||
| 2079 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | URINE MACRO PANEL | Ur Blood | Negative | Ref Rng:$Negative-Trace | |||||||||
| 2080 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | URINE MACRO PANEL | Ur Nitrite | Negative | Ref Rng:Negative | |||||||||
| 2081 | CZ100110004 | 64 | years | Female | Part 1 Screening | Oct 3, 2025 9:33 AM | 6225351077 | URINE MACRO PANEL | Ur Leukocyte Esterase | Negative | Ref Rng:Negative | |||||||||
| 2082 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | C-REACTIVE PROTEIN | C Reactive Protein HS | 1.0 | 0 - 5 | mg/L | ||||||||
| 2083 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | CHEMISTRY PANEL | Total Bilirubin | 9 | 3 - 21 | umol/L | ||||||||
| 2084 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 3.5 | 0 - 6.2 | umol/L | ||||||||
| 2085 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | CHEMISTRY PANEL | Alkaline Phosphatase | 61 | 35 - 104 | U/L | ||||||||
| 2086 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | CHEMISTRY PANEL | ALT (SGPT) | 13 | 4 - 43 | U/L | ||||||||
| 2087 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | CHEMISTRY PANEL | AST (SGOT) | 16 | 8 - 40 | U/L | ||||||||
| 2088 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | CHEMISTRY PANEL | GGT | 14 | 4 - 49 | U/L | ||||||||
| 2089 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | CHEMISTRY PANEL | LDH | 137 | 53 - 234 | U/L | ||||||||
| 2090 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | CHEMISTRY PANEL | Urea Nitrogen | 4.3 | 1.4 - 8.6 | mmol/L | ||||||||
| 2091 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 79 | 31 - 101 | umol/L | ||||||||
| 2092 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | CHEMISTRY PANEL | Glucose Fasting | 4.5 | 3.9 - 5.6 | mmol/L | ||||||||
| 2093 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | CHEMISTRY PANEL | Serum Uric Acid | 273 | 125 - 428 | umol/L | ||||||||
| 2094 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | CHEMISTRY PANEL | Calcium (EDTA) | 2.34 | 2.07 - 2.64 | mmol/L | ||||||||
| 2095 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | CHEMISTRY PANEL | Phosphorus | 1.07 | 0.71 - 1.65 | mmol/L | ||||||||
| 2096 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | CHEMISTRY PANEL | Total Protein | 69 | 61 - 84 | g/L | ||||||||
| 2097 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | CHEMISTRY PANEL | Albumin-BCG | 45 | 33 - 49 | g/L | ||||||||
| 2098 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | CHEMISTRY PANEL | Creatine Kinase | 123 | 26 - 192 | U/L | ||||||||
| 2099 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | CHEMISTRY PANEL | Serum Sodium | 139 | 132 - 147 | mmol/L | ||||||||
| 2100 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | CHEMISTRY PANEL | Serum Potassium | 4.3 | 3.5 - 5.2 | mmol/L | ||||||||
| 2101 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | CHEMISTRY PANEL | Serum Bicarbonate | 22.8 | 19.3 - 29.3 | mmol/L | ||||||||
| 2102 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | CHEMISTRY PANEL | Serum Chloride | 101 | 94 - 112 | mmol/L | ||||||||
| 2103 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | CREATININE CLEARANCE CC&G | CreatininClearancCockcrftGault | 1.59 | 1.25 - 1.92 | mL/sec | ||||||||
| 2104 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | CREATININE CLEARANCE CC&G | Creatinine(Rate Blanked)-2dp | 79 | 31 - 101 | umol/L | ||||||||
| 2105 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | CREATININE CLEARANCE CC&G | Weight (kg,1dec place) | Y | 68.1 | kg | ||||||||
| 2106 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | DRUG SCREEN URINE | Amphetamines/MDMA | Neg | Neg;$Cutoff = 1000 ng/mL | |||||||||
| 2107 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | DRUG SCREEN URINE | Barbiturates | Neg | Neg;$Cutoff = 200 ng/mL | |||||||||
| 2108 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | DRUG SCREEN URINE | Cannabinoids | Neg | Neg;$Cutoff = 50 ng/mL | |||||||||
| 2109 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | DRUG SCREEN URINE | Cocaine | Neg | Neg;$Cutoff = 300 ng/mL | |||||||||
| 2110 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | DRUG SCREEN URINE | Opiates | Neg | Neg;$Cutoff = 300 ng/mL | |||||||||
| 2111 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | DRUG SCREEN URINE | Methadone | Neg | Neg;$Cutoff = 300 ng/mL | |||||||||
| 2112 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | DRUG SCREEN URINE BENZO NON-US | Benzodiazepines Gen 2 | Neg | Neg;$Cutoff = 200 ng/mL | |||||||||
| 2113 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | FEMALE OF CHILDBEARING POT? | Female/of Childbearing pot.? | Y | Yes | |||||||||
| 2114 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | GFR | EGFR by MDRD | 73 | mL/min/1.73m^2$No Ref Rng | |||||||||
| 2115 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 125 | 116 - 164 | g/L | ||||||||
| 2116 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.38 | 0.34 - 0.48 | |||||||||
| 2117 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.2 | 4.1 - 5.6 | TI/L | ||||||||
| 2118 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||
| 2119 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 90 | 79 - 98 | fL | ||||||||
| 2120 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 4.30 | 3.8 - 10.7 | GI/L | ||||||||
| 2121 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 2.33 | 1.96 - 7.23 | GI/L | ||||||||
| 2122 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.57 | 0.91 - 4.28 | GI/L | ||||||||
| 2123 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.29 | 0.12 - 0.92 | GI/L | ||||||||
| 2124 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.10 | 0 - 0.57 | GI/L | ||||||||
| 2125 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.01 | 0 - 0.2 | GI/L | ||||||||
| 2126 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 54.1 | 40.5 - 75 | % | ||||||||
| 2127 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 36.6 | 15.4 - 48.5 | % | ||||||||
| 2128 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 6.7 | 2.6 - 10.1 | % | ||||||||
| 2129 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 2.3 | 0 - 6.8 | % | ||||||||
| 2130 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 0.3 | 0 - 2 | % | ||||||||
| 2131 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 250 | 140 - 400 | GI/L | ||||||||
| 2132 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | HEMOGLOBIN A1C | Hemoglobin A1c,Variant(-70)-QT | 5.5 | <6.5% | |||||||||
| 2133 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | 4.11 | 1.9 - 23 | uIU/mL | ||||||||
| 2134 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||
| 2135 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | IS SUBJECT OF BLACK RACE? | Subject of black race? | Y | No | |||||||||
| 2136 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | LIPID PANEL | Direct HDL-C 4th Generation | 1.65 | H | 1.03 - 1.53 | mmol/L | |||||||
| 2137 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | LIPID PANEL | Triglycerides (GPO) | 0.93 | 0.44 - 1.99 | mmol/L | ||||||||
| 2138 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | LIPID PANEL | Cholesterol (High Performance) | 4.65 | 3.65 - 6.21 | mmol/L | ||||||||
| 2139 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | LIPID PANEL | LDL Chol Friedewald 4th | 2.57 | 0 - 3.34 | mmol/L | ||||||||
| 2140 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | POSTMENOPAUSAL FEMALE? | <40yrs & amenorrhea >/= 12mo | No | ||||||||||
| 2141 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | RETICULOCYTES | Reticulocyte Count % | 0.9 | 0.6 - 2.5 | % | ||||||||
| 2142 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | SERUM BETA HCG | B-hCG, Qualitative | Negative | Ref Rng: Negative | |||||||||
| 2143 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | SERUM BETA HCG | B-hCG, Quantitative | <0.6 | Units: mIU/mL$Pre-menopausal$<5.0: Negative$5.0-24.9:Borderline$>/= 25.0: Positive | |||||||||
| 2144 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | TSH | TSH 3rd IS-QT | 3.025 | 0.45 - 5.33 | mIU/L | ||||||||
| 2145 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | URINE MACRO PANEL | Ur Specific Gravity | 1.014 | 1 - 1.04 | |||||||||
| 2146 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | URINE MACRO PANEL | Ur pH | 6.5 | 5 - 8 | |||||||||
| 2147 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | URINE MACRO PANEL | Ur Protein | Negative | Ref Rng:Negative | |||||||||
| 2148 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | URINE MACRO PANEL | Ur Glucose | Normal | Ref Rng:Normal | |||||||||
| 2149 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | URINE MACRO PANEL | Ur Ketones | Negative | Ref Rng:Negative | |||||||||
| 2150 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | URINE MACRO PANEL | Ur Bilirubin | Negative | Ref Rng:Negative | |||||||||
| 2151 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | URINE MACRO PANEL | Ur Urobilinogen | Normal | Ref Rng:Normal | |||||||||
| 2152 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | URINE MACRO PANEL | Ur Blood | Negative | Ref Rng:$Negative-Trace | |||||||||
| 2153 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | URINE MACRO PANEL | Ur Nitrite | Negative | Ref Rng:Negative | |||||||||
| 2154 | CZ100110003 | 35 | years | Female | Part 1 Screening | Sep 26, 2025 9:10 AM | 6225351081 | URINE MACRO PANEL | Ur Leukocyte Esterase | Negative | Ref Rng:Negative | |||||||||
| 2155 | CZ100110002 | 25 | years | Male | Part 1 DB Baseline | Aug 28, 2025 11:45 AM | 6225351082 | C-REACTIVE PROTEIN | C Reactive Protein HS | 0.3 | Result verified by repeat analysis | 0 - 5 | mg/L | |||||||
| 2156 | CZ100110002 | 25 | years | Male | Part 1 DB Baseline | Aug 28, 2025 11:45 AM | 6225351082 | CHEMISTRY PANEL | Total Bilirubin | 10 | 3 - 21 | umol/L | ||||||||
| 2157 | CZ100110002 | 25 | years | Male | Part 1 DB Baseline | Aug 28, 2025 11:45 AM | 6225351082 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 3.4 | 0 - 6.2 | umol/L | ||||||||
| 2158 | CZ100110002 | 25 | years | Male | Part 1 DB Baseline | Aug 28, 2025 11:45 AM | 6225351082 | CHEMISTRY PANEL | Alkaline Phosphatase | 94 | 40 - 129 | U/L | ||||||||
| 2159 | CZ100110002 | 25 | years | Male | Part 1 DB Baseline | Aug 28, 2025 11:45 AM | 6225351082 | CHEMISTRY PANEL | ALT (SGPT) | 46 | 5 - 48 | U/L | ||||||||
| 2160 | CZ100110002 | 25 | years | Male | Part 1 DB Baseline | Aug 28, 2025 11:45 AM | 6225351082 | CHEMISTRY PANEL | AST (SGOT) | 18 | 8 - 40 | U/L | ||||||||
| 2161 | CZ100110002 | 25 | years | Male | Part 1 DB Baseline | Aug 28, 2025 11:45 AM | 6225351082 | CHEMISTRY PANEL | GGT | 93 | H | 10 - 61 | U/L | |||||||
| 2162 | CZ100110002 | 25 | years | Male | Part 1 DB Baseline | Aug 28, 2025 11:45 AM | 6225351082 | CHEMISTRY PANEL | LDH | 165 | 53 - 234 | U/L | ||||||||
| 2163 | CZ100110002 | 25 | years | Male | Part 1 DB Baseline | Aug 28, 2025 11:45 AM | 6225351082 | CHEMISTRY PANEL | Urea Nitrogen | 5.7 | 1.4 - 8.6 | mmol/L | ||||||||
| 2164 | CZ100110002 | 25 | years | Male | Part 1 DB Baseline | Aug 28, 2025 11:45 AM | 6225351082 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 94 | 40 - 110 | umol/L | ||||||||
| 2165 | CZ100110002 | 25 | years | Male | Part 1 DB Baseline | Aug 28, 2025 11:45 AM | 6225351082 | CHEMISTRY PANEL | Glucose Fasting | 4.6 | 3.9 - 5.6 | mmol/L | ||||||||
| 2166 | CZ100110002 | 25 | years | Male | Part 1 DB Baseline | Aug 28, 2025 11:45 AM | 6225351082 | CHEMISTRY PANEL | Serum Uric Acid | 427 | 125 - 488 | umol/L | ||||||||
| 2167 | CZ100110002 | 25 | years | Male | Part 1 DB Baseline | Aug 28, 2025 11:45 AM | 6225351082 | CHEMISTRY PANEL | Calcium (EDTA) | 2.57 | 2.07 - 2.64 | mmol/L | ||||||||
| 2168 | CZ100110002 | 25 | years | Male | Part 1 DB Baseline | Aug 28, 2025 11:45 AM | 6225351082 | CHEMISTRY PANEL | Phosphorus | 1.18 | 0.71 - 1.65 | mmol/L | ||||||||
| 2169 | CZ100110002 | 25 | years | Male | Part 1 DB Baseline | Aug 28, 2025 11:45 AM | 6225351082 | CHEMISTRY PANEL | Total Protein | 77 | 61 - 84 | g/L | ||||||||
| 2170 | CZ100110002 | 25 | years | Male | Part 1 DB Baseline | Aug 28, 2025 11:45 AM | 6225351082 | CHEMISTRY PANEL | Albumin-BCG | 49 | 33 - 49 | g/L | ||||||||
| 2171 | CZ100110002 | 25 | years | Male | Part 1 DB Baseline | Aug 28, 2025 11:45 AM | 6225351082 | CHEMISTRY PANEL | Creatine Kinase | 89 | 39 - 308 | U/L | ||||||||
| 2172 | CZ100110002 | 25 | years | Male | Part 1 DB Baseline | Aug 28, 2025 11:45 AM | 6225351082 | CHEMISTRY PANEL | Serum Sodium | 140 | 132 - 147 | mmol/L | ||||||||
| 2173 | CZ100110002 | 25 | years | Male | Part 1 DB Baseline | Aug 28, 2025 11:45 AM | 6225351082 | CHEMISTRY PANEL | Serum Potassium | 4.3 | 3.5 - 5.2 | mmol/L | ||||||||
| 2174 | CZ100110002 | 25 | years | Male | Part 1 DB Baseline | Aug 28, 2025 11:45 AM | 6225351082 | CHEMISTRY PANEL | Serum Bicarbonate | 21.0 | 19.3 - 29.3 | mmol/L | ||||||||
| 2175 | CZ100110002 | 25 | years | Male | Part 1 DB Baseline | Aug 28, 2025 11:45 AM | 6225351082 | CHEMISTRY PANEL | Serum Chloride | 101 | 94 - 112 | mmol/L | ||||||||
| 2176 | CZ100110002 | 25 | years | Male | Part 1 DB Baseline | Aug 28, 2025 11:45 AM | 6225351082 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 165 | 127 - 181 | g/L | ||||||||
| 2177 | CZ100110002 | 25 | years | Male | Part 1 DB Baseline | Aug 28, 2025 11:45 AM | 6225351082 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.47 | 0.39 - 0.54 | |||||||||
| 2178 | CZ100110002 | 25 | years | Male | Part 1 DB Baseline | Aug 28, 2025 11:45 AM | 6225351082 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 5.2 | 4.5 - 6.4 | TI/L | ||||||||
| 2179 | CZ100110002 | 25 | years | Male | Part 1 DB Baseline | Aug 28, 2025 11:45 AM | 6225351082 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | Normocytic | NORMOCYTIC;$NORMOCHROMIC | |||||||||
| 2180 | CZ100110002 | 25 | years | Male | Part 1 DB Baseline | Aug 28, 2025 11:45 AM | 6225351082 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 89 | 79 - 96 | fL | ||||||||
| 2181 | CZ100110002 | 25 | years | Male | Part 1 DB Baseline | Aug 28, 2025 11:45 AM | 6225351082 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 6.70 | 3.8 - 10.7 | GI/L | ||||||||
| 2182 | CZ100110002 | 25 | years | Male | Part 1 DB Baseline | Aug 28, 2025 11:45 AM | 6225351082 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 3.28 | 1.96 - 7.23 | GI/L | ||||||||
| 2183 | CZ100110002 | 25 | years | Male | Part 1 DB Baseline | Aug 28, 2025 11:45 AM | 6225351082 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.74 | 0.91 - 4.28 | GI/L | ||||||||
| 2184 | CZ100110002 | 25 | years | Male | Part 1 DB Baseline | Aug 28, 2025 11:45 AM | 6225351082 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.34 | 0.12 - 0.92 | GI/L | ||||||||
| 2185 | CZ100110002 | 25 | years | Male | Part 1 DB Baseline | Aug 28, 2025 11:45 AM | 6225351082 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 1.34 | R | H | 0 - 0.57 | GI/L | ||||||
| 2186 | CZ100110002 | 25 | years | Male | Part 1 DB Baseline | Aug 28, 2025 11:45 AM | 6225351082 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.00 | 0 - 0.2 | GI/L | ||||||||
| 2187 | CZ100110002 | 25 | years | Male | Part 1 DB Baseline | Aug 28, 2025 11:45 AM | 6225351082 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 49.0 | 40.5 - 75 | % | ||||||||
| 2188 | CZ100110002 | 25 | years | Male | Part 1 DB Baseline | Aug 28, 2025 11:45 AM | 6225351082 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 26.0 | 15.4 - 48.5 | % | ||||||||
| 2189 | CZ100110002 | 25 | years | Male | Part 1 DB Baseline | Aug 28, 2025 11:45 AM | 6225351082 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 5.0 | 2.6 - 10.1 | % | ||||||||
| 2190 | CZ100110002 | 25 | years | Male | Part 1 DB Baseline | Aug 28, 2025 11:45 AM | 6225351082 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 20.0 | R | H | 0 - 6.8 | % | ||||||
| 2191 | CZ100110002 | 25 | years | Male | Part 1 DB Baseline | Aug 28, 2025 11:45 AM | 6225351082 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 0.0 | 0 - 2 | % | ||||||||
| 2192 | CZ100110002 | 25 | years | Male | Part 1 DB Baseline | Aug 28, 2025 11:45 AM | 6225351082 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 250 | 140 - 400 | GI/L | ||||||||
| 2193 | CZ100110002 | 25 | years | Male | Part 1 DB Baseline | Aug 28, 2025 11:45 AM | 6225351082 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | Test cancelled: Hemolysis-test not performed | ||||||||||
| 2194 | CZ100110002 | 25 | years | Male | Part 1 DB Baseline | Aug 28, 2025 11:45 AM | 6225351082 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||
| 2195 | CZ100110002 | 25 | years | Male | Part 1 DB Baseline | Aug 28, 2025 11:45 AM | 6225351082 | LIPID PANEL | Direct HDL-C 4th Generation | 0.77 | L | Result verified by repeat analysis | 1.03 - 1.53 | mmol/L | ||||||
| 2196 | CZ100110002 | 25 | years | Male | Part 1 DB Baseline | Aug 28, 2025 11:45 AM | 6225351082 | LIPID PANEL | Triglycerides (GPO) | 1.72 | 0.5 - 2.81 | mmol/L | ||||||||
| 2197 | CZ100110002 | 25 | years | Male | Part 1 DB Baseline | Aug 28, 2025 11:45 AM | 6225351082 | LIPID PANEL | Cholesterol (High Performance) | 4.31 | 3.31 - 6.1 | mmol/L | ||||||||
| 2198 | CZ100110002 | 25 | years | Male | Part 1 DB Baseline | Aug 28, 2025 11:45 AM | 6225351082 | LIPID PANEL | LDL Chol Friedewald 4th | 2.75 | 0 - 3.34 | mmol/L | ||||||||
| 2199 | CZ100110002 | 25 | years | Male | Part 1 DB Baseline | Aug 28, 2025 11:45 AM | 6225351082 | RETICULOCYTES | Reticulocyte Count % | 1.1 | 0.6 - 2.5 | % | ||||||||
| 2200 | CZ100110002 | 25 | years | Male | Part 1 DB Baseline | Aug 28, 2025 11:45 AM | 6225351082 | URINE MACRO PANEL | Ur Specific Gravity | 1.018 | 1 - 1.04 | |||||||||
| 2201 | CZ100110002 | 25 | years | Male | Part 1 DB Baseline | Aug 28, 2025 11:45 AM | 6225351082 | URINE MACRO PANEL | Ur pH | 5.5 | 5 - 8 | |||||||||
| 2202 | CZ100110002 | 25 | years | Male | Part 1 DB Baseline | Aug 28, 2025 11:45 AM | 6225351082 | URINE MACRO PANEL | Ur Protein | Negative | Ref Rng:Negative | |||||||||
| 2203 | CZ100110002 | 25 | years | Male | Part 1 DB Baseline | Aug 28, 2025 11:45 AM | 6225351082 | URINE MACRO PANEL | Ur Glucose | Normal | Ref Rng:Normal | |||||||||
| 2204 | CZ100110002 | 25 | years | Male | Part 1 DB Baseline | Aug 28, 2025 11:45 AM | 6225351082 | URINE MACRO PANEL | Ur Ketones | Negative | Ref Rng:Negative | |||||||||
| 2205 | CZ100110002 | 25 | years | Male | Part 1 DB Baseline | Aug 28, 2025 11:45 AM | 6225351082 | URINE MACRO PANEL | Ur Bilirubin | Negative | Ref Rng:Negative | |||||||||
| 2206 | CZ100110002 | 25 | years | Male | Part 1 DB Baseline | Aug 28, 2025 11:45 AM | 6225351082 | URINE MACRO PANEL | Ur Urobilinogen | Normal | Ref Rng:Normal | |||||||||
| 2207 | CZ100110002 | 25 | years | Male | Part 1 DB Baseline | Aug 28, 2025 11:45 AM | 6225351082 | URINE MACRO PANEL | Ur Blood | Negative | Ref Rng:Negative | |||||||||
| 2208 | CZ100110002 | 25 | years | Male | Part 1 DB Baseline | Aug 28, 2025 11:45 AM | 6225351082 | URINE MACRO PANEL | Ur Nitrite | Negative | Ref Rng:Negative | |||||||||
| 2209 | CZ100110002 | 25 | years | Male | Part 1 DB Baseline | Aug 28, 2025 11:45 AM | 6225351082 | URINE MACRO PANEL | Ur Leukocyte Esterase | Negative | Ref Rng:Negative | |||||||||
| 2210 | CZ100110001 | 31 | years | Female | Part 1 DB Baseline | Aug 28, 2025 7:07 AM | 6225351083 | C-REACTIVE PROTEIN | C Reactive Protein HS | 2.1 | 0 - 5 | mg/L | ||||||||
| 2211 | CZ100110001 | 31 | years | Female | Part 1 DB Baseline | Aug 28, 2025 7:07 AM | 6225351083 | CELLULAR ELEMENTS | Ur WBC/HPF | 3 | 0 - 12 | /HPF | ||||||||
| 2212 | CZ100110001 | 31 | years | Female | Part 1 DB Baseline | Aug 28, 2025 7:07 AM | 6225351083 | CHEMISTRY PANEL | Total Bilirubin | 12 | 3 - 21 | umol/L | ||||||||
| 2213 | CZ100110001 | 31 | years | Female | Part 1 DB Baseline | Aug 28, 2025 7:07 AM | 6225351083 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 3.8 | 0 - 6.2 | umol/L | ||||||||
| 2214 | CZ100110001 | 31 | years | Female | Part 1 DB Baseline | Aug 28, 2025 7:07 AM | 6225351083 | CHEMISTRY PANEL | Alkaline Phosphatase | 83 | 35 - 104 | U/L | ||||||||
| 2215 | CZ100110001 | 31 | years | Female | Part 1 DB Baseline | Aug 28, 2025 7:07 AM | 6225351083 | CHEMISTRY PANEL | ALT (SGPT) | 10 | 4 - 43 | U/L | ||||||||
| 2216 | CZ100110001 | 31 | years | Female | Part 1 DB Baseline | Aug 28, 2025 7:07 AM | 6225351083 | CHEMISTRY PANEL | AST (SGOT) | 11 | 8 - 40 | U/L | ||||||||
| 2217 | CZ100110001 | 31 | years | Female | Part 1 DB Baseline | Aug 28, 2025 7:07 AM | 6225351083 | CHEMISTRY PANEL | GGT | 14 | 4 - 49 | U/L | ||||||||
| 2218 | CZ100110001 | 31 | years | Female | Part 1 DB Baseline | Aug 28, 2025 7:07 AM | 6225351083 | CHEMISTRY PANEL | LDH | 133 | 53 - 234 | U/L | ||||||||
| 2219 | CZ100110001 | 31 | years | Female | Part 1 DB Baseline | Aug 28, 2025 7:07 AM | 6225351083 | CHEMISTRY PANEL | Urea Nitrogen | 4.4 | 1.4 - 8.6 | mmol/L | ||||||||
| 2220 | CZ100110001 | 31 | years | Female | Part 1 DB Baseline | Aug 28, 2025 7:07 AM | 6225351083 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 68 | 31 - 101 | umol/L | ||||||||
| 2221 | CZ100110001 | 31 | years | Female | Part 1 DB Baseline | Aug 28, 2025 7:07 AM | 6225351083 | CHEMISTRY PANEL | Glucose Fasting | 4.7 | 3.9 - 5.6 | mmol/L | ||||||||
| 2222 | CZ100110001 | 31 | years | Female | Part 1 DB Baseline | Aug 28, 2025 7:07 AM | 6225351083 | CHEMISTRY PANEL | Serum Uric Acid | 303 | 125 - 428 | umol/L | ||||||||
| 2223 | CZ100110001 | 31 | years | Female | Part 1 DB Baseline | Aug 28, 2025 7:07 AM | 6225351083 | CHEMISTRY PANEL | Calcium (EDTA) | 2.36 | 2.07 - 2.64 | mmol/L | ||||||||
| 2224 | CZ100110001 | 31 | years | Female | Part 1 DB Baseline | Aug 28, 2025 7:07 AM | 6225351083 | CHEMISTRY PANEL | Phosphorus | 1.06 | 0.71 - 1.65 | mmol/L | ||||||||
| 2225 | CZ100110001 | 31 | years | Female | Part 1 DB Baseline | Aug 28, 2025 7:07 AM | 6225351083 | CHEMISTRY PANEL | Total Protein | 72 | 61 - 84 | g/L | ||||||||
| 2226 | CZ100110001 | 31 | years | Female | Part 1 DB Baseline | Aug 28, 2025 7:07 AM | 6225351083 | CHEMISTRY PANEL | Albumin-BCG | 45 | 33 - 49 | g/L | ||||||||
| 2227 | CZ100110001 | 31 | years | Female | Part 1 DB Baseline | Aug 28, 2025 7:07 AM | 6225351083 | CHEMISTRY PANEL | Creatine Kinase | 79 | 26 - 192 | U/L | ||||||||
| 2228 | CZ100110001 | 31 | years | Female | Part 1 DB Baseline | Aug 28, 2025 7:07 AM | 6225351083 | CHEMISTRY PANEL | Serum Sodium | 140 | 132 - 147 | mmol/L | ||||||||
| 2229 | CZ100110001 | 31 | years | Female | Part 1 DB Baseline | Aug 28, 2025 7:07 AM | 6225351083 | CHEMISTRY PANEL | Serum Potassium | 4.2 | 3.5 - 5.2 | mmol/L | ||||||||
| 2230 | CZ100110001 | 31 | years | Female | Part 1 DB Baseline | Aug 28, 2025 7:07 AM | 6225351083 | CHEMISTRY PANEL | Serum Bicarbonate | 22.2 | 19.3 - 29.3 | mmol/L | ||||||||
| 2231 | CZ100110001 | 31 | years | Female | Part 1 DB Baseline | Aug 28, 2025 7:07 AM | 6225351083 | CHEMISTRY PANEL | Serum Chloride | 105 | 94 - 112 | mmol/L | ||||||||
| 2232 | CZ100110001 | 31 | years | Female | Part 1 DB Baseline | Aug 28, 2025 7:07 AM | 6225351083 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 129 | 116 - 164 | g/L | ||||||||
| 2233 | CZ100110001 | 31 | years | Female | Part 1 DB Baseline | Aug 28, 2025 7:07 AM | 6225351083 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.40 | 0.34 - 0.48 | |||||||||
| 2234 | CZ100110001 | 31 | years | Female | Part 1 DB Baseline | Aug 28, 2025 7:07 AM | 6225351083 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.7 | 4.1 - 5.6 | TI/L | ||||||||
| 2235 | CZ100110001 | 31 | years | Female | Part 1 DB Baseline | Aug 28, 2025 7:07 AM | 6225351083 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||
| 2236 | CZ100110001 | 31 | years | Female | Part 1 DB Baseline | Aug 28, 2025 7:07 AM | 6225351083 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 85 | 79 - 98 | fL | ||||||||
| 2237 | CZ100110001 | 31 | years | Female | Part 1 DB Baseline | Aug 28, 2025 7:07 AM | 6225351083 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 5.56 | 3.8 - 10.7 | GI/L | ||||||||
| 2238 | CZ100110001 | 31 | years | Female | Part 1 DB Baseline | Aug 28, 2025 7:07 AM | 6225351083 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 3.30 | 1.96 - 7.23 | GI/L | ||||||||
| 2239 | CZ100110001 | 31 | years | Female | Part 1 DB Baseline | Aug 28, 2025 7:07 AM | 6225351083 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.54 | 0.91 - 4.28 | GI/L | ||||||||
| 2240 | CZ100110001 | 31 | years | Female | Part 1 DB Baseline | Aug 28, 2025 7:07 AM | 6225351083 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.39 | 0.12 - 0.92 | GI/L | ||||||||
| 2241 | CZ100110001 | 31 | years | Female | Part 1 DB Baseline | Aug 28, 2025 7:07 AM | 6225351083 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.20 | 0 - 0.57 | GI/L | ||||||||
| 2242 | CZ100110001 | 31 | years | Female | Part 1 DB Baseline | Aug 28, 2025 7:07 AM | 6225351083 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.11 | 0 - 0.2 | GI/L | ||||||||
| 2243 | CZ100110001 | 31 | years | Female | Part 1 DB Baseline | Aug 28, 2025 7:07 AM | 6225351083 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 59.4 | 40.5 - 75 | % | ||||||||
| 2244 | CZ100110001 | 31 | years | Female | Part 1 DB Baseline | Aug 28, 2025 7:07 AM | 6225351083 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 27.9 | 15.4 - 48.5 | % | ||||||||
| 2245 | CZ100110001 | 31 | years | Female | Part 1 DB Baseline | Aug 28, 2025 7:07 AM | 6225351083 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 7.1 | 2.6 - 10.1 | % | ||||||||
| 2246 | CZ100110001 | 31 | years | Female | Part 1 DB Baseline | Aug 28, 2025 7:07 AM | 6225351083 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 3.6 | 0 - 6.8 | % | ||||||||
| 2247 | CZ100110001 | 31 | years | Female | Part 1 DB Baseline | Aug 28, 2025 7:07 AM | 6225351083 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 2.0 | 0 - 2 | % | ||||||||
| 2248 | CZ100110001 | 31 | years | Female | Part 1 DB Baseline | Aug 28, 2025 7:07 AM | 6225351083 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 255 | 140 - 400 | GI/L | ||||||||
| 2249 | CZ100110001 | 31 | years | Female | Part 1 DB Baseline | Aug 28, 2025 7:07 AM | 6225351083 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | 5.14 | 1.9 - 23 | uIU/mL | ||||||||
| 2250 | CZ100110001 | 31 | years | Female | Part 1 DB Baseline | Aug 28, 2025 7:07 AM | 6225351083 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||
| 2251 | CZ100110001 | 31 | years | Female | Part 1 DB Baseline | Aug 28, 2025 7:07 AM | 6225351083 | LIPID PANEL | Direct HDL-C 4th Generation | 1.22 | 1.03 - 1.53 | mmol/L | ||||||||
| 2252 | CZ100110001 | 31 | years | Female | Part 1 DB Baseline | Aug 28, 2025 7:07 AM | 6225351083 | LIPID PANEL | Triglycerides (GPO) | 0.56 | 0.44 - 1.99 | mmol/L | ||||||||
| 2253 | CZ100110001 | 31 | years | Female | Part 1 DB Baseline | Aug 28, 2025 7:07 AM | 6225351083 | LIPID PANEL | Cholesterol (High Performance) | 3.42 | L | 3.65 - 6.21 | mmol/L | |||||||
| 2254 | CZ100110001 | 31 | years | Female | Part 1 DB Baseline | Aug 28, 2025 7:07 AM | 6225351083 | LIPID PANEL | LDL Chol Friedewald 4th | 1.94 | 0 - 3.34 | mmol/L | ||||||||
| 2255 | CZ100110001 | 31 | years | Female | Part 1 DB Baseline | Aug 28, 2025 7:07 AM | 6225351083 | RETICULOCYTES | Reticulocyte Count % | 0.8 | 0.6 - 2.5 | % | ||||||||
| 2256 | CZ100110001 | 31 | years | Female | Part 1 DB Baseline | Aug 28, 2025 7:07 AM | 6225351083 | URINE MACRO PANEL | Ur Specific Gravity | 1.029 | 1 - 1.04 | |||||||||
| 2257 | CZ100110001 | 31 | years | Female | Part 1 DB Baseline | Aug 28, 2025 7:07 AM | 6225351083 | URINE MACRO PANEL | Ur pH | 5.5 | 5 - 8 | |||||||||
| 2258 | CZ100110001 | 31 | years | Female | Part 1 DB Baseline | Aug 28, 2025 7:07 AM | 6225351083 | URINE MACRO PANEL | Ur Protein | Trace | H | Ref Rng:Negative | ||||||||
| 2259 | CZ100110001 | 31 | years | Female | Part 1 DB Baseline | Aug 28, 2025 7:07 AM | 6225351083 | URINE MACRO PANEL | Ur Glucose | Normal | Ref Rng:Normal | |||||||||
| 2260 | CZ100110001 | 31 | years | Female | Part 1 DB Baseline | Aug 28, 2025 7:07 AM | 6225351083 | URINE MACRO PANEL | Ur Ketones | Negative | Ref Rng:Negative | |||||||||
| 2261 | CZ100110001 | 31 | years | Female | Part 1 DB Baseline | Aug 28, 2025 7:07 AM | 6225351083 | URINE MACRO PANEL | Ur Bilirubin | Negative | Ref Rng:Negative | |||||||||
| 2262 | CZ100110001 | 31 | years | Female | Part 1 DB Baseline | Aug 28, 2025 7:07 AM | 6225351083 | URINE MACRO PANEL | Ur Urobilinogen | Normal | Ref Rng:Normal | |||||||||
| 2263 | CZ100110001 | 31 | years | Female | Part 1 DB Baseline | Aug 28, 2025 7:07 AM | 6225351083 | URINE MACRO PANEL | Ur Blood | Trace | Ref Rng:$Negative-Trace | |||||||||
| 2264 | CZ100110001 | 31 | years | Female | Part 1 DB Baseline | Aug 28, 2025 7:07 AM | 6225351083 | URINE MACRO PANEL | Ur Nitrite | Negative | Ref Rng:Negative | |||||||||
| 2265 | CZ100110001 | 31 | years | Female | Part 1 DB Baseline | Aug 28, 2025 7:07 AM | 6225351083 | URINE MACRO PANEL | Ur Leukocyte Esterase | Trace | H | Ref Rng:Negative | ||||||||
| 2266 | CZ100110001 | 31 | years | Female | Part 1 DB Baseline | Aug 28, 2025 7:07 AM | 6225351083 | URINE MICRO PANEL | Ur Microscopic | Positive | NEGATIVE$ | NEGATIVE | ||||||||
| 2267 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | C-REACTIVE PROTEIN | C Reactive Protein HS | 0.2 | Result verified by repeat analysis | 0 - 5 | mg/L | |||||||
| 2268 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | CHEMISTRY PANEL | Total Bilirubin | 13 | 3 - 21 | umol/L | ||||||||
| 2269 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 3.7 | 0 - 6.2 | umol/L | ||||||||
| 2270 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | CHEMISTRY PANEL | Alkaline Phosphatase | 85 | 40 - 129 | U/L | ||||||||
| 2271 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | CHEMISTRY PANEL | ALT (SGPT) | 73 | H RX | 5 - 48 | U/L | |||||||
| 2272 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | CHEMISTRY PANEL | AST (SGOT) | 31 | 8 - 40 | U/L | ||||||||
| 2273 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | CHEMISTRY PANEL | GGT | 149 | H | 10 - 61 | U/L | |||||||
| 2274 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | CHEMISTRY PANEL | LDH | 171 | 53 - 234 | U/L | ||||||||
| 2275 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | CHEMISTRY PANEL | Urea Nitrogen | 6.0 | 1.4 - 8.6 | mmol/L | ||||||||
| 2276 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 104 | 40 - 110 | umol/L | ||||||||
| 2277 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | CHEMISTRY PANEL | Glucose Fasting | 4.9 | 3.9 - 5.6 | mmol/L | ||||||||
| 2278 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | CHEMISTRY PANEL | Serum Uric Acid | 469 | 125 - 488 | umol/L | ||||||||
| 2279 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | CHEMISTRY PANEL | Calcium (EDTA) | 2.57 | 2.07 - 2.64 | mmol/L | ||||||||
| 2280 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | CHEMISTRY PANEL | Phosphorus | 1.15 | 0.71 - 1.65 | mmol/L | ||||||||
| 2281 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | CHEMISTRY PANEL | Total Protein | 80 | 61 - 84 | g/L | ||||||||
| 2282 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | CHEMISTRY PANEL | Albumin-BCG | 50 | H | 33 - 49 | g/L | |||||||
| 2283 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | CHEMISTRY PANEL | Creatine Kinase | 138 | 39 - 308 | U/L | ||||||||
| 2284 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | CHEMISTRY PANEL | Serum Sodium | 140 | 132 - 147 | mmol/L | ||||||||
| 2285 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | CHEMISTRY PANEL | Serum Potassium | 4.5 | 3.5 - 5.2 | mmol/L | ||||||||
| 2286 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | CHEMISTRY PANEL | Serum Bicarbonate | 21.5 | 19.3 - 29.3 | mmol/L | ||||||||
| 2287 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | CHEMISTRY PANEL | Serum Chloride | 103 | 94 - 112 | mmol/L | ||||||||
| 2288 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | CREATININE CLEARANCE CC&G | CreatininClearancCockcrftGault | 2.14 | H | 1.42 - 2.08 | mL/sec | |||||||
| 2289 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | CREATININE CLEARANCE CC&G | Creatinine(Rate Blanked)-2dp | 104 | 40 - 110 | umol/L | ||||||||
| 2290 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | CREATININE CLEARANCE CC&G | Weight (kg,1dec place) | Y | 93.8 | kg | ||||||||
| 2291 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | DRUG SCREEN URINE | Amphetamines/MDMA | Neg | Neg;$Cutoff = 1000 ng/mL | |||||||||
| 2292 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | DRUG SCREEN URINE | Barbiturates | Neg | Neg;$Cutoff = 200 ng/mL | |||||||||
| 2293 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | DRUG SCREEN URINE | Cannabinoids | Neg | Neg;$Cutoff = 50 ng/mL | |||||||||
| 2294 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | DRUG SCREEN URINE | Cocaine | Neg | Neg;$Cutoff = 300 ng/mL | |||||||||
| 2295 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | DRUG SCREEN URINE | Opiates | Neg | Neg;$Cutoff = 300 ng/mL | |||||||||
| 2296 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | DRUG SCREEN URINE | Methadone | Neg | Neg;$Cutoff = 300 ng/mL | |||||||||
| 2297 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | DRUG SCREEN URINE BENZO NON-US | Benzodiazepines Gen 2 | Neg | Neg;$Cutoff = 200 ng/mL | |||||||||
| 2298 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | GFR | EGFR by MDRD | 76 | mL/min/1.73m^2$No Ref Rng | |||||||||
| 2299 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 169 | 127 - 181 | g/L | ||||||||
| 2300 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.49 | 0.39 - 0.54 | |||||||||
| 2301 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 5.4 | 4.5 - 6.4 | TI/L | ||||||||
| 2302 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||
| 2303 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 91 | 79 - 96 | fL | ||||||||
| 2304 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 4.17 | 3.8 - 10.7 | GI/L | ||||||||
| 2305 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 2.44 | 1.96 - 7.23 | GI/L | ||||||||
| 2306 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.28 | 0.91 - 4.28 | GI/L | ||||||||
| 2307 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.29 | 0.12 - 0.92 | GI/L | ||||||||
| 2308 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.10 | 0 - 0.57 | GI/L | ||||||||
| 2309 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.06 | 0 - 0.2 | GI/L | ||||||||
| 2310 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 58.4 | 40.5 - 75 | % | ||||||||
| 2311 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 30.7 | 15.4 - 48.5 | % | ||||||||
| 2312 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 6.9 | 2.6 - 10.1 | % | ||||||||
| 2313 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 2.5 | 0 - 6.8 | % | ||||||||
| 2314 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 1.4 | 0 - 2 | % | ||||||||
| 2315 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 259 | 140 - 400 | GI/L | ||||||||
| 2316 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | HEMOGLOBIN A1C | Hemoglobin A1c,Variant(-70)-QT | 4.8 | <6.5% | |||||||||
| 2317 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | 7.13 | 1.9 - 23 | uIU/mL | ||||||||
| 2318 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||
| 2319 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | IS SUBJECT OF BLACK RACE? | Subject of black race? | Y | No | |||||||||
| 2320 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | LIPID PANEL | Direct HDL-C 4th Generation | 0.96 | L | 1.03 - 1.53 | mmol/L | |||||||
| 2321 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | LIPID PANEL | Triglycerides (GPO) | 2.37 | 0.5 - 2.81 | mmol/L | ||||||||
| 2322 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | LIPID PANEL | Cholesterol (High Performance) | 5.50 | 3.31 - 6.1 | mmol/L | ||||||||
| 2323 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | LIPID PANEL | LDL Chol Friedewald 4th | 3.45 | H | 0 - 3.34 | mmol/L | |||||||
| 2324 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | RETICULOCYTES | Reticulocyte Count % | 1.0 | 0.6 - 2.5 | % | ||||||||
| 2325 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | TSH | TSH 3rd IS-QT | 2.030 | 0.45 - 5.33 | mIU/L | ||||||||
| 2326 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | URINE MACRO PANEL | Ur Specific Gravity | 1.019 | 1 - 1.04 | |||||||||
| 2327 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | URINE MACRO PANEL | Ur pH | 6.0 | 5 - 8 | |||||||||
| 2328 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | URINE MACRO PANEL | Ur Protein | Negative | Ref Rng:Negative | |||||||||
| 2329 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | URINE MACRO PANEL | Ur Glucose | Normal | Ref Rng:Normal | |||||||||
| 2330 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | URINE MACRO PANEL | Ur Ketones | Negative | Ref Rng:Negative | |||||||||
| 2331 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | URINE MACRO PANEL | Ur Bilirubin | Negative | Ref Rng:Negative | |||||||||
| 2332 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | URINE MACRO PANEL | Ur Urobilinogen | Normal | Ref Rng:Normal | |||||||||
| 2333 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | URINE MACRO PANEL | Ur Blood | Negative | Ref Rng:Negative | |||||||||
| 2334 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | URINE MACRO PANEL | Ur Nitrite | Negative | Ref Rng:Negative | |||||||||
| 2335 | CZ100110002 | 25 | years | Male | Part 1 Screening | Aug 6, 2025 9:40 AM | 6225351072 | URINE MACRO PANEL | Ur Leukocyte Esterase | Negative | Ref Rng:Negative | |||||||||
| 2336 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | C-REACTIVE PROTEIN | C Reactive Protein HS | 3.4 | 0 - 5 | mg/L | ||||||||
| 2337 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | CHEMISTRY PANEL | Total Bilirubin | 6 | 3 - 21 | umol/L | ||||||||
| 2338 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 2.4 | 0 - 6.2 | umol/L | ||||||||
| 2339 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | CHEMISTRY PANEL | Alkaline Phosphatase | 77 | 35 - 104 | U/L | ||||||||
| 2340 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | CHEMISTRY PANEL | ALT (SGPT) | 10 | 4 - 43 | U/L | ||||||||
| 2341 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | CHEMISTRY PANEL | AST (SGOT) | 12 | 8 - 40 | U/L | ||||||||
| 2342 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | CHEMISTRY PANEL | GGT | 14 | 4 - 49 | U/L | ||||||||
| 2343 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | CHEMISTRY PANEL | LDH | 127 | 53 - 234 | U/L | ||||||||
| 2344 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | CHEMISTRY PANEL | Urea Nitrogen | 6.1 | 1.4 - 8.6 | mmol/L | ||||||||
| 2345 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 65 | 31 - 101 | umol/L | ||||||||
| 2346 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | CHEMISTRY PANEL | Glucose Fasting | 4.6 | 3.9 - 5.6 | mmol/L | ||||||||
| 2347 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | CHEMISTRY PANEL | Serum Uric Acid | 273 | 125 - 428 | umol/L | ||||||||
| 2348 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | CHEMISTRY PANEL | Calcium (EDTA) | 2.35 | 2.07 - 2.64 | mmol/L | ||||||||
| 2349 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | CHEMISTRY PANEL | Phosphorus | 1.14 | 0.71 - 1.65 | mmol/L | ||||||||
| 2350 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | CHEMISTRY PANEL | Total Protein | 72 | 61 - 84 | g/L | ||||||||
| 2351 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | CHEMISTRY PANEL | Albumin-BCG | 44 | 33 - 49 | g/L | ||||||||
| 2352 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | CHEMISTRY PANEL | Creatine Kinase | 88 | 26 - 192 | U/L | ||||||||
| 2353 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | CHEMISTRY PANEL | Serum Sodium | 139 | 132 - 147 | mmol/L | ||||||||
| 2354 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | CHEMISTRY PANEL | Serum Potassium | 4.5 | 3.5 - 5.2 | mmol/L | ||||||||
| 2355 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | CHEMISTRY PANEL | Serum Bicarbonate | 21.2 | 19.3 - 29.3 | mmol/L | ||||||||
| 2356 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | CHEMISTRY PANEL | Serum Chloride | 105 | 94 - 112 | mmol/L | ||||||||
| 2357 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | CREATININE CLEARANCE CC&G | CreatininClearancCockcrftGault | 2.33 | H | 1.25 - 1.92 | mL/sec | |||||||
| 2358 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | CREATININE CLEARANCE CC&G | Creatinine(Rate Blanked)-2dp | 65 | 31 - 101 | umol/L | ||||||||
| 2359 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | CREATININE CLEARANCE CC&G | Weight (kg,1dec place) | Y | 79.2 | kg | ||||||||
| 2360 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | DRUG SCREEN URINE | Amphetamines/MDMA | Neg | Neg;$Cutoff = 1000 ng/mL | |||||||||
| 2361 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | DRUG SCREEN URINE | Barbiturates | Neg | Neg;$Cutoff = 200 ng/mL | |||||||||
| 2362 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | DRUG SCREEN URINE | Cannabinoids | Neg | Neg;$Cutoff = 50 ng/mL | |||||||||
| 2363 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | DRUG SCREEN URINE | Cocaine | Neg | Neg;$Cutoff = 300 ng/mL | |||||||||
| 2364 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | DRUG SCREEN URINE | Opiates | Neg | Neg;$Cutoff = 300 ng/mL | |||||||||
| 2365 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | DRUG SCREEN URINE | Methadone | Neg | Neg;$Cutoff = 300 ng/mL | |||||||||
| 2366 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | DRUG SCREEN URINE BENZO NON-US | Benzodiazepines Gen 2 | Neg | Neg;$Cutoff = 200 ng/mL | |||||||||
| 2367 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | FEMALE OF CHILDBEARING POT? | Female/of Childbearing pot.? | Y | Yes | |||||||||
| 2368 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | FSH | Follicle Stimulating Hormone | 3.55 | RX | Follicular:$3.90-8.80 IU/L$Midcycle:$4.50-22.50 IU/L$Luteal:$1.80-5.10 IU/L$Postmenopausal:$16.70-113.60 IU/L | ||||||||
| 2369 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | GFR | EGFR by MDRD | 92 | mL/min/1.73m^2$No Ref Rng | |||||||||
| 2370 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 128 | 116 - 164 | g/L | ||||||||
| 2371 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | Test cancelled: Beyond stability | ||||||||||
| 2372 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.5 | 4.1 - 5.6 | TI/L | ||||||||
| 2373 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||
| 2374 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | Test cancelled: Beyond stability | ||||||||||
| 2375 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 5.62 | 3.8 - 10.7 | GI/L | ||||||||
| 2376 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 3.19 | 1.96 - 7.23 | GI/L | ||||||||
| 2377 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.85 | 0.91 - 4.28 | GI/L | ||||||||
| 2378 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.34 | 0.12 - 0.92 | GI/L | ||||||||
| 2379 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.19 | 0 - 0.57 | GI/L | ||||||||
| 2380 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.05 | 0 - 0.2 | GI/L | ||||||||
| 2381 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 56.7 | 40.5 - 75 | % | ||||||||
| 2382 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 33.0 | 15.4 - 48.5 | % | ||||||||
| 2383 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 6.0 | 2.6 - 10.1 | % | ||||||||
| 2384 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 3.4 | 0 - 6.8 | % | ||||||||
| 2385 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 1.0 | 0 - 2 | % | ||||||||
| 2386 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 253 | 140 - 400 | GI/L | ||||||||
| 2387 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | HEMOGLOBIN A1C | Hemoglobin A1c,Variant(-70)-QT | 5.1 | <6.5% | |||||||||
| 2388 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | 5.61 | 1.9 - 23 | uIU/mL | ||||||||
| 2389 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||
| 2390 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | IS SUBJECT OF BLACK RACE? | Subject of black race? | Y | No | |||||||||
| 2391 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | LIPID PANEL | Direct HDL-C 4th Generation | 1.23 | 1.03 - 1.53 | mmol/L | ||||||||
| 2392 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | LIPID PANEL | Triglycerides (GPO) | 0.46 | 0.44 - 1.99 | mmol/L | ||||||||
| 2393 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | LIPID PANEL | Cholesterol (High Performance) | 3.59 | R | L | 3.65 - 6.21 | mmol/L | ||||||
| 2394 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | LIPID PANEL | LDL Chol Friedewald 4th | 2.15 | 0 - 3.34 | mmol/L | ||||||||
| 2395 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | POSTMENOPAUSAL FEMALE? | <40yrs & amenorrhea >/= 12mo | Yes | ||||||||||
| 2396 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | RETICULOCYTES | Reticulocyte Count % | 1.0 | 0.6 - 2.5 | % | ||||||||
| 2397 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | SERUM BETA HCG | B-hCG, Qualitative | Negative | Ref Rng: Negative | |||||||||
| 2398 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | SERUM BETA HCG | B-hCG, Quantitative | <0.6 | Units: mIU/mL$Pre-menopausal$<5.0: Negative$5.0-24.9:Borderline$>/= 25.0: Positive | |||||||||
| 2399 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | TSH | TSH 3rd IS-QT | 1.803 | 0.45 - 5.33 | mIU/L | ||||||||
| 2400 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | URINE MACRO PANEL | Ur Specific Gravity | 1.024 | 1 - 1.04 | |||||||||
| 2401 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | URINE MACRO PANEL | Ur pH | 5.5 | 5 - 8 | |||||||||
| 2402 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | URINE MACRO PANEL | Ur Protein | Negative | Ref Rng:Negative | |||||||||
| 2403 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | URINE MACRO PANEL | Ur Glucose | Normal | Ref Rng:Normal | |||||||||
| 2404 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | URINE MACRO PANEL | Ur Ketones | Negative | Ref Rng:Negative | |||||||||
| 2405 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | URINE MACRO PANEL | Ur Bilirubin | Negative | Ref Rng:Negative | |||||||||
| 2406 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | URINE MACRO PANEL | Ur Urobilinogen | Normal | Ref Rng:Normal | |||||||||
| 2407 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | URINE MACRO PANEL | Ur Blood | Negative | Ref Rng:$Negative-Trace | |||||||||
| 2408 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | URINE MACRO PANEL | Ur Nitrite | Negative | Ref Rng:Negative | |||||||||
| 2409 | CZ100110001 | 31 | years | Female | Part 1 Screening | Aug 3, 2025 9:05 AM | 6225351076 | URINE MACRO PANEL | Ur Leukocyte Esterase | Negative | Ref Rng:Negative |